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ABSTRACT
Atherosclerosis is a degenerative and inflammatory vascular disease characterized by the
accumulation of inflammatory cells, lipids, calcium, and formation of large fibrofatty lesions
within the intima of arteries resulting in the disorganization of the arterial wall and stenosis of
the lumen. Despite the importance of atherosclerosis in psittacine cardiology, there are few
pathologic, clinical, and experimental investigations in psittaciformes.
In order to expand the knowledge on psittacine atherosclerosis and provide fundamental
observational information for future research, a series of studies was conducted on
psittaciformes: 1) psittacine atherosclerotic lesions were characterized and categorized based on
histopathology, histochemistry, transmission (TEM), and scanning electron microscopy (SEM)
of 63 arterial samples, 2) the prevalence of clinically significant atherosclerotic lesions and the
influence of several epidemiological variables were investigated in a multi-center case-control
study on 7683 psittaciformes, 3) a diet-induced experimental model of atherosclerosis was
developed and characterized in Quaker parrots (Myiopsitta monachus), and 4) a computedtomography angiographic (CTA) protocol was developed and standardized to image the arterial
lumen in Hispaniolan Amazon parrots (Amazona ventralis).
Seven lesion types could be described in psittaciformes, which were similar to the human
classification system. Digital image analysis, TEM, and SEM helped to further describe the
lesions and refine the classification system. Atherosclerosis prevalence significantly increased
with age, female sex, and the genera Psittacus, Amazona, and Nymphicus. Mild associations with
reproductive, hepatic diseases, and myocardial fibrosis were also evidenced. Experimental
induction of atherosclerosis with dietary 1% cholesterol lead to significant lesions within 2
months in Quaker parrots. An increase in arterial and plasma cholesterol and LDL was also
documented. Reference limits for arterial luminal diameter of Hispaniolan Amazon parrots were
determined by CTA and measurements revealed high intraobserver and interobserver agreement.
In conclusion, psittacine atherosclerotic lesions displayed distinctive features that allowed the
development of an effective classification system. The prevalence of advanced lesions (type IVVI) was associated with several risk factors: age, female sex, and three psittacine genera. The
Quaker parrot was found to be a suitable experimental model for psittacine atherosclerosis and
dyslipidemia. Finally CTA was determined to be safe, reliable, and of potential diagnostic value
in parrots for diagnosing stenotic atherosclerotic lesions.
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INTRODUCTION
Atherosclerosis is the leading cause of human deaths in the world and its clinical
manifestations include coronary heart disease, ischemic stroke, and peripheral arterial
disease.(WHO 2012; WHO 2011) Likewise, atherosclerosis appears to be common in
psittaciformes maintained in captivity, leads to clinical signs, and appears to be a significant
cause of mortality in older birds.(Bavelaar, 2004a)
According to the American Veterinary Medical Association (AVMA), 10.1 million birds are
kept as pets in the United States and generate 2 million veterinary visits per year.(AVMA 2002)
Numerous parrots are also displayed in zoological collections because of their bright colors and
playful behavior. The International Union for Conservation of Nature (IUCN) reports that
psittaciformes are one of the most endangered groups of birds in the world with 28% of the
species considered threatened with extinction in their native environment.(Snyder et al. 2000) In
addition, research on African grey parrots (Psittacus erithacus) has demonstrated that parrots are
among the animals with the greatest cognitive abilities.(Pepperberg 2002) For all these reasons,
humans have a responsibility to ensure that captive parrots are provided living conditions
promoting healthy habits, long lifespans and preventing chronic medical conditions associated
with captivity. Atherosclerosis is connected to a sedentary lifestyle and improper dietary habits
in humans. Psittacine atherosclerosis is likely to share these factors, which are also commonly
encountered in captive animals.
Atherosclerotic lesions develop slowly over decades and psittaciformes have long lifespans
and varied nutrition. Despite the impact of atherosclerosis on psittaciformes health and the fact
that it appears to be one of the most prevalent diseases of aging birds, research investigations
have been scarce and only basic information is known about the disease in these species. There is
an urgent need for research to provide epidemiological and pathophysiological basis for
implementing more effective diagnostic, therapeutic, and preventative measures in avian species.
Furthermore, considering the importance of the disease in humans, research investigations on
psittacine atherosclerosis may lead to useful comparative pathologic findings.
The current knowledge of psittacine atherosclerosis is restricted to pathologic surveys, rough
prevalence estimations, and case reports. There is no standardization or homogeneity of
techniques on lesion grading that could help foster further research. The available information is
confounded by lack of consistent methodology and conflicting data: the reported prevalence
varies between 1.9 and 91.8%, authors do not agree on risk factors alternatively citing each
gender as predisposed, studies do not control for confounding factors, and much knowledge is
extrapolated from distant species with a significant taxonomy and ecological gap such as
humans. There are no diagnostic methods or screening markers that have been established as
useful and much diagnostic information is speculative. Experimental research is impaired by this
inconsistency and by the lack of animal models to test psittaciformes-specific research
hypothesis.
The goal of our work was to fill this gap of knowledge in psittacine atherosclerosis research,
so that the elementary characteristics of the disease in psittaciformes could be understood better.
We also wanted to stimulate research in this area by providing fundamental observational
information and developing an animal model. The first step in fulfilling these goals was to
thoroughly describe the psittacine atherosclerotic lesions and derive a classification system based
on pathologic and ultrastructural criteria. This classification scheme was then used to determine
the prevalence and risk factors of clinically significant atherosclerotic lesions, as surrogates of
1

atherosclerotic diseases, in one of the largest retrospective studies ever conducted on
psittaciformes. An experimental model of diet-induced atherosclerosis was then established and
characterized in Quaker parrots (Myiopsitta monachus) and the induced lesions were compared
with the spontaneous disease using the same classification system. Finally, since arterial luminal
narrowing consecutive to atherosclerosis was found to be the primary cause of clinical signs in
psittacine birds, we undertook a diagnostic imaging study in which a computed-tomography
angiographic protocol was described and standardized for use in psittacines.
Our research was driven by the following hypotheses:
-Atherosclerotic lesions have similar pathologic organization in psittacines than humans and
the classification system endorsed by the American Heart Association applies to psittacine
lesions.
-The prevalence of atherosclerosis increases with age and some psittacine species show
increased susceptibility.
-Myocardial, hepatic, and reproductive diseases are significantly associated with the presence
of advanced atherosclerotic lesions.
-Advanced atherosclerosis and dyslipidemia can be induced using dietary cholesterol in
Quaker parrots and mirror spontaneous disease in the same species.
-A CT angiographic protocol can be standardized and shows good reliability in measurements
of arterial luminal diameter, which could be used to evaluate clinical cases of atherosclerosis.
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LITERATURE REVIEW
I. Avian Cardiology
A. Anatomy and physiology of the avian cardiovascular system
i. Heart
All birds have a four-chambered heart with complete separation of the pulmonary and
systemic circulation. The major anatomical differences of the avian cardiovascular system from
its mammalian counterparts are summarized in Table 1.
Table 1: Some avian cardiovascular anatomical and physiological peculiarities which differ from
mammals. AV: atrioventricular.(Smith et al. 2000; Lumeij & Ritchie 1994; Fletcher & AbdulAziz 2008; Baumel 1993; King & McLelland 1984)
Avian cardiovascular system peculiarities
Muscular unicuspid right AV valve
No chordae tendineae in the right AV valve
Tricuspid (poorly defined) left AV valve
Muscular ring around aortic valve
Negative cardiac mean electrical axis (except broilers,
Pekin ducks)
Ring of Purkinje fibers around aorta and right AV valve
Depolarization of epicardium precedes endocardium
Higher stroke volume, arterial blood pressure, cardiac
output, lower total peripheral resistance
Larger heart proportionally
Smaller cardiac muscle fibers
Absence of T-tubules in cardiac myocytes
Absence of M-bands connecting myosin filaments
Ascending aorta on the right
Two cranial vena cava
Brachiocephalic arteries larger than aorta
Cartilage/ossification at base of aorta
Most of myocardium vascularization derived from deep
arteries
No cerebral arterial circle of Willis
Renal portal system
Birds have a much larger heart than mammals that scales to the body mass as Mheart=0.014 x
Mbird0.91. They also have proportionally a higher stroke volume, mean arterial blood pressure, and
cardiac output than mammals to enable them to meet their higher metabolic requirements. Birds
have the fastest heart rate of any animals but it can actually be lower than mammals of similar
body weight. The heart rate can increase 2 to 4 times during flight.(Smith et al. 2000; Maina
1996) It is located in the cranial thorax and lies ventrally in a concave indentation of the keel
bone, the fascies visceralis sterni pars cardiac.(Baumel 1993) The heart is partially enclosed
laterally and dorsally by the cranial part of the liver, not the lungs as in mammals, which are
3

located dorsally in birds.(Smith et al. 2000; King & McLelland 1984) The heart rests dorsally
against the bifurcation of the trachea (syrinx), the esophagus, and the horizontal septum on each
side. It is surrounded by the cervical airsacs and interclavicular airsac cranially (and ventrally
through a diverticulum that raises the pericardium in some species) and the cranial thoracic
airsacs laterally.(Nickel et al. 1977)
The heart is located in the pericardial cavity, which is delimited by the pericardium and
contains a small volume of serous fluid that acts as a lubricant during the cardiac cycle. The
pericardial cavity protrudes into the hepatoperitoneal cavities. The pericardial sac is attached to
the sternum ventrally and laterally, to the hilus of the lungs and the horizontal septum dorsally to
which it is fused, to the oblique septum laterally, and to the liver caudally by the
hepatopericardial ligament.(McLelland 1993; Smith et al. 2000; Duncker 1979) The
hepatopericardial ligament is a doubled layer sheet that is continuous to the ventral mesentery
caudally.(McLelland 1993) The fibrous layer of the pericardium is also continuous to the
adventitia of the large blood vessels cranially.(Smith et al. 2000; Nickel et al. 1977) The
pericardial sac is noncompliant.

Figure 1: Anatomical drawing of the avian heart. Right, the right ventricle is open. Sa,
subclavian artery; bt, brachiocephalic trunks; pa, pulmonary arteries; ao, aorta; ra, right atrium;
la, left atrium; rv, right ventricle; lv, left ventricle; mcv, middle cardiac vein; cvc, caudal vena
cava; raav, right atrioventricular valve; rvw, right ventricular wall; is, interventricular septum.
The avian cardiac chambers are functionally equivalent to their mammalian counterparts with
two atria and two ventricles composed of the endocardium, myocardium, and epicardium. In
some species (e.g. chickens, crows, ostriches, kiwis), a sinus venosus is present prior to the right
atrium and not fully incorporated into its wall and presents a thin sinoatrial valve composed of
two valvules. It received blood from the caudal vena cava and the right cranial vena cava and is
separated from the opening of the left cranial vena cava by the septum sinus venosi.(Baumel
1993; King & McLelland 1984) The right atrium is generally larger than the left and possesses a
tubular recess (recessus sinister atrii dextri) which extends to the left dorsally to the aortic
root.(Baumel 1993; West et al. 1981) The left and right pulmonary veins open into the left atrium
either separately or combined in a common pulmonary vein outside the heart. In the left atrium,
4

the veins coalesce in a single vessel whose opening protrudes into the left atrium (pulmonary
chamber) and is guarded by the valve of the pulmonary vein.(Baumel 1993; King & McLelland
1984) The atrial muscle is composed of muscular bundles. The atria are separated from the
ventricles externally by the coronary groove filled with fat and the main coronary arteries. They
are separated internally by fibrous rings which are well developed at the origin of the aorta,
pulmonary artery, and right atrioventricular orifice.(Nickel et al. 1977) A cardiac cartilage,
sometimes mineralized, is present in the fibrous rings around the aorta and the pulmonary
arteries.(Nickel et al. 1977) The cone-shaped left ventricle extends to the apex of the heart and its
right wall forms the interventricular septum. The right ventricle wraps around the left ventricle
(at least one half of it) forming a crescent-shaped cavity and does not reach the apex (Figure 1).
The wall of the left ventricle is about 2-3 times thicker and is able to generate 4-5 times higher
systolic pressure than the right.(Smith et al. 2000; King & McLelland 1984) The right
atrioventricular valve is unique to birds and is a triangular muscular flap formed of both atrial
and ventricular musculature (Figure 1). This valve is also connected to the roof of the right
ventricle by a muscle bundle and to the interventricular septum by a small and narrow
membrane.(Baumel 1993; Nickel et al. 1977) The mechanisms of the avian right atrioventricular
valve closure are poorly understood and is probably partially active.(Smith et al. 2000) The left
atrioventricular valve is a tricuspid valve with poorly defined cusps attached by chordae
tendinae to the three left ventricular papillary muscles.(Nickel et al. 1977; Smith et al. 2000) The
aortic valve located at the root of the ascending aorta also has three cusps and is apparent
externally by the bulbus aortae where, in contrast with mammals, a complete sphincter-like ring
of muscular tissue is present that may regulate outflow by contraction.(Baumel 1993; Smith et al.
2000) The pulmonary valve is tricuspid. Avian cardiomyocytes are smaller than their
mammalian counterparts, lack the T-tubules which are invaginations of the sarcolemma, and lack
M-band that connects myosin filaments.(Smith et al. 2000) The physiological significance of
these differences on the conduction velocity or the contractile properties of the avian
cardiomyocytes is poorly understood.
Two coronary arteries, the left and right, provide the arterial supply to the heart. Each branch
into 2 vessels (superficial and deep) near their origin. The superficial vessel is located in the
coronary groove. Most of the avian cardiac coronary vascularization is provided through the
deep rather than the superficial arteries.(Baumel 1993; Nickel et al. 1977; Smith et al. 2000;
King & McLelland 1984) The right coronary artery is the largest in most avian species and the
coronary arteries anastomose frequently.(Smith et al. 2000) Blood is returned to the right
ventricle through several cardiac veins for which the middle cardiac vein and the left circumflex
cardiac vein are the largest.
The avian cardiac conduction system is, similar to mammals, composed of a sinoatrial node,
atrioventricular node, right atrioventricular ring (specific to birds), and Purkinje fibers (bundle of
His, bundle branches). The role of the electrical system of the heart is to maintain an adequate
heart rate and coordinate contraction of each cardiac chamber. The sinoatrial node, the
pacemaker, is located between the right cranial vena cava and the caudal vena cava openings
into the right atrium.(Lumeij & Ritchie 1994; Smith et al. 2000) The atrioventricular node seems
to be located at the base of the interatrial septum and serves to transmit electrical activity from
the atria to the ventricles and delay ventricular contraction. Right and left ventricular bundle
branches composed of Purkinje fibers run the length of the interventricular septum in the
subendocardium and penetrate the myocardium along the coronary arteries. In birds, an
atrioventricular ring of Purkinje fibers is present around the right atrioventricular valve and
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around the aorta in a figure eight and connected to the atrioventricular node.(Smith et al. 2000)
The heart is innervated by both the sympathetic and parasympathetic autonomic system through
the cardiac sympathetic nerve and the vagal nerve, respectively and is controlled by
cathecholamine release. (see section on electrocardiogram for additional information on
electrophysiology)
ii. Vessels
In birds, the aorta curves to the right and derives from the right fourth aortic arch as opposed
to mammals where it comes from the left. The coronary arteries are the first to branch from the
aorta followed by the brachiocephalic trunks. These trunks supply the large flight muscles
through the subclavian arteries, therefore are larger than the ascending aorta which supplies the
rest of the body.(Smith et al. 2000; Baumel 1993; West et al. 1981) The common carotid arteries
branch from the brachiocephalic trunks as they curve to each side and supply the neck and head.
The carotid arteries do not empty distally into a cerebral arterial circle of Willis as in mammals
but have numerous intercarotid anastomosis that include the vertebral arteries.(Smith et al. 2000)
The ascending aorta supplies the trunk, visceral organs, and pelvic limbs through its successive
branches namely the coeliac, cranial renal, external iliac (also known as femoral), ischiatic,
caudal mesenteric, and internal iliac arteries for its major arterial trunks.(Baumel 1993) The
pulmonary trunk emerges from the right ventricle and divides into the left and right pulmonary
arteries.(Baumel 1993)
Structurally the arteries can be classified into the elastic arteries composed of the aortic arch,
thoracic aorta up to the coeliac artery, brachiocephalic trunks, and extrapulmonary portions of
the pulmonary arteries, and the muscular arteries comprising the remainder of the arterial
system.(West et al. 1981; Smith et al. 2000) The elastic arteries act as pressure reservoir
redistributing the pulsatile input over time by expansion and recoil.(Smith et al. 2000) These
arteries expand smoothly over a range of pressure allowed by the compliance of elastin and the
stiffness of collagen. The resilience of avian elastic arteries (ratio energy recovered/energy
needed to expand the vessel) is superior to that of mammals.(Smith et al. 2000) The arterial wall
of the elastic arteries are composed of three layers, the tunica intima which is a single-cell layer
of endothelial cells adjacent to the arterial lumen, the tunica media which is composed of
concentric layers of collagen and elastic fibers composed of smooth muscle cells and elastin, and
the tunica adventitia which is an outer layer of collagen fibers and connective tissue (Figure
2).(Smith et al. 2000; Fletcher & Abdul-Aziz 2008) The intima is separated from the media by a
poorly defined internal elastic lamina which is itself separated from the adventitia by the external
elastic lamina. Lamellar units do not entirely circumscribe the arteries.(Fletcher & Abdul-Aziz
2008; West et al. 1981) Muscular arteries have the 3 same tunica but the media is only composed
of smooth muscle cells and elastin and the adventitia is much thicker and has less compliance.
The venous system presents some peculiarities in birds with notably two cranial vena cavae
and a renal portal system. The cranial vena cava receive blood from the jugular veins and the
subclavian veins. The jugular veins anastomose at the base of the head.(Smith et al. 2000) The
renal portal system constitutes a ring ventral to the kidney with blood supplied from the gut and
pelvic region through the vertebral sinus, external iliac vein, ischiatic vein, internal iliac vein,
and caudal mesenteric vein. A valve, the renal portal valve, is present in the common iliac vein
that is open under sympathetic stimulation with blood diverting to the caudal vena cava which
increases blood return directly to the heart. The venous flow can be diverted to the hepatic portal
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system through the caudal mesenteric vein where flow at this location can be bidirectional.(West
et al. 1981)
Venous walls have the same organization than arterial walls with a tunica intima, media, and
adventitia. However, the venous walls are thinner, have less muscle tissue in the media and more
connective tissue in the adventitia. Veins are capacitance vessels and contain about 60-80% of
the total blood volume.(Smith et al. 2000)

Figure 2: Schematic representation of the microanatomy of an avian elastic artery. The media
is composed of alternate layers of elastic laminae (smooth muscle cells between 2 sheets of
elastin fibers) and collagen fibers.
The control of peripheral blood flow is achieved by contraction of the muscular fibers
modulated by a combination of autoregulatory mechanisms, action of humoral factors, and
neural control.(Smith et al. 2000)
B. Diagnostic techniques
i. Physical examination
A complete history and thorough physical examination should be performed as for any
clinical presentation. Species, age, gender, captive lifestyle and diet are thought to predispose
individuals to cardiovascular diseases. Parrots are most often diagnosed with congestive heart
failure and atherosclerosis whereas commercial poultry (e.g. broilers, turkeys) suffer from a high
rate of cardiac diseases related to selection for production (Table 10). Clinical presentation of
cardiac diseases may include dyspnea, exercise intolerance, falling off the perch, hind limb
ataxia, altered mentation, neurological signs, syncope, collapse, and sudden death. Non-specific
signs of disease are also frequently present such as lethargy, weight loss, and anorexia. Coughing
does not usually occur in birds due to an enlarged heart because the aorta curves to the right and
a cardiac enlargement does not cause bronchial compression.(Rosenthal & Miller 1997) Upon
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physical examination, findings often present with cardiovascular disease include ascites,
cyanosis or hypoperfusion [bluish or pale comb in chicken, bluish periorbital skins in some
parrot species (e.g. African grey parrots, macaws), and increased ulnar vein refilling time], and
increased dyspnea when restrained. Ascites is frequently present in cases of congestive heart
failure but is also commonly associated with other disease conditions (Table 2). Hepatomegaly
induced by liver congestion may be visible under the skin caudal to the keel in some patients.
Preoxygenation may be necessary to conduct a physical examination in severely distressed
patients.
Birds must be handled upright to prevent circulatory collapse.(Pees, Krautwald-Junghanns, et
al. 2006) The arterial pulse is difficult to palpate in birds and not practical without anesthesia, it
is typically obtained from the ulnar superficial artery at the level of the proximal inner aspect of
the wing. Cardiac auscultation, while not sensitive in birds due to their fast heart rate, can be
obtained by placing a pediatric or neonatal stethoscope over the cranial keel bone. The use of
pediatric digital stethoscope may allow the amplification and the recording of the heart sounds,
which can then be played at a slower speed for more accurate interpretation. In at least one case,
a phonocardiogram was used to characterize a cardiac murmur in a bird.(Vink-Nooteboom et al.
1998)
Table 2: Common differential diagnoses for peritoneal fluid in birds
Differential diagnoses for peritoneal fluid in birds
-Congestive heart failure
-Portal hypertension
-Advanced hepatic disease (fibrosis, amyloidosis, iron
storage disease)
-Reproductive-associated ascites (egg yolk coelomitis,
ovarian cysts, cystic right oviduct, ectopic egg)
-Blockage of lymphatic drainage
-Hypoproteinemia
-Neoplastic ascites (e.g. biliary cystadenoma, ovarian)
-Viral ascites (avian viral serositis, polyomavirus,
eastern equine encephalitis)
-Septic coelomitis (foreign body, ruptured intestine)
-Pancreatitis
-Coelomic hemorrhage
Murmurs and arrhythmias may be detected but are difficult to characterize, and the patients
may be reexamined under anesthesia. However, systolic murmurs were detected in multiple
cardiologic cases in birds.(Vink-Nooteboom et al. 1998; Mitchell et al. 2008; Evans et al. 2001;
Beehler et al. 1980; Oglesbee & Lehmkuhl 2001; Pees et al. 2001; Isaza et al. 1992) Muffled
heart sounds may indicate pericardial effusion, accumulation of fluid in the ventral hepatoperitoneal cavities, or hepatomegaly surrounding the heart. In some species (e.g.
pelecaniformes), the presence of air from the interclavicular airsac between the heart and the keel
may also muffle the heart sounds. The normal heart rate of birds is high, scales negatively with
body weight, can increase up to 4 times the resting heart rate during flight and is expected to
increase similarly during restraint (Table 3). As such, the avian normal heart rate can vary
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tremendously within an individual. Pulmonary auscultation is usually of low value to detect
pleural effusion or pulmonary edema in birds.
Table 3: Normal heart rates of birds (bpm) as a function of weight using the following
formula: resting, HR=744xW-0.209; flight, HR=1506xW-0.157. Average values are likely to reflect
the approximate range (resting-flight/restraint) of heart rates to be expected in most avian
species.(West et al. 1981)
Weight Heart rate
Heart rate
Factor
(g)
(resting) (flight/restraint) increase
25
380
909
2.4
50
329
815
2.5
100
284
731
2.6
200
245
655
2.7
300
226
615
2.7
400
213
588
2.8
500
203
568
2.8
1000
175
509
2.9
2000
152
457
3.0
ii. Blood pressure measurement
Arterial blood pressure is higher in birds than in mammals. Direct arterial blood pressure is
typically obtained by placing an arterial catheter either in the superficial ulnar artery in the
proximal inner aspect of the wing or in the deep radial artery in the distal wing. The external
carotid artery has also been used. It is then connected to a pressure transducer and measured by
an anesthetic monitor (Table 4).
Indirect blood pressure can be obtained using a Doppler transducer and a sphygmomanometer
usually placed on the wing or leg with a cuff measured at 30-40% of the limb circumference.
However it has been consistently demonstrated that values obtained with this method do not
agree with direct systolic blood pressure measurements and may therefore be of low clinical
values as a diagnostic tool.(Acierno et al. 2008; Johnston et al. 2011; Zehnder et al. 2009) Limits
of agreement were wide in a study in Hispaniolan Amazon parrots (Amazona ventralis) at -37 to
85 mmHg and -14 to 42 mmHg for wing and leg measurements, respectively. In a study on
various species of psittacines, large variation was seen in repeated indirect blood pressure
measurements with most variability attributable to individual variation and cuff
placement.(Johnston et al. 2011) However, this suggested that monitoring trends in indirect
blood pressure measurement may be useful in the same bird during a single cuff placement such
as occurring during an anesthetic event. In an experiment in red-tailed hawks (Buteo
jamaicensis), indirect blood pressure measurements were found to be in disagreement with direct
systolic blood pressure but with acceptable agreement with mean blood pressure with limits of
agreement of -9 to 13.(Zehnder et al. 2009) This suggests that accuracy of indirect techniques
may be higher in large birds. The oscillometric method of indirect blood pressure measurements
has been found unreliable in all studied birds.(Acierno et al. 2008; Zehnder et al. 2009)
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Table 4: Direct arterial blood pressure [mean, (mean ±2SD reference interval) mmHg] in
selected species of birds
Species
Amazon parrot
(isoflurane, n=8)
Amazon parrot
(isoflurane, n=16)
Pigeon
(isoflurane, n=15)
Red-tailed hawk
(conscious, n=8)
Red-tailed hawk
(sevoflurane, n=6)
Great horned owl
(conscious, n=6)
Bald eagle
(isoflurane, n=17)
Bald eagle
(sevoflurane, n=17)
Chicken
(anesthetized, n=40)
Turkey
(conscious, n=20)
Pekin duck
(anesthetized, n=72)

SAP
133 (88-177)

MAP
117 (76-158)

DAP
102 (58-146)

163 (127-199)

155 (119-191)

148 (112-184)

93 (73-113)

82 (54-110)

72 (46-98)

220 (119-331)

187 (104-271)

160 (70-2500

178 (124-232)

159 (109-209)

143 (95-191)

231.5 (157-306)

203 (146-260)

178 (128-228)

195 (165-225)

171 (142-200)

148 (120-176)

144 (116-172)

139 (111-167)

134.5 (106-163)

141 (118-163)

136 (114-158)

131 (109-153)

302 (289-315)

253 (242-264)

204 (194-214)

165 (138-192)

143 (111-174)

121 (85-157)

Ref
(Schnellbacher et
al. 2012)
(Acierno et al.
2008)
(Touzot-Jourde et
al. 2005)
(Hawkins et al.
2003)
(Zehnder et al.
2009)
(Hawkins et al.
2003)
(Joyner et al.
2008)
(Joyner et al.
2008)
(Koch et al. 1983)
(Speckmann et al
2011)
(Langille et al
1975)

In general, hypotension is defined as a systolic blood pressure lower than 90 mmHg and mean
lower than 60 mmHg.(Lichtenberger & Ko 2007) On the other hand, values for hypertension in
birds have been poorly defined and are expected to be higher than in mammals owing to their
greater blood pressure. Systolic values over 200 mmHg have been proposed as
hypertensive.(Lichtenberger & Ko 2007)
iii. Clinical pathology
Apart from assessing the general health of the avian patient, clinical pathology tests may
reveal specific changes associated with cardiovascular diseases but are of low sensitivity.
Erythrocytosis may be caused by chronic hypoxia due to persistent ventilatory-perfusion
mismatching and increased oxygen demands. Leukocytosis may occur in avian bacterial
myocarditis and valvular endocarditis cases. Cardiovascular microfilariae may be observed on
the blood smear. Blood samples from patients with severe microfilarial infestation may be
positive on canine heartworm antigenic test.(Echols et al. 2000) Arterial blood samples and
blood gas analyses may help pinpoint an oxygenation problem. Myocardial damage can lead to a
rise in CK (and cardiac CK isoenzyme) and cardiac troponin T (only 68% sequence homology
between chicken and humans which may affect diagnostic tests accuracy, BLAST analysis,
2012) or I.(Shrubsole-Cockwill et al. 2008) Electrolyte disorders (Ca, Mg, K, Na),
hypoproteinemia, and hyperuricemia can also cause arrhythmia and cardiac diseases. Bile acids
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are frequently elevated with hepatic congestion secondary to congestive heart failure. Thyroid
imbalance may contribute to heart disease but is rare in pet birds. Lipoprotein abnormalities may
also be diagnosed in conjunction with some degenerative lesions but have to be interpreted in the
context of the egg-laying cycle and pathologic elevations have been poorly characterized.
Finally, ascitic, pericardial, and effusion fluid should always be analyzed and can provide useful
information. Cardiac-induced ascitic fluid is a pure or modified transudate, with low protein and
cellular content and specific gravity. Fluid should also be submitted for culture. Blood culture
may be valuable to isolate causative agents responsible for cardiac bacterial infections and can be
performed with only 0.1-2 mL.
iv. Electrocardiography
An ECG records the cardiac electrical activity and is invaluable to investigate conduction
disorders and arrhythmias. Most avian cardiovascular diseases are accompanied by changes on
the ECG which may also provide clues about chamber enlargement.(Lumeij & Ritchie 1994)
However, cardiopathy can occur without electrocardiographic changes. The avian ECG is
typically obtained in the frontal plane by placing two front electrodes on the propatagia and one
(left) or two (earth on right) back electrodes on the knee webs using needle electrodes or flat
clips. Each lead evaluates the cardiac electrical activity on a different direction and a standard
examination classically includes 3 bipolar leads (I, II, and III) and 3 augmented unipolar leads
(aVR, aVL, aVF) (Figure 3).

Figure 3: Schematic representation of the electrical activity of the heart with depiction of lead
recordings (Einthoven’s triangle). Lead I, II, and III are bipolar leads and lead aVR, aVL, aVF
are augmented unipolar leads. Tracings represent the vectorial projection of the summation of the
electrical activity. P wave, atrial depolarization from the SA to the AV node; R wave,
depolarization at the apex of the left ventricle; S wave, ventricular depolarization.
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A proper ECG recording is easier to obtain on anesthetized birds as few will tolerate the
procedure awake or movement and muscle tremors may impair the recordings.(Oglesbee et al.
2001) However, ECG tracings on awake birds can still be obtained on pigeons, some raptors, and
lethargic birds. Recordings need to be performed at a speed of 50-100 mm/s with 100 mm/s
being optimal to better assess QRS complexes morphology. Electrocardiographic measurements
are typically performed on lead II tracings. Electrical current from heating devices and anesthetic
equipment can interfere with ECG tracings and electrical filters from ECG machines may be
used. The significance of the different parts of an ECG complex during the cardiac cycle is
explained on Table 5 and Figure 3.
The normal avian ECG is usually composed of P, S, T, and a small R wave. The Q wave is
usually missing and a Ta wave is present in certain birds. The QRS complexes are mainly of the
(Q)rS types on lead II meaning the S wave is the most prominent. This contrasts with mammals
where the QRS complexes are most often of the qRs type. Interpretation of the ECG obeys to the
same rules as in mammals, should be methodical, and include determination of the heart rate,
heart rhythm, mean electrical axis (MEA), and measurements.(Lumeij & Ritchie 1994)
Table 5: Significance of the different sections of an ECG during one cardiac cycle, sections
are in order of appearance.
ECG segment Electrophysiologic meaning
P wave
Depolarization of atria, conduction from SA to AV nodes
F waves
Absent in normal birds
Baseline undulations occurring in atrial fibrillation
Ta wave
Present in pigeons, some poultry species
Repolarization of atria
PR interval
P wave + delayed conduction at AV node
QRS complex Ventricular depolarization
Q wave absent in most birds. Most birds have (Q)rS
complexes on lead II
R’ wave
Absent in normal birds
Observed in bundle branch block
QT interval
Corresponds to length of ventricular contraction
ST segment
Period between end of ventricular depolarization and
beginning of ventricular repolarization
T wave
Repolarization of the ventricles
U wave
Absent in normal birds
Repolarization of papillary muscles or repolarization of
conducting system
In contrast to mammals, the cardiac mean electrical axis is negative in birds with a prominent
S wave, which gives negative QRS complexes on lead II. This is caused by transmission of the
depolarization from subepicardial to endocardial.(Lumeij & Ritchie 1994) However, some
poultry breeds have a positive MEA and QRS complexes such as broilers and Pekin ducks. The
MEA is affected by changes in heart position and relative dilation of cardiac chambers. The
MEA can be calculated using the vector method, the isoelectric method, or the largest net
deflection method. The isoelectric method is the most practical and consists of identifying the
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lead closest to isoelectricity (summation of waves without P and T=0 mmV), the MEA lies along
and has the polarity of the perpendicular lead (Figure 4). Changes in ventricular MEA are due to
changes in cardiac shape and position and are typically associated with right ventricular
enlargement and left ventricular hypertrophy.(Lumeij & Ritchie 1994)

Figure 4: Determination of the ventricular mean electrical axis using the isoelectric method
and the Bailey’s hexaxial system. Example on a tracing where the ventricular depolarization is
isoelectric in lead I and negative in the orthogonal aVF lead resulting in a MEA of -90º.
Usually, measurements include P amplitude and duration, PR interval, S amplitude, QRS
duration, ST segment, T amplitude, QT interval, and MEA (Figure 5). The shape of the P wave
may indicate left atrial hypertrophy (wide), right atrial hypertrophy (tall), or biatrial (wide and
tall). However, the sensitivity and specificity of these ECG criteria are low. Each P wave should
precede and be related to a QRS complex. Increase in the PR interval indicates an increased
delay in electrical conduction at the AV node (AV block). Morphologic alteration of the QRS
complexes may indicate left ventricular hypertrophy (increased S amplitude or QRS complex
duration) or right ventricular hypertrophy (prominent R wave). The T wave is usually positive in
birds in lead II and a change in polarity indicates myocardial hypoxia.(Lumeij & Ritchie 1994)
In high heart rates, generally over 300-500 bpm, P and T waves may be fused (atria depolarized
before ventricles are completely repolarized) and the P wave not discernible.(Sturkie 1976;
Zandvliet 2005) This P on T phenomenon also seems to be a normal finding in Amazon and
African grey parrots.(Zandvliet 2005; Nap et al. 1992) ST segment elevation is common in
healthy birds and does not indicate cardiac diseases as in mammals.(Lumeij & Ritchie 1994;
Oglesbee et al. 2001) ST slurring is common, in which the ST segment is short or absent or the S
wave is merged with the T wave.(Lumeij & Ritchie 1994; Zandvliet 2005) Accounting for these
electrophysiologic specificities of birds, the interpretation of the avian ECG is similar to that of
mammals.
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Figure 5: Typical avian ECG complex with depiction of the different measurement
landmarks.
Reference intervals have been published for several species (Table 6). Anesthesia is suspected
to affect only the ECG measurements of heart rate, QT interval, and the frequency of
arrhythmias (AV blocks).(Nap et al. 1992; Joyner et al. 2008; Aguilar et al. 1995)
Table 6: ECG measurements reference values on lead II in selected avian species (amplitude
in mV, duration in s)(Nap et al. 1992; Lumeij & Stokhof 1985; Oglesbee et al. 2001; Burtnick &
Degernes 1993; Cinar et al. 1996; Sturkie 1976)
Note: to obtain a 95% interval, all published results in the form of mean±SD were reported as
mean±2SD and in the form of mean±sem were reported as mean±2sem√n, when only the range
was published, it was reported as is. N=number of birds examined.
Racing Amazon
pigeon parrot
N
60
37
Heart rate 160- 340-600
300
P-wave
0.4-0.6
0.25amplitude
0.60
P
0.015- 0.008duration
0.020
0.017
PR
0.045- 0.042interval
0.070
0.055
S-wave
1.5-2.8 0.7-2.3
amplitude
QRS
0.013- 0.010duration
0.016
0.015
T
0.3-0.8 0.3-0.8
amplitude
QT
0.060- 0.050interval
0.075
0.095
MEA
-83 to
-90 to
-99
-107
Species

Grey
RT
Bald Pekin
Macaw Cockatoo
Chicken
parrot
hawk eagle duck
45
41
31
11
20
50
72
340255259-575
8050200- 180-340
600
555
220
160
360
0.250.03- 0.13-0.53 -0.1- 0.0500.55
0.47
0.175 0.325
0.012- 0.0090.0090.020- 0.030- 0.015- 0.0350.018 0.021
0.025
0.035 0.060 0.035
0.043
0.040- 0.0400.0390.050- 0.070- 0.040.0730.055 0.068
0.071
0.090 0.110
0.08
0.089
0.90.27- 0.27-1.59 0.300- 0.150- 0.35- 0.10-1.0
2.2
1.43
0.900 1.450
1.03
0.010- 0.0020.0140.020- 0.020- 0.0280.020.016 0.030
0.026
0.030 0.040 0.044
0.028
0.180.12- 0.17-0.97 0.000- 0.050- 0.040.030.6
0.80
0.300 0.200
0.40
0.28
0.048- 0.0530.0650.080- 0.110- 0.080.080 0.109
0.125
0.165 0.165
0.12
-79 to -76 to
-73 to
-50 to -30 to -160
-91 to
-103
-87
-89
-110
-150
to 95
-120
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v. Radiography
While radiologic examination is of low sensitivity for cardiovascular diseases, severe cardiac
enlargement and vascular mineralization may be detected.(Pees, Krautwald-Junghanns, et al.
2006; Mans & Brown 2007) Other changes that frequently accompany cardiovascular radiologic
signs include loss of coelomic contrast and airsac space due to ascites and hepatomegaly due to
hepatic congestion. Several ratios have been determined but the most practical is the heart width
to thoracic width ratio on the ventrodorsal view because these two measurements are highly
correlated in birds (Figure 6). In medium sized psittacine birds, this ratio is 51-61%.(Straub et al.
2002; Pees, Krautwald-Junghanns, et al. 2006) In Harris’ hawks, this ratio was found to have
similar values.(Barbon et al. 2010) This ratio may also vary up to 10% based on the respiratory
phase.(Lumeij et al. 2011) In falcons, this ratio is considerably greater with an upper limit of
70%.(Barbon et al. 2010; Lumeij et al. 2011)

Figure 6: Left, heart width and thoracic width landmarks in a macaw (Ara spp.). Right, heart
width and sternal width landmarks in a peregrine falcon (Falco peregrinus).
Rather than using a simple and similar ratio for all individuals, regression-based reference
intervals for cardiac radiographic sizes have been determined in peregrine falcons (Falco
peregrinus), red-tailed hawks (Buteo jamaicensis), screech owls (Otus asio), and Canada geese
(Branta canadensis).(Hanley et al. 1997; Lumeij et al. 2011) With this approach, a predictive
reference interval is calculated using established regression equations based on either the
thoracic or the sternal width on ventrodorsal views and compared with the measured value of the
patient (Table 7). The sternal width should be measured at the same level as the heart width,
however the sternal landmarks may be obscured by an enlarged heart or fluids in diseased birds
(Figure 6). In peregrine falcons, the sternal width on the ventrodorsal view was found to be a
better predictor of the heart width than the thoracic width and the sternal and thoracic width were
found to be collinear (thus could not be incorporated into the same equation).(Lumeij et al. 2011)
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Table 7: Regression-based equations for reference heart width (in cm) in selected avian
species.(Hanley et al. 1997; Lumeij et al. 2011)
HW, heart width; SW, sternal width; TW, thoracic width. The higher the R-square, the better
the precision of the reference limits. These equations are for the 95% confidence interval of the
fitted value, the 95% confidence interval of the predictive value is slightly wider but predictive
equations are not practical.
Species
N Regression equation
R-square
Peregrine falcon 60 HW=0.83×SW+0.37±0.16
0.68
HW=0.41×TW+1.27±0.18
0.33
Red-tailed hawk 50 HW=0.42×SW+0.20×TW+3.42±2.02
0.50
Screech owl
50 HW=0.36×SW+0.13×TW+7.03±1.40
0.36
Canada goose
50 HW=0.27×SW+0.21×TW+15.15±5.00
0.27
vi. Echocardiography
Echocardiography is undoubtedly the single most useful diagnostic tool in avian cardiology
and its clinical application and value have been documented in multiple case reports in various
species.(Vink-Nooteboom et al. 1998; Pees et al. 2001; Straub et al. 2003; Phalen et al. 1996;
Pees, Schmidt, et al. 2006; Oglesbee & Lehmkuhl 2001; Mitchell et al. 2008; ShrubsoleCockwill et al. 2008; Mans & Brown 2007; Sedacca et al. 2009; Evans et al. 2001)
Echocardiography can detect changes in chamber dimensions, valvular lesions and insufficiency,
pericardial diseases, cardiac masses, pulmonary arterial hypertension, wall motion disorders,
septal defects and diastolic disorders.
However, cardiac ultrasound examination presents some major limitations in birds due to the
location of the heart in an indentation of the keel and the surrounding airsacs (see anatomy
section). Therefore, available acoustic windows and cardiac views are limited. Two standardized
approaches have been described for transcoelomic examination: a ventromedian and a
parasternal approach.(Pees et al. 2004; Pees & Krautwald-Junghanns 2005; KrautwaldJunghanns et al. 1995; Pees, Krautwald-Junghanns, et al. 2006) A high frequency transducer
with a small contact surface and high frame rate are recommended. The use of alcohol should be
limited in anesthetized birds to prevent hypothermia. The ventromedian approach consists of
placing the probe caudal to the keel and imaging the heart cranially using the liver as an acoustic
window to avoid airsacs laterally and the keel ventrally (Figure 7). This approach is used most
often in psittacines and raptors. It can be performed on the bird awake or anesthetized. Birds
should be fasted to limit interference with the gastrointestinal tract. Simultaneous ECG can be
performed to better interpret images in relation to the cardiac cycle but is not essential.
Only two views can classically be obtained through this approach: the horizontal fourchamber view and the vertical two-chamber view by rotating the probe by 90 degrees (Figure 8).
All views are longitudinal (long axis) and cardiac transverse views (short axis) and M-mode
echocardiography, which has better temporal resolution, cannot be performed in birds by the
transcoelomic approach. This precludes the establishment of the same echocardiographic
standards in birds as in small animal cardiology.(Thomas et al. 1993) Therefore the amount of
information gathered from the transcoelomic echocardiographic examinations is much limited in
birds and all morphometric and functional measurements have to be performed on twodimensional images (B-mode). Measurements on several cardiac cycles should be averaged to
obtain representative values. Reference intervals have been published for ventricular and atrial
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dimensions and fractional shortening [(diastole-systole)/diastole %] in several avian species
(Table 8).(Pees et al. 2004; Krautwald-Junghanns et al. 1995; Pees, Krautwald-Junghanns, et al.
2006) Transcoelomic echocardiography is also thought to underestimate the true fractional
shortening of the highly efficient avian heart.(Beaufrere et al. 2012) Right ventricular
measurements are rarely taken in mammals due to its complex three-dimensional
configuration.(Bélanger 2005) Furthermore, recent evidence suggest that taking
echocardiographic measurements may not be clinically useful considering the avian heart size,
heart rate, current equipment resolution and that observers can add up to 30%
variability.(Beaufrere et al. 2012)

Figure 7: Schematic representation of the ventromedian echocardiographic approach in an
Amazon parrot. The bird is oriented cranio-caudally and dorso-ventrally. The heart is imaged
through the liver. It can easily be inferred from this diagram that a filled gastrointestinal tract
may interfere with the acoustic window.
In most dogs and cats, a good impression of cardiac chamber size and function can be
achieved without making any quantitative measurements.(Boon 2011) Likewise, an adequate
morphologic and functional assessment of the avian heart can be performed qualitatively during
the echocardiographic examination. Nevertheless, pathologic changes imaged in birds are usually
severe when cardiac disease is present with drastic chambers dilation (commonly the right heart),
pericardial effusion, ascites, and poor contractility, which do not require measurements for
confirmation. If measurements are obtained for follow up evaluation, it is recommended that the
same echocardiographer and equipment are used and changes in measurements should be larger
than 20% to be considered genuine. Left ventricular measurements seem to be more reliable
overall.(Beaufrere et al. 2012)
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Figure 8: Horizontal four-chamber view and vertical two-chamber view in birds as classically
obtained through the ventromedian approach.
Color Doppler echocardiography can be used for detection of turbulence and reflux indicative
of valvular insufficiency with right atrioventricular insufficiency being most commonly imaged.
Spectral Doppler echocardiography can be used to measure inflow and outflow velocities and
reference intervals have been published in a few species (Table 9).(Pees, Krautwald-Junghanns,
et al. 2006; Straub et al. 2004; Pees et al. 2004; Straub et al. 2003) Fortunately,
echocardiographic examinations are easier and more rewarding in birds with cardiac disease
because the ascitic fluid, pericardial effusion, hepatomegaly, and cardiac enlargement greatly
improve acoustic windows and facilitate the procedure.
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Table 8: Echocardiographic reference intervals (mm) in selected avian species obtained in the
horizontal four-chamber view.(Pees et al. 2004; Boskovic et al. 1995; Pees, KrautwaldJunghanns, et al. 2006)
Note: to obtain a 95% interval, all published results in the form of mean±SD were reported as
mean±2SD, N=number of birds examined, FS=Fractional shortening. Echocardiographic
measurements may not be reliable and clinically useful. *European diurnal raptors included
common buzzard, European sparrowhawk, northern goshawk, and black kite.
Parameter
N
Left ventricle
Systole length
Systole width
Diastole length
Diastole width
FS (%)
Right ventricle
Systole length
Systole width
Diastole length
Diastole width
FS (%)
Aorta
Systole diameter
Diastole diameter

African grey Amazon
parrots
parrots
60
10

Cockatoos

Diurnal
raptors*
100

Pigeons
(parasternal)
50

18.4-26
4.8-8.8
20.2-27.8
6.6-10.6
13.8-31.4

16.5-25.7
4.3-9.1
17.7-26.5
6.4-10.4
14.4-31.2

16.4-21.6
3.0-9.8
16.7-23.1
5.3-11.3
11.6-39.6

9.1-20.3
4.1-8.5
11.0-21.8
5.3-10.1

15.9-19.9
4.4-6.0
17.3-22.9
6.2-8.6

6.4-12.0
1.0-4.6
7.7-15.3
2.6-7.0
17.0-64.6

5.8-13.0
1.7-4.5
7.7-12.9
2.6-7.8
26.7-41.5

7.9-12.7
7.9-12.7
6.7-15.9
2.5-4.5
12.7-53.9

7.3-18.1
0.9-3.3
8.9-18.9
0.9-4.1

8.3-11.5
3.0-5.0

2.8-4.4
2.8-5.2

2.0-4.0
2.2-4.6

2.0-3.6

2.8-3.2
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Table 9: Spectral Doppler echocardiographic reference intervals (m/s) in selected avian
species obtained in the horizontal four-chamber view.(Pees, Krautwald-Junghanns, et al. 2006;
Straub et al. 2004; Straub 2003)
Note: to obtain a 95% interval, all published results in the form of mean±SD were reported as
mean±2SD, N=number of birds examined. Parrots were anesthetized, raptors were awake.
Species

N

Amazon parrots
Cockatoos
African grey parrots
Macaws
Harris’ hawks
Falcons
Common buzzard
Barn owls

10
15
10
10

Left diastolic
inflow
0.12-.24
0.02-0.62
0.27-0.51
0.40-0.68
0.13-0.25
0.18-0.38
0.16-0.28
0.14-0.26

Right diastolic Aortic systolic
inflow
outflow
0.12-0.32
0.67-0.99
0.40-1.16
0.63-1.15
0.55-1.07
0.15-0.27
0.75-1.43
0.17-0.37
1.07-1.43
0.13-0.25
1.04-1.68
0.10-0.34
0.84-1.32

The parasternal approach consists of placing the probe laterally (typically on the right to avoid
the ventriculus) behind the ribs and above the sternum and imaging the heart cranio19

medially.(Krautwald-Junghanns et al. 1995; Pees, Krautwald-Junghanns, et al. 2006) This
approach can be performed on pigeons, some raptors, and is the preferred choice when
examining gallinaceous birds (especially younger chicken). In these birds, the limited caudal
extension of the ribs and the larger fenestration of the keel allow a lateral approach to the heart.
Typically, more imaging planes can be obtained and transverse views have been described in
pigeons and chickens.(Krautwald-Junghanns et al. 1995; Martinez-Lemus et al. 1998)
A transesophageal echocardiographic protocol has been implemented in several species of
birds in an attempt to alleviate the limitations associated with the transcoelomic approach. With
this technique, a transesophageal ultrasonographic probe is inserted into the upper digestive
system with the bird under general anesthesia and the heart is imaged from inside the
proventriculus.(Beaufrere et al. 2010) Better resolution imaging and details of cardiac structures
are typically obtained with 3 positions of the probe (cranial, middle, caudal) giving 5 consistent
echocardiographic views. Furthermore, transverse views and M-mode imaging are possible
through the transesophageal approach. However, the equipment is expensive, not widely
available, the bird must be anesthetized, and the procedure cannot be performed in small
psittacine birds because of a narrow entrance to the thoracic inlet.(Beaufrere et al. 2010) The
procedure has been used to diagnose and monitor a case of dilated cardiomyopathy in a Harris’
hawk at the Louisiana State University School of Veterinary Medicine.
vii. Advanced cross-sectional imaging
Computed tomography and magnetic resonance imaging are seldom used to image the avian
heart as scans cannot be gated to the fast cardiac cycle in birds to reduce motion artifacts and
improve diagnostic value. However computed tomography can be used to image the arteries and
can readily diagnose cardiomegaly, venous congestion, and edema.
viii. Angiography
Angiography can be achieved on avian patients through the use of fluoroscopy or computed
tomography. The circulation of intravenous contrast agents in birds is extremely fast and image
acquisition should be performed during injection or shortly thereafter. The use of angiography in
birds has recently been reviewed.(Beaufrère et al. 2010)
Fluoroscopic angiography can visualize the heart and vascular tree in real time. Under general
anesthesia, the bird is initially positioned in left lateral recumbency on a fluoroscopy table. A
bolus of nonionic iodinated contrast agent (2 mL/kg IV; iohexol 240 mg/mL; Omnipaque, GE
Healthcare Inc, Princeton, NJ, USA) is injected, at a rate of 1–2 mL/kg per second, through a
catheter inserted into the basilic or medial metatarsal vein during video acquisition at a rate of 30
frames/s for the best resolution. The same bolus is repeated to obtain the ventrodorsal view with
the bird placed in dorsal recumbency. The brachiocephalic trunks, aorta, pulmonary arteries,
pulmonary veins, and caudal vena cava can be observed. The brachiocephalic trunks and aorta
can be seen pulsating with the heartbeats. Marked lumen changes are noted during the cardiac
cycle. The procedure is easy, inexpensive, and can be recorded for further analysis and
measurements. For measurement, to account for different degrees of magnification, a calibrated
marker should be kept in the field during fluoroscopic acquisition but fluoroscopic angiography
is likely more useful for qualitative assessment and investigation of aneurysm and stenosis.
Digital subtraction angiography is a fluoroscopic technique used in interventional radiology to
clearly visualize blood vessels in a dense soft tissue or bone environment. Images are produced
by subtracting a pre-contrast image from later images once the contrast medium has been
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introduced into the vascular system, which results in visualizing only the contrast-filled vessels,
without the background. It considerably increases the outlines of the arteries and the detection of
smaller arteries not seen with conventional angiography, specifically for extremities, such as
legs, wings, and the head, however the images tend to be easily degraded by small motions and
noise (Figure 9). A preliminary, nonenhanced fluoroscopic image is recorded before
administering a bolus of contrast medium and is digitally subtracted during the angiography
procedure. The same bolus technique and a similar dose of contrast medium as used for regular
fluoroscopic angiography are required for digital subtraction angiography, except that this option
is selected in the machine. Reports of angiography applications are still limited in birds. A
coronary aneurysm was diagnosed with angiography in an umbrella cockatoo.(Vink-Nooteboom
et al. 1998) Angiocardiography has also been used clinically in a racing pigeon, 2 blue and gold
macaws (Ara ararauna), and a whooper swan (Cygnus cygnus).(Lumeij & Ritchie 1994; Phalen
et al. 1996)

Figure 9: Digital subtraction angiography on the wing of a barred owl (Strix varia), ventral
view. 1, brachial artery; 2, deep radial artery; 3, superficial ulnar artery.
A CT examination provides an excellent assessment of all major arteries and their anatomy in
psittacines and raptors.(Krautwald-junghanns et al. 2008) The addition of contrast media greatly
enhances the visualization of the arteries and veins and their lumen but a standardized protocol
has yet to be established. In particular, the optimal timing of the scan in respect to the
intravenous injection of contrast, and the reliability of measurement in different window and
level presets have not been evaluated. It is expected that CT angiography will be a valuable
diagnostic tool for avian vascular diseases due to its three-dimensional resolution and
reconstruction capabilities.
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ix. Coelioscopy
Coelioscopy allows direct visualization of the heart and major arteries through the standard
lateral approaches with the endoscope located in the cranial thoracic airsacs, the interclavicular
approach with the endoscope located in the interclavicular airsac, and the ventral midline
approach with the endoscope located in the ventral hepato-peritoneal cavities.(Taylor 1994;
Beaufrère et al. 2010) Endoscopy can only detect gross, color, and structural changes to the
cardiovascular system such as cardiomegaly, pericardial effusion, pericardial exudate, arterial
discoloration, and the presence of granulomas in the area. Pericardial biopsy and
pericardiocentesis can be performed via endoscopy. The midline approach is recommended for
pericardiocentesis to reduce the possibility of fluid leakage into the airsacs. An endoscopic
needle is used with its sheath and should only protrude from the sheath by 1-2mm to prevent
puncturing the heart during the procedure. Pericardial fluids should be analyzed.
C. Cardiovascular diseases of birds (other than atherosclerosis)
i. Prevalence of cardiovascular disease in birds
Overall, cardiac diseases are only common in poultry and companion psittacine birds (Tables
10 and 11). In other avian groups, cardiac disease appears to be a relatively rare occurrence but
several disease entities have been documented (Table 11). In large pathologic reviews of birds of
prey, primary cardiac diseases were not or rarely reported except for atherosclerosis.(Griner
1983; Cooper & Pomerance 1982; Naldo & Samour 2004)
Table 10: Prevalence (%) of selected cardiovascular diseases / lesions in psittaciformes (other
than atherosclerosis)
Oglesbee, 1998
KrautwaldGriner, 1983 Kellin, 2009
(n=269)
Junghanns, 2004
(n=1322)
(n=1298)
(n=107)
Cardiac disease
9.7
36
5.5
5.2
Congestive heart failure
5.6
Pericardial effusion
1
6
Fibrinous pericarditis
15
Ascites
1.5
2
Table 11: Some commonly reported cardiovascular diseases / lesions by species (other than
atherosclerosis).(Griner 1983; Oglesbee & Oglesbee 1998; Lumeij & Ritchie 1994)
Species
Psittacines
Ducks, geese, swans
Chickens, turkeys
Ostriches
Birds of prey
Mynahs

Common cardiovascular diseases
Congestive heart failure
Vascular nematodiasis (schistosomes, filarioids)
Ascites syndrome, cardiomyopathies, infectious, aortic rupture
Aortic rupture
Viral myocarditis (West Nile virus)
Dilated cardiomyopathy
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ii. Congestive heart failure
1. Pathophysiology of avian heart failure
Congestive heart failure is not a disease in itself but is the ultimate consequence of disease
processes that affect parts of the avian cardiovascular and pulmonary systems (Table 12).
Congestive heart failure occurs when the volume of blood presented to the heart is in excess of
what can be pumped into the arterial system with ensuring organ congestion and decreased
cardiac output. Heart failures can be due to abnormalities in the cardiac conduction system,
valvular system, cardiac muscle, blood shunting, infection, impaired systolic and diastolic
function, and to inadequate preload and afterload. All heart diseases do not necessarily lead to
congestive heart failure but this condition is a frequent clinical end-point.
Table 12: Documented causes of congestive heart failure in birds
Causes
Valvular insufficiency
Valvular stenosis
Septal defects
Ischemic cardiomyopathy
Dilated cardiomyopathy
Hypertrophic
cardiomyopathy
Arrhythmias
Nutritional causes
Pericardial effusion
Iron storage disease
Pulmonary
arterial
hypertension
Pulmonary
fibrosis/aspergillosis
Cardiac infection
Toxic causes
Atherosclerosis

References
(Oglesbee et al. 2001; Pees et al. 2001; Beehler et al. 1980; Ensley
et al. 1979; K. Rosenthal et al. 1993)
(Mitchell et al. 2008)
(Evans et al. 2001; Bailey et al. 2001; Schmidt et al. 2003; Harari et
al. 1983; Risi et al. 2011)
(Shrubsole-Cockwill et al. 2008)
(Knafo et al. 2011; Julian 1998; Risi et al. 2011; Crespo et al. 2008)
(Pees et al. 2009; Schmidt et al. 2003; Oglesbee et al. 1998)
(Olkowski & Classen 1998)
(Lumeij et al. 1994; Crespo et al. 2008)
(Straub et al. 2003; Balamurugan et al. 2004)
(Ensley et al. 1979; Morris et al. 1989)
(Sedacca et al. 2009; Currie 1999)
(Zandvliet et al. 2001; Oglesbee et al.1998)
(Lumeij et al. 1994; Schmidt et al. 2003; Isaza et al. 1992; Jessup
1980)
(Burger et al. 1994; Fulton 2008; Czarnecki 1986)
(Mans et al. 2007; Phalen et al. 1996; Sedacca et al. 2009;
Shrubsole-Cockwill et al. 2008; Vink-Nooteboom et al. 1998)

Since birds possess similar neuroendocrine regulation of the cardiovascular system as
mammals, the general pathophysiology of congestive heart failure is expected to be
analogous.(Smith et al. 2000) One difference is that in birds, right congestive heart failure is
more common than left which is suspected to be related to the particular anatomy of the right
atrioventricular valve.(Julian 2002; Oglesbee & Oglesbee 1998) In addition, the pathophysiology
of avian heart failure has been well studied in the prevalent chicken ascites syndrome but this
disease is mainly related to production and rapid growth so not all findings may translate well to
companion avian patients.(Julian 1993; Olkowski 2007; Currie 1999) In chicken ascites
syndrome, the increased workload of the heart and oxygen demand brought about by fast
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growing is coupled with an overall insufficient pulmonary capillary capacity and decreased
respiratory efficiency in chickens compared to other birds. The cumulative effects of these
conditions quickly leads to pulmonary hypertension which in turns leads to right ventricular
hypertrophy and ultimately to dilation. Erythrocytosis also occurs which renders the blood more
viscous thereby further increasing the cardiac workload. With the dilatory changes affecting the
right ventricle, the right atrioventricular valve, which extends from its wall, develops
insufficiency, which in turn increases the preload leading to systemic congestion and ascites by
increased hydrostatic pressure (Figure 10). In the turkey spontaneous dilated cardiomyopathy,
abnormal troponin T structure, and dysregulation of some cardiac enzymatic pathways may
participate in the pathogenesis.(Crespo & Shivaprasad 2008; Biesiadecki & Jin 2002)

Figure 10: Ascites syndrome in a broiler chicken (Courtesy of Dr. John Barnes, North
Carolina State University)
The decrease in cardiac output and blood pressure is detected by chemoreceptors,
baroreceptors, cardiac mechanoreceptors, and the renal juxtaglomerular complex. Then, several
compensatory measures similar to those induced by blood loss and dehydration take place, which
may be counterproductive in the long-term in congestive heart failure cases.(Sisson 2010)
Sympathetic tone increases causing an increase in heart rate, contractility, vasomotor tone,
activation of the renin-angiotensin-aldosterone system (RAAS), and stimulation of the release of
arginine vasopressin (arginine vasotocin in birds).(Sisson 2010) Renin released from the
juxtaglomerular complex under stimuli such as hypotension, hypovolemia, decreased plasma
sodium, and catecholamines accelerates the conversion of circulating angiotensinogen into
angiotensin I which is itself converted into angiotensin II by the angiotensin-converting
enzyme.(Sisson 2010) Angiotensin II promotes drinking, vasomotor tone, and the production of
aldosterone (to a lesser extent than in mammals) which causes water and sodium
retention.(Smith et al. 2000) Aldosterone is also a mediator of inflammation and fibrosis. (Sisson
2010) Most clinical signs are the results of these compensatory mechanisms to restore and
maintain cardiac output and blood pressure associated with an increase in preload and afterload.
Furthermore the heart undergoes some changes (cardiac remodeling) in response to the
hemodynamic challenges (pressure or volume overload) such as dilation and hypertrophy.(Sisson
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2010) The increased preload leads to edema and effusion with the increased afterload further
impairing cardiac output.
2. Clinical findings
Low cardiac output and limited cardiovascular adaptive abilities in response to exercise can
cause exercise intolerance, syncope, tachycardia, cyanosis, decreased peripheral perfusion and
arrhythmias. Since right heart failure is more common in birds, signs of fluid retention from the
systemic circulation usually prevail and include ascites, hepatomegaly, pericardial effusion,
jugular distension, and dyspnea from airsac compression. Pulmonary edema and congestion are
associated with left heart failure.(Oglesbee & Oglesbee 1998) However, any cardiologic sign can
be encountered in bilateral congestive heart failure. Pleural effusion is possible in birds but, if
present, does not cause dyspnea. Fluid analysis will reveal either a pure or modified transudate.
A moderate increase in bile acids due to hepatic congestion is common.
Electrocardiographic findings may include MEA deviations (usually right deviation),
tachycardia, widened or tall P wave, atrial fibrillation, widened QRS complex, prominent R
wave, widening of QT interval, and AV blocks.(Lumeij & Ritchie 1994; Olkowski et al. 1997)
These changes are associated with delayed electrical conduction and chamber enlargement.
Radiographs usually show a cardiomegaly with ascites and loss of abdominal airspace and
details (Figure 11). The axillary diverticula of the interclavicular airsac may appear hyperinflated
from volume compensation of the airsac system and severe dyspnea.

Figure 11: African grey parrot diagnosed with congestive heart failure. Radiographic findings
include cardiomegaly (heart width to thoracic width ratio=71%), ascites, loss of abdominal
details and airspace, hyperinflation of axillary diverticula.
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Echocardiography is the definitive tool to diagnose congestive heart failure and ascites. Some
degrees of pericardial effusion, right heart dilation and hepatic congestion are usually observed,
along with valvular regurgitation and poor contractility (Figure 12). Angiocardiography will
demonstrate an enlarged heart but is seldom indicated when considering other more practical
imaging modalities.

Figure 12: Four chamber horizontal view echocardiography in an African grey parrot with
congestive heart failure. RV, right ventricle; LV, left ventricle; RA, right atrium; arrow,
pericardial effusion
iii. Arrhythmias
Alterations of the ECG are common but do not always correlate with clinical signs and are
rarely primary disease processes in birds. Arrhythmias can be classified into excitability
disturbances and conduction disturbances. Reported arrhythmias in birds are summarized in
Table 13.
Excitability disturbances have various causes and are common with dilated cardiac chambers
and organic diseases. Atrioventricular blocks are associated with disrupted conduction between
the sinoatrial and atrioventricular node where the conduction can be delayed (first degree), fail to
propagate to the AV node (second degree), or be independent from the AV node (third degree)
during which, an atrioventricular escape rhythm can occur. Second degree AV block may be
characterized as Mobitz type 1 (PR progressively lengthening prior to block) usually caused by
excessive vagal tone and atropine responsive and Mobitz type 2 (constant PR) often initiated by
diseases of the His bundle and is non-responsive to atropine. Atrioventricular blocks are
normally found in certain avian species and may occur with some frequency during anesthetic
events. However, a drop in blood pressure or clinical signs associated with AV blocks are
abnormal. Syncopes have been reported in a Moluccan cockatoo (Cacatua moluccensis) and
during hypotensive episodes in a Hispaniolan Amazon parrot (Amazona ventralis) with second
degree AV block.(Van Zeeland et al. 2010; Rembert et al. 2008) Hypotension associated with 2nd
degree AV blocks was observed following dobutamine administration in four Hispaniolan
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Amazon parrots.(Schnellbacher et al. 2012) A bundle branch block was associated with lead
toxicosis in a galah cockatoo (Eolophus roseicollis).(Westerhof et al. 2011)
In addition, various waves alterations have been associated with cardiac chamber
enlargement, toxicities, nutritional imbalances, electrolytic disorders, and infectious
agents.(Lumeij & Ritchie 1994; Sturkie 1976)
Table 13: Selected arrhythmias and some documented causes in birds.(Lumeij & Ritchie
1994; Westerhof et al. 2011; Sturkie 1976; Zandvliet 2005; van Zeeland et al. 2010; Rembert et
al. 2008; Aguilar et al. 1995; Kushner 1999; Martinez et al. 1997; Odom et al. 1991; Cote &
Ettinger 2005)
Arrhythmias
Excitability
disturbances
Respiratory sinus
arrhythmia
Sinus bradycardia

Sinus tachycardia
Atrial tachycardia
Atrial fibrillation
Ventricular premature
Contraction (VPC)
Ventricular tachycardia
Ventricular fibrillation
Conduction
disturbances
1st degree AV block
2nd degree AV block
3rd degree AV block

Bundle branch block

ECG changes

Causes

Slowing of HR
during expiration
Low HR. normal
sinus rhythm

Physiologic

High HR, normal
sinus rhythm
Series of fast atrial
extrasystoles
Absent P wave,
irregular SS intervals
Wide, bizarre QRS
unrelated to P
Series of VPC
Chaotic ventricular
depolarization

Long PR intervals
Long PR intervals,
some P without QRS
Escape ventricular
rhythm (slow and
bizarre QRS), no
consistent PR
Short PR, bizarre
and widened QRS

Vagal stimulation, atropine, anesthesia,
hypokalemia, hyperkalemia, Vitamins E and
B1 deficiency, acetylcholinesterase inhibitors
Sympathetic, catecholamine stimulation
Atrial distension, ectopic foci
Atrial enlargement, cardiac disease
Ectopic foci, hypo/hyperkaliemia, Vitamin
B1 and E deficiency, paramyxovirus 1, avian
influenza, myocardial infarction
Similar causes as for VPCs
Myocardial hypoxia, shock, severe disorders

Anesthetics, increased vagal tone
Anesthetics, increased vagal tone,
occasionally normal in pigeons, parrots,
raptors
Severe cardiomegaly

Lead, myopathy, myocarditis, uncommon in
birds
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iv. Valvular diseases
Valvular diseases appear more prevalent with the right than the left atrioventricular valve,
which frequently results in insufficiency. This valve responds to right ventricular dilation by
thickening and readily acquires insufficiency because of its fixed position on the ventricular
wall.(Lumeij & Ritchie 1994; Pees, Krautwald-Junghanns, et al. 2006; Julian 2002; Oglesbee &
Oglesbee 1998; Krautwald-Junghanns et al. 2004) A congenital valvular fissure was reported in a
blue-fronted Amazon parrot (Amazona aestiva) with congestive heart failure.(Pees et al. 2001)
Left atrioventricular valve insufficiency has been reported in an Indian ringneck parakeet
(Psittacula krameri) with valvular myxomatous degeneration, an Indian hill mynah (Gracula
religiosa), and a Pukeko (Porphyrio melanotus) with valvular endocardiosis.( Oglesbee &
Lehmkuhl 2001; Rosenthal & Stamoulis 1993; Beehler et al. 1980) Endocardiosis is a noninflammatory nodular thickening of the valves and is more commonly diagnosed on the left
atrioventricular valve in birds. It is a common lesion of chickens and is a frequent occurrence in
the ascites syndrome.(Crespo & Shivaprasad 2008; Fletcher & Abdul-Aziz 2008) Valvular
stenosis is not common in birds but has been reported in a duck.(Mitchell et al. 2008) Idiopathic
valvular degeneration may also occur.
In addition, valvular endocarditis is a common manifestation of bacterial cardiac infections,
may result from chronic infections, and lead to septic emboli.(Lumeij & Ritchie 1994; Isaza et al.
1992; Jessup 1980) The left atrioventricular valve appears more often affected than the
right.(Schmidt et al. 2003) In severe cases, Trichomonas can colonize the atrioventricular valves
in pigeons.(Lumeij & Ritchie 1994) A variety of bacterial agents have been isolated from hearts
of birds diagnosed with valvular endocarditis (Table 14, endocarditis).
In cases of significant insufficiency, a systolic murmur may be audible on cardiac
auscultation. Complete blood cell count may reveal a leukocytosis and blood culture can be
performed to attempt isolation of a bacterial organism. Cardiomegaly may be evident in
advanced cases on radiographic images along with signs of congestive heart failure. Valvular
vegetative growths may be identified on a cardiac ultrasound examination and signs of
congestive heart failure, valvular regurgitation (Doppler echocardiography), and myocardial
dysfunction may also be evident.
v. Myocardial diseases
Dilated cardiomyopathy refers to primary myocardial disorders leading to a dilated heart. Due
to volume overload, the cardiac chambers usually dilate during congestive heart failure but this
should not be confused with dilated cardiomyopathy. Spontaneous dilated cardiomyopathy is a
well-known disorder of 1-4 week old turkeys. The exact cause of the disease is unknown in
turkeys but it is associated with rapid growth and production. Genetic factors, previous
myocarditis, hypoxia during incubation, and other environmental and dietary factors have also
been proposed to play a role in the etiology.(Charlton et al. 2006; Julian 2005; Crespo &
Shivaprasad 2008) Gross findings include a large right ventricle with thin walls and signs of
congestive heart failure. Histopathologic lesions include degeneration of myofibers with
vacuolation, secondary endocardiosis, focal infiltration of lymphocytes, and secondary changes
in the liver.(Crespo & Shivaprasad 2008; Fletcher & Abdul-Aziz 2008) On the ECG, the
following changes, associated with dilation and hypertrophy of the ventricles, can be identified:
increased R wave amplitude, negative T wave, and rotation of the mean electrical axis.(Martinez
et al. 1997; Czarnecki & Good 1980) Chicken round heart disease is characterized by en
enlarged heart, hypertrophy of the left ventricle, and myofiber degeneration but currently the
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disease is extremely rare.(Crespo & Shivaprasad 2008) In other avian species, the diagnosis of
dilated cardiomyopathy is unclear. A red-tailed hawk (Buteo jamaicensis) was reported with
primary right dilated cardiomyopathy and concurrent plasma troponin I elevation. No valvular
regurgitation or other potential causes could not be identified with that case.(Knafo et al. 2011)
A macaw was also diagnosed with lesions compatible with right dilated
cardiomyopathy.(Oglesbee & Oglesbee 1998) In addition, some cases of left dilated
cardiomyopathy have been diagnosed in pet birds.(Schmidt et al. 2003) Dilated cardiomyopathy
is best diagnosed by echocardiography and is characterized, apart from chamber enlargement, by
poor contractility and systolic dysfunction.
Hypertrophic cardiomyopathy has been poorly documented in birds.( Schmidt et al. 2003;
Krautwald-Junghanns et al. 2004; Oglesbee & Oglesbee 1998) On echocardiography,
hypertrophic cardiomyopathy shows the ventricular lumen with diminished dimensions,
thickened ventricular walls, and diastolic dysfunction. Restrictive cardiomyopathy has not been
reported in birds. Ischemic cardiomyopathy and myocardial infarction is rare overall but has
been documented in several cases in relation to atherosclerosis (see corresponding section p69).
Myocarditis can occur with a variety of infectious agents (Table 14). In North American birds
of prey, West Nile virus infection seems to be a common cause of myocarditis.(Ellis et al. 2007;
Saito et al. 2007) In psittacines, myocarditis with cell infiltration of Purkinje fibers can be
present in up to 79% of proventricular dilation disease cases.(Gancz et al. 2012; Lumeij &
Ritchie 1994; Krautwald-Junghanns et al. 2004) Iron storage disease can induce myocarditis but,
only in mynahs (Gracula religiosa) has this disease been suspected to lead to clinical myocardial
disorders.(Ensley et al. 1979; Morris et al. 1989) Electrocardiographic changes usually
accompany myocarditis due to increased excitability (Table 13).
Myocardial degeneration often results from nutritional deficiencies (vitamin E / selenium),
toxicities (Table 15), or ischemia.( Schmidt et al. 2003) A fatal disease primarily characterized
by myocardial degeneration has been reported in great billed parrot (Tanygnathus
megalorynchos) along with skeletal muscle and neural lesions resembling vitamin E
deficiency.(Schmidt et al. 2003)
vi. Pericardial diseases
Pericardial effusion is common with congestive heart disease in birds and can precipitate
decompensation if cardiac tamponade occurs.(Lumeij & Ritchie 1994; Pees, KrautwaldJunghanns, et al. 2006) Cardiac tamponade first affects the right heart diastolic function because
of the lower pressure. Pericardial effusion can also be caused by hypoproteinemia, exudative
pericarditis, hemorrhage, atrial rupture, coagulopathy, neoplasm, and idiopathic syndromes.
Viral causes of hydropericardium producing transudates have been recorded (Table 14).
Avocado toxicity can also induce pericardial effusion.(Hargis et al. 1989) Right auricle rupture
leads to hemopericardium and sudden death in poultry.(Crespo & Shivaprasad 2008; Bougiouklis
et al. 2005) Pericardial fluid analysis and culture may be helpful to pinpoint a cause when
primary cardiac disease is not suspected. Pericardial fluid can be collected by endoscopy through
a midline approach or guided by ultrasound.(Straub et al. 2003) Pericardial biopsies may also be
valuable in some cases. A permanent surgical window or partial pericardectomy can be
performed if necessary by endoscopy.(Lumeij & Ritchie 1994) Enlargement of the cardiac
silhouette is observed radiographically but may not be differentiable from true cardiomegaly
(Figure 13). Echocardiography will readily diagnose pericardial effusion (Figure 12).
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Electrocardiographic findings may include left axis deviation and low voltage.(Lumeij & Ritchie
1994)
Pericarditis has been associated with a variety of infectious agents (Table 14). Clinical signs
are usually non-specific but fibrinous pericarditis can result in constrictive pericarditis.
Pericardial filarioids have also been documented in birds including cockatoos housed
outdoors.(Greiner & Ritchie 1994; Greenacre et al. 1993) Uric acid deposits on the pericardium
are common with visceral gout and should not be confused with infectious pericarditis.
Echocardiography is of low value to diagnose pericardial diseases without effusion. In these
cases endoscopy and direct visualization of the pericardium is more sensitive.

Figure 13: Ventrodorsal radiograph of an African grey parrot showing a widened cardiac
silhouette caused by pericardial effusion.
vii. Infectious and parasitic
The different bacterial, viral, fungal, and parasitic agents reported to cause cardiovascular
disorders are summarized in Table 14.
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Table 14: Infectious agents reported to cause cardiovascular lesions in birds
Pericarditis / Epicarditis

Myocarditis

Listeria monocytogenes

Escherichia coli

Riemerella anatipestifer
(turkeys, ducks)

Salmonella spp.

Chlamydophila psittaci

Listeria monocytogenes

Mycoplasma gallisepticum

Pasteurella multocida

Salmonella spp.

Mycobacterium spp.

Escherichia coli

Aspergillus spp.

Mycobacterium spp.

West Nile virus

Aspergillus spp.

Eastern equine encephalitis virus

Trichomonas gallinae (pigeons)

Avian leucosis virus

Reovirus

Parvovirus (geese and Muscovy ducks)
Avian encephalomyelitis virus

Endocarditis
Enterococcus spp.

Reovirus

Streptococcus spp.

Avian paramyxovirus 1

Staphylococcus spp.

Avian influenza

Pasteurella multocida

Proventricular dilation disease (ABV)

Erysipelothrix rhusopathiae

Sarcocystis spp.

Pseudomonas aeruginosa

Leucocytozoon spp.

Escherichia coli

Toxoplasma gondii

Reovirus

Atoxoplasma serini (canaries)

Intravascular / intracardiac parasites

Pericardial effusion

Trichomonas gallineae (pigeons)

Fowl adenovirus (serotype IV)

Splendidofilaria spp.

Reovirus

Chandlerella spp.

Polyomavirus

Cardiofilaria spp.

Cardiac neoplasias

Paronchocerca spp.

Marek's disease virus

Sarconema spp. (swans, geese)

Avian leukosis virus

Schistosomes (geese)

Reticuloendotheliosis virus

Blood culture is the diagnostic test of choice for bacterial cardiopathies. Specific viral
diagnostic tests can also be performed depending on the infectious dynamic of the agent.
Electrocardiographic changes have been recorded in some instances. Cardiac parasites that can
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be encountered include myocardial protozoans and filarioid nematodes living in cardiac
chambers, vessels, and body cavities.(Bartlett 2008; Greenacre et al. 1993; Latimer et al. 1990)
These parasites infest mainly birds housed outside where they get exposed to definitive hosts
(cats, opossums) and arthropod hosts or mechanical vectors (cockroaches, simuliids,
mosquitoes). Examinations of blood smears and buffy coats may be helpful.
viii. Congenital
Congenital diseases are rare and include atrial or ventricular septal defects and valvular
stenosis. Some defects may be functionally closed. Cockatoos seem to have a higher prevalence
of congenital defects than other psittacine species.(Schmidt et al. 2003; Evans et al. 2001) In
addition, persistent truncus arteriosus and aortic hypoplasia have been reported in combination
with septal defects in 2 cockatoos.(Evans et al. 2001) In these two cockatoos, an audible murmur
and tachycardia were present on cardiac auscultation and an ante-mortem diagnosis could be
reached with a cardiac ultrasound examination. A congenital valvular defect was suspected in a
blue-fronted Amazon parrot.(Pees et al. 2001) Congenital and toxin-induced cardiac
malformations have also been reported in the chicken and turkey.(Siller 1958; Einzig et al. 1972)
A ventricular septal defect was reported in a tundra swan (Cygnus columbianus), a Houbara
bustard (Chlamydotis undulata), and a Griffon vulture (Gyps fulvus).(Harari & Miller 1983;
Bailey & Kinne 2001; Risi et al. 2011) A duck presenting an audible murmur was diagnosed
with congenital mitral stenosis and subvalvular aortic stenosis by echocardiography.(Mitchell et
al. 2008) Ventricular or atrial septal defects associated with heart murmurs were diagnosed in
8/111 Mississippi sandhill cranes (Grus canadensis pulla) in a mortality survey at the Patuxent
Widlife Research Center.(Olsen et al. 1997)
Bifid sternum in which the sternum is split longitudinally thereby exposing the heart to
external trauma has been reported in 3 African grey parrots (Psittacus erithacus) and an orangewinged Amazon parrot (Amazona amazonica).(Buerkle & Wust 2010; Bennett & Gilson 1999)
ix. Aneurysm and aortic rupture
Arterial aneurysm is a focal, blood filled dilation of the arterial wall communicating with the
arterial lumen and may be caused in birds by atherosclerosis, copper deficiency, hypertension,
and fungal infection.(Vink-Nooteboom et al. 1998; Grosset et al. 2012; Ferreras et al. 2001;
Baptiste et al. 1997; Courchesne & M. Garner 2009; Vanhooser et al. 1994; Mitchinson &
Keymer 1977) Non-atherosclerotic aneurysms with aortic dissection and rupture are mainly seen
in ostriches (Struthio camelus) and turkeys (Meleagridis gallopavo).(Mitchinson & Keymer
1977; Vanhooser et al. 1994; Ferreras et al. 2001; Baptiste et al. 1997; Gresham & Howard 1961;
Crespo & Shivaprasad 2008) The exact cause of aortic dissecting aneurysm is not known in these
two species. However, systemic hypertension (common in meat-type turkeys, especially young
males), genetic factors, connective tissue disorders, peas in the ration (peas' toxin βaminopropionitrile will cause aortic rupture experimentally by interference with collagen
formation), and dietary deficiencies notably in copper may contribute to the
pathogenesis.(Charlton et al. 2006; Crespo & Shivaprasad 2008; Julian 2002; Simpson et al.
1970) A copper-dependent enzyme is needed for connective cross-linking of collagen and elastin
in the arterial wall.(Schmidt et al. 2003)
x. Toxicity
Documented cardiotoxins in birds are summarized in Table 15.
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Table 15: Selected cardiotoxic compounds in birds. Note/ Toxicities may vary by species,
especially for plant toxins. Some toxin effects are poorly documented in birds.
Toxic
Dietary and phytotoxins
Avocado (persin)

Effect

References

Pericardial effusion

Sweet pea (βaminopropionitrile)
Lily of the valley (glycosides)
Oleander (glycosides)

Aneurysm

(Hargis et al. 1989;
Burger et al. 1994)
(Simpson et al. 1970)

Kalanchoe (glycosides)
Cassia
Crotalaria (pyrrolizidine,
monocrotaline)
Rapeseed (erucic acid,
glucosinolate)
Chocolate (theobromine,
caffein)
Alcohol
Moniliformin (Fusarium
mycotoxin)
Iron
Sodium
Potassium
Vitamin D3
Environmental toxins
Lead / Zinc

Organochlorines
Organophosphates/carbamates
Iatrogenic toxins
Furazolidone (nitrofuran)
Ionophores (monensin,
salinomycin)
Antipsychotic (haloperidol)
Lidocaine/bupivacaine
Doxorubicin

Tachycardia, arrhythmias
Tachycardia, arrhythmias
Tachycardia, arrhythmias
Myocardial degeneration and
necrosis
Ascites, hydropericardium
Ascites, hydropericardium, fatty
changes
Tachycardia, hypertension,
arrhythmias
Fatty changes
Myocardial degeneration and
necrosis
Oxidative myocardial injury
Congestive heart failure
Arrhythmias, hypertrophy and
degeneration of myofibers
Cardiac mineralization

(Lightfoot et al. 2008)
(Lightfoot et al. 2008;
Shropshire et al. 1992)
(Lightfoot et al. 2008)
(Fletcher et al. 2008)
(Fulton 2008)
(Fulton 2008)
(Lightfoot et al. 2008;
Dumonceaux et al.
1994)
(Fulton 2008)
(Hoerr 2008)
(Ensley et al. 1979;
Morris et al. 1989)
(Jullian 2002)
(Fletcher et al. 2008)
(Fletcher et al. 2008)

Conduction abnormalities,
hydropericardium (geese, swans),
myocardial necrosis
Cardiac malformation
Bradycardia

(Degernes 2008; Redig
et al. 2008; Westerhof et
al. 2011)

Dilated cardiomyopathy
Myocardial degeneration and
necrosis
Bradycardia, hypotension
Arrhythmias, hypotension
Cardiomyopathy, arrhythmias

(Czarnecki 1986)
(Fletcher et al. 2008;
Fulton 2008)
(Martin 2006)
(da Cunha et al. 2011)
(Gilbert et al. 2007;
Czarnecki 1986)

33

(Redig et al. 2008)

i. Neoplasms
Cardiovascular neoplasms are rare in birds. Oncogenic viruses can induce various cardiac
tumor formations in chickens (Table 14). A vascular hemangiosarcoma arising from the right
internal carotid artery was reported in a double yellow headed Amazon parrot (Amazona
ochrocephala oratrix).(Hanley et al. 2005) Hemangiomas and are often present as a cutaneous
growth.(Reavill & Dorrestein 2010)
D. Treatment and management
i. Prognosis
Once an avian patient is diagnosed with cardiovascular diseases, the long-term prognosis is
poor, even with treatment. For instance, a review of 14 clinical cases of congestive heart failure
in birds showed a median survival time of 32.5 days (Table 16).
Table 16: Survival time of selected avian cases of congestive heart failure (CHF) after
diagnosis. AV, atrioventricular.
Species

Diagnosis

CHF

African
grey parrot

Atherosclerosis
Cor pulmonale

Right

African
grey parrot

Valve
regurgitations,
hyperechoic aorta
Myxomatous
degeneration of left
AV valve
Right AV valve
insufficiency
Right AV valve
insufficiency
Atherosclerosis

Indian
ringneck
parakeet
Amazon
parrot
Amazon
parrot
Blue and
gold
macaw
Greycheeked
parakeet
Umbrella
cockatoo
Fischer
lovebird

Survival
time
35 days

Reference

30 days

(Beaufrere et
al. 2007)

10 months

(Oglesbee et
al. 2001)

8 days

Right

Furosemide
Digoxin
Enalapril
Furosemide
Furosemide

(M Pees et al.
2001)
(M Pees et al.
2006)
(Phalen et al.
1996)

Right

Supportive

3 days

(Mans et al.
2007)

Atherosclerosis
Right
Coronary aneurysm

Supportive

Euthanized
at diagnosis

Pericardial effusion Right
Pericarditis,
myocarditis

Pericardiocentesis 11 months
Enalapril
Furosemide

(VinkNooteboom et
al. 1998)
(Straub et al.
2003)

Atherosclerosis

Treatment

Furosemide
Spironolactone
Benazepril
Pimobendan
Coelomocentesis
Bilateral Pimobendan
Furosemide
Imidapril
Bilateral Furosemide
Digoxin
Right
Right
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27 months
70 days

(Sedacca et al.
2009)

(Table 16 continued)
Species
Diagnosis
Pukeko
Left AV valve
insufficiency
RedDilated
tailed
cardiomyopathy
hawk
Mynah
Left AV valve
insufficiency
Mynah
Coronary
calcification
Cause not
determined
Duck
Congenital left AV
valve stenosis
Subvalvular aortic
stenosis

CHF
Treatment
Bilateral Digoxin
Right

Furosemide

Survival time Reference
49 days
(Beehler et
al. 1980)
Euthanized at (Knafo et al.
diagnosis
2011)

Bilateral Furosemide
10 months
Digoxin
Right
Abdominocentesis 12 days

(Rosenthal et
al. 1993)
(Ensley et al.
1979)

Bilateral Supportive
Furosemide
Coelomocentesis

(Mitchell et
al. 2008)

29 days

The variety of therapeutic treatments, causative conditions, outcomes, and species hamper the
formation of any conclusion regarding the association between therapeutic protocols and survival
time. In small animals, long-term prognosis for congestive heart failure is also poor with dogs
having a median survival times of 27-133 days for dilated cardiomyopathy and 588 days for
preclinical mitral valve disease.(Tidholm et al. 1997; Borgarelli et al. 2012; Martin et al. 2009)
The shorter survival time in birds may be associated with the paucity of pharmacologic
information on cardiac drugs, poor standardization of treatment protocols, greater cardiac
efficiency and metabolism, diagnoses achieved at advanced clinical stages, and the challenges of
long term treatment in birds.
ii. Therapeutics
Therapeutic management is the cornerstone of cardiac disease management and is directed
toward the heart, vessels, and regulation of volemia. In general, goals are to extend the patient’s
quality of life and survival time. Since congestive heart failure is not a diagnosis, the correct
treatment will also depend on an accurate diagnosis of the underlying cause of heart failure.
There is a scarcity of pharmacologic information on cardiovascular agents in companion birds.
Few pharmacokinetic studies have been performed (Table 17) but no clinical trials are available.
This emphasizes the need for therapeutic drug monitoring when possible when treating the
individual avian patient. Several commercial laboratories offer plasma drug measurements
including those for digoxin or carvedilol.
Diuretics are used to reduce fluid overload, edema, and effusion. The reduction of vascular
volume is a double-edged sword where the decrease in organ congestion and edema should be
counterbalanced with the decrease in the cardiac output. In a study in chickens, urine output was
measured after administration of the diuretics furosemide, spironolactone, hydrochlorothiazide,
and urotropin.(Esfandiary et al. 2010) Furosemide had the greatest diuretic effect, especially
when given parenterally. Other diuretics did not have a greater effect than the control group at
the dosage used. Loriinae may be extremely susceptible to furosemide and doses used in these
species should be lower.(Hawkins et al. 2013) Furosemide is a potent loop diuretic with good
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efficiency and rapid onset of action in birds despite the presence of only 10-30% of looped
nephrons in the avian kidney.(Goldstein & Skadhauge 2000) Cardiac tamponade is a
contraindication for the use of furosemide because of its effect on cardiac output and it should be
used with caution in birds with renal diseases. Hypokalemia is a possible side-effect.(Pees,
Krautwald-Junghanns, et al. 2006; Schroeder 2010) Electrolytes and renal parameters (BUN, uric
acid) should be monitored when chronically using furosemide on an avian patient.
Spironolactone, an aldosterone antagonist, is a potassium-sparing diuretic which decreases
myocardial fibrosis. It may be used concomitantly with furosemide to offset the loss of
potassium. Hyperaldosteronism is one of the key compensatory mechanisms leading to
congestive heart failure. Overall, spironolactone is considered a weak diuretic.(Schroeder 2010)
Furosemide should not be used alone in the long term but combined to an ACE inhibitor as it
further activates the RAAS.(Schroeder 2010)
Angiotensin-converting enzyme (ACE) inhibitors block the formation of angiotensin II, which
promotes venous and arterial vasodilation and blocks aldosterone production. This reduces pre
and afterload but hypotension and hyperkalemia are potential side-effects and ACE inhibitors are
contraindicated for cardiac tamponade.(Bulmer 2010) Enalapril and benazepril are the most
commonly used ACE inhibitors (Table 17) because of their longer half-life. Empirical evidence
suggest than enalapril is safe and effective in companion psittacine birds.(Pees, Kuhring, et al.
2006)
Positive inotropes are used to enhance cardiac contractility. Disadvantages of positive
inotrope use include an increase in myocardial oxygen consumption, arrhythmias (except
pimobendan), and are contraindicated in cases of hypertrophic cardiomyopathy. Digoxin is a
digitalis glycoside which enhances contractility by inhibiting Na/K ATPase pump promoting
intracellular sodium thus Na/Ca exchange results in an increase calcium cytosolic
concentration.(Fuentes 2010) Several pharmacokinetic studies exist in birds and digoxin has
been used in several cases with monitoring of plasma levels (Table 17).(Oglesbee & Lehmkuhl
2001; Beehler et al. 1980; Rosenthal & Stamoulis 1993) Digoxin is a positive inotrope, negative
chronotrope, and positive lusitrope. However, the use of digoxin is becoming more controversial
in small animal and human cardiology because of the failure to reduce overall mortality and is
mainly indicated to treat atrial fibrillation. Digoxin is a weak positive inotrope and side-effects
are common, therapeutic levels are 0.8-1.2 ng/mL in humans and dogs.(Fuentes 2010)
Pimobendan is a positive inotrope and arterial vasodilator (inodilator) with its mode of action
associated with calcium sensitization of myofibrils and phosphodiesterases III
inhibition.(Beaufrère & Pariaut 2009; Guzman et al. in press.; Fuentes 2010) Pimobendan is
commonly used in small animal cardiology and has been shown to increase both survival time
and quality of life in canine dilated cardiomyopathy.(Summerfield et al. 2012) There has been
more clinical trials with pimobendan than with any other drug in veterinary cardiology.
However, only in 2 psittacines cases has the use of pimobendan been reported at a dose of 0.250.6 mg/kg q12h in triple therapy achieving mixed results.(Sedacca et al. 2009; Beaufrere et al.
2007) However, the required pimobendan dose appears to be much higher in parrots and this
may partially explain the poor clinical effect.(Guzman et al. in press) Dobutamine is a potent
positive inotrope that exerts its activity by selective β1 adrenergic activity. Since it is short-lived,
it is used as a constant rate infusion (CRI) in refractory cases with severe systolic dysfunction
and cardiogenic shock. In Amazon parrots, dopamine and dobutamine significantly increased the
blood pressure in a dose-dependent manner.(Schnellbacher et al. 2012) Side-effects of
dobutamine treatment include arrhythmias and tachycardia.
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Beta-blockers (e.g. carvedilol, atenolol, propranolol) and calcium channel blockers (e.g.
diltiazem) are negative inotrope. They are mainly used in the treatment of hypertrophic
cardiomyopathy and supraventricular arrhythmias and tachycardia. Side-effects include
bradycardia and hypotension.
The initial treatment of congestive heart failure with severe clinical signs aims to achieve a
marked reduction in volemia mainly through the use of diuretics and vasodilators (trap blood in
venous system which already contains 70% of total blood volume). Oxygen supplementation
should be instituted for dyspneic animals especially if pulmonary edema is present. Injectable
inotropes and vasodilators may be indicated in anorexic patients. Fluid therapy is not indicated in
the initial treatment of congestive heart failure where the goal is to reduce fluid overload but can
be instituted at low dose once cardiac function has improved if dehydration and azotemia are
present. Combination therapy with furosemide, ACE inhibitor and pimobendan can then be
initiated and are the consensus recommendations for long-term treatment of canine chronic
valvular disease.(Keene et al. 2010) The diuretic dose can then be tapered to the lowest effective
level. Beta-blockers can be used in supraventricular tachycardia and atrial fibrillation. Multiple
diuretic therapies may be necessary to control effusion formation and limit side effects.
Furthermore moderate sodium restriction is recommended. Coelomocentesis is indicated to
relieve respiratory signs due to airsac compression and is an effective means of decreasing
volume overload. Coelomocentesis can be performed on a regular basis for chronic treatment of
right heart failure in birds. Pericardiocentesis (guided by endoscopy or ultrasound) is indicated in
severe pericardial effusion and cardiac tamponade. Slow aspiration is essential.
Table 17: Doses of selected cardiac therapeutic agents in birds. PK, pharmacokinetic study;
PD, pharmacodynamics study; EU, empirical use.
Drug
Diuretics
Furosemide

Species

Dose

Parrots,
raptors
Chickens

EU
PD
PD

Spironolactone

Chickens
Parrots

0.15-2 mg/kg PO,
IM q12-24h
5 mg/kg PO
2.5 mg/kg IM
1 mg/kg PO
1 mg/kg PO q12h

PD
EU

(Pees, KrautwaldJunghanns, et al. 2006)
(Esfandiary et al. 2010)
(Esfandiary et al. 2010)
(Esfandiary et al. 2010)
(Sedacca et al. 2009)

0.02 mg/kg PO q24h
0.02 mg/kg PO q24h
0.05 mg/kg PO q24h

PK
PK
PK

(Hamlin & Stalnaker 1987)
(Hamlin & Stalnaker 1987)
(Wilson et al. 1989)

10 mg/kg PO q12h
0.25 mg/kg PO q12h
0.25 mg/kg PO q12h

PK
PK,
EU
EU
PD

(Guzman et al. n.d.)
(Guzman et al. n.d.)
(Sedacca et al. 2009; van
Zeeland et al. 2010)
(Schnellbacher et al. 2012)

PD

(Schnellbacher et al. 2012)

Positive inotropes
Digoxin

Pimobendan

Dobutamine
Dopamine

Budgerigars
Sparrows
Quaker
parrots
Amazon
parrots
Harris hawk
Parrots
Amazon
parrots
Amazon
parrots

Reference

5-15 µg/kg/min
(CRI)
5-10 µg/kg/min
(CRI)
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(Table 17 continued)
Drug
Species
Negative inotropes
Propranolol
Most species

Dose

Reference

0.2 mg/kg IM, 0.04
mg/kg IV
5-10 mg/kg PO q1224h
1-2 mg/kg PO q824h

EU

PK
PK
EU

(Pees, Kuhring, et al. 2006)
(Pees, Kuhring, et al. 2006)
(Straub et al. 2003; Pees,
Schmidt, et al. 2006)

Parrots

1.25 mg/kg PO q128h
1.25 mg/kg PO q128h
2.5-5 ,g/kg PO q12h
0.5 mg/kg PO q24h

EU

(Sedacca et al. 2009)

Most species
Most species

0.01-0.02 mg/kg IM
0.01-0.02 mg/kg IM

EU
EU

2.5 mg/kg IV

PK

Mexiletine

Amazon
parrot
Parrots

EU

Proprantheline

Parrots

4-8 mg/kg PO q1224h
0.1-0.3 mg/kg PO
q8h

Atenolol

Most species

Diltiazem

Most species

Vasodilators
Enalapril

Benazepril
Parasympatholytics
Atropine
Glycopyrrolate
Antiarrhythmics
Lidocaine

Pigeons
Amazons
Parrots

EU
EU

EU

(da Cunha et al. 2011)

(van Zeeland et al. 2010)

II. Atherosclerosis in mammals
A. Pathogenesis
i. Response to injury hypothesis and endothelial dysfunction
Atherosclerosis is an inflammatory and degenerative disease of the arterial wall characterized
by the disorganization of the arterial intima due to the accumulation of inflammatory cells, fat,
cholesterol, calcium, cellular debris, and inflammatory cells, potentially leading to complications
such as stenosis, ischemia, thrombosis, hemorrhage, and aneurysm.
The etiology and development of the atherosclerotic lesions can be broadly explained by the
response-to-injury hypothesis first proposed by Ross et al.(Ross et al. 1977) While this widely
accepted hypothesis has been constantly refined, it postulates that damage to the endothelium
lining of the artery sets the stage for atherogenesis. Direct mechanical damage to the
endothelium such as endothelial denudation was initially thought to be required, but an
increasing body of scientific evidence has highlighted the importance of endothelial dysfunction
and oxidative stress in lesion initiation.(Cullen et al. 2005; Falk 2006; George & Lyon 2010;
McGorisk & Treasure 1996; Poredos 2001)
Apart from the maintenance of vessel wall permeability, the endothelium participates in many
physiologic processes and has hemodynamic, hemostatic, inflammatory, and endocrine
functions. The endothelium regulates blood flow through secretion of mediators that affect
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vascular hemodynamics and blood fluidity. Secreted vasoactive molecules include vasodilators
such as nitric oxide (NO), prostacyclin (PGI2) and vasoconstrictors such as endothelin-1 (ET-1)
and platelet activating factor (PAF).(Cullen et al. 2005; Falk 2006; George & Lyon 2010; Cines
et al. 1998; Sitia et al. 2010) NO and ET are some of the most potent vasodilators and
vasoconstrictors known, respectively.(Poredos 2001) Nitric oxide has also protective effects
against vascular injury, inflammation, thrombosis, and inhibits leukocyte adhesion and limits
platelet adhesion and aggregation.(Szmitko et al. 2003; Cullen et al. 2005; Cines et al. 1998)
Endothelial cells also produce an endothelium-derived hyperpolarizing factor (EDHF) that
relaxes smooth muscles.(Cines et al. 1998) The endothelium provides an antithrombotic surface
and limits local thrombosis by the production of tissue plasminogen activator, heparans, and
thrombomodulin.(Cullen et al. 2005; Rabelink et al. 2010; Cines et al. 1998) Finally, endothelial
cells express cell surface molecules that plays a role in blood cells trafficking and
chemotaxis.(Cines et al. 1998) The endothelial surface molecules assists the direction of the
migration of leukocytes during physiologic and pathologic processes.
Under certain circumstances, interactions with blood cells, and stimulation by cytokines and
other inflammatory factors, the endothelium becomes activated and increases its production of
procoagulant and proinflammatory factors such as tissue factor, Von Willebrand’s factor,
monocyte chemotactic factor-1, vascular cell adhesion molecule-1, and interleukin 1, 6, and
18.(Cullen et al. 2005; Hamburg & Vita 2005) During sustained endothelial-cell activation,
endothelial microparticles containing a variety of proinflammatory agents and procoagulant
factors may be released and endothelial cells may detach from the vessel wall and are referred to
as circulating endothelial cells.(Rabelink et al. 2010) Ultrastructurally, activated endothelial cells
are characterized by cytoplasmic volume increase, pinocytotic vesicles, filopodia, increased
vacuolization, and blood cells attachment.(Cheville 1994b) Endothelial dysfunction is
characterized by a specific state of endothelial activation and is associated with specific risk
factors that promote an atherogenic environment.(Cullen et al. 2005) For instance,
hypercholesterolemia promotes attachment of blood leukocytes to the endothelium, oxidized
lipoproteins and reactive oxygen species cause endothelial activation and endothelial damage,
and angiotensin II, associated with hypertension, antagonizes the effects of NO.(Szmitko et al.
2003) Several atherogenic risk factors such as dyslipidemia, diabetes, metabolic syndrome,
smoking, inflammation, and hypertension increase oxidative stress which has been suggested as
an important cause of endothelial dysfunction.(Poredos 2001; Stocker & Keaney 2005)
Endothelial dysfunction is initially characterized by a decrease in the production and
bioavailability of NO coupled with an increase in vasoconstrictors such as with ET-1.(Cullen et
al. 2005; George & Lyon 2010; Hamburg & Vita 2005; Szmitko et al. 2003) This leads to
impairment of endothelium-derived vasodilation and promotion of a proinflammatory,
proliferative, prooxidative, and procoagulatory state that is atherogenic.(Cullen et al. 2005;
Szmitko et al. 2003; Sitia et al. 2010; Ross 1999) Impairment of endothelial vasodilator function
may also play a role in the pathogenesis of tissue ischemia.(Poredos 2001) The decreased
expression of NO, increased expression of selectins, vascular cell adhesion molecule-1 (VCAM1) and intercellular adhesion molecule-1 (ICAM-1) promotes the adherence of monocytes and, to
a lesser extent lymphocytes, and their migration into the subintimal space, which is one of the
earliest events in atherogenesis (Figures 14 and 15).(Cullen et al. 2005; Szmitko et al. 2003;
Poredos 2001; Libby 2012; Hansson 2005; Cybulsky & Gimbrone 1991) A dysfunctional
endothelium fails to inhibit the proliferation and migration of smooth muscle cells.(Cullen et al.
2005) In addition, local factors such as hemodynamic shear stress and genetic factors are also
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associated with endothelial dysfunction and platelet and leukocytes attachment to the
endothelium.(Cullen et al. 2005; Cines et al. 1998) Once within the subintimal area, the
monocytes differentiate into macrophages and begin internalization of lipoprotein particles and
evolved into foam cells. Other cells contribute to atherosclerotic lesion formation such as smooth
muscles cells, T-cells, dendritic cells, and mast cells. Furthermore, entrapment of low-density
lipoproteins (LDL, apolipoprotein-B containing lipoproteins) in the arterial wall coupled with the
increased permeability of the endothelium promotes the accumulation of lipid, the
chemoattraction of macrophages, and the formation of foam cells. There is evidences that arterial
extracellular matrix components such as proteoglycans can bind to LDL leading to LDL
retention.(Stocker & Keaney 2005) This has been formulated as the response-to-retention
hypothesis(Williams & Tabas 1998) but can also be considered part of the complex changes that
can lead to initial vascular injury and subsequent effects on vascular physiology, homeostasis
and endothelial dysfunction. Heightened oxidative stress in the arterial wall promotes the
oxidization of lipoproteins which are readily taken up by macrophages. Oxidized LDL and other
polypeptides are recognized as auto-antigens that have strong pro-inflammatory stimulus thereby
sustaining chronic inflammation, leukocytes recruitment, immune activation, and endothelial
dysfunction.(Sitia et al. 2010) The subendothelial retention of modified LDL is a key event in the
early attraction of monocytes and their differentiation into macrophages.(Raines et al. 2005;
Moore & Tabas 2011) Inflammation has a preponderant role in atherogenesis and intervenes in
the effects of many known risk factors.(Libby et al. 2011; Hansson 2005)
ii. Cells of atherosclerosis and development of lesions
Proliferation and accumulation of macrophages is one of the main characteristics of
atherosclerotic lesions and happens at all stages of lesion development with foam cell formation,
secretion of signaling molecules, cytokines, inflammatory mediators, proteolytic enzymes,
growth factors, reactive oxygen species, and components of the extracellular matrix.(Cullen et al.
2005; Moore & Rayner 2010; Moore & Tabas 2011; Ross 1999) Adhesion of macrophages and
their diapedesis are mediated by chemoattractants, integrins, and adhesion molecules secreted by
activated endothelial cells (VCAM, ICAM).(Moore & Tabas 2011) There is evidence that
different subsets of macrophages (M1 and M2) may act at different levels of the inflammatory
response occurring in atheromas.(Moore & Tabas 2011; Woollard & Geissmann 2010; Libby et
al. 2011) Also, a large number of molecules contribute to LDL retention, modification, and
uptake.(Moore & Rayner 2010; Williams & Tabas 1998) Modified lipoproteins have the ability
to trigger key signaling pathways of inflammation and foam cell formation. Oxidized LDL and
monocyte chemotactic protein 1 (MCP-1), produced by endothelial cells, macrophages, and
smooth muscles cells, are potent atherogenic chemoattractants.(Libby 2012) The proliferation of
macrophages is upregulated by modified lipoproteins, macrophage growth factor, macrophage
colony stimulating factor 1 (M-CSF), and cytokines (TNF-α, IFN-γ) produced by inflammatory
cells.(Cullen et al. 2005; Raines et al. 2005) Macrophages express several scavenger receptors
namely scavenger receptor A (SR-A), B1 (SR-B1), and CD36 implicated in uptake of oxidized
LDL.(Cullen et al. 2005; George & Lyon 2010) Lipid accumulates within the macrophages and
some expressed scavenger receptors (SR-A) are not subject to negative feedback regulation
unlike the standard LDL receptors (see lipoproteins).(Cullen et al. 2005; Moore & Rayner 2010)
Macrophages store cholesterol in the form of cholesteryl esters and become foam cells (Figure
14). Additionally, macrophages deal with excess cholesterol with various cholesterol efflux
pathways including transfer to high-density lipoproteins (HDL) via SR-B1, transfer to apoA1
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and apoE-containing lipoproteins (HDL) and to other cholesterol acceptors via ATP binding
cassette A1 (ABCA-1) and ABCG-1 transporters, and shedding of lipid rafts (Figure 15).(Cullen
et al. 2005; Moore & Tabas 2011; Cuchel et al. 2010) Thus, SR-A seems to be atherogenic
whereas SR-B1 and cholesterol efflux transporters are atheroprotective.(George & Lyon 2010)
Cholesterol efflux is thought to be fundamental in lesion regression when risk factors are
reduced.(Moore & Tabas 2011) With continuous exposure to excess cholesterol, adapting
mechanisms of the macrophages eventually fail (particularly due to the absence of downregulation of scavenger receptors by cellular cholesterol accumulation) and the cells die which
may lead to further release of proteases and inflammatory molecules and accumulation of
extracellular lipid and necrotic debris. Modified lipoproteins can also induce macrophages
apoptosis.(Moore & Tabas 2011) Atherosclerosis is a non-resolving inflammatory condition
where macrophages continue to enter lesions, accumulate cholesterol and modified lipoproteins
and die by apoptosis or necrosis which ultimately lead to the necrotic core of the atheromatous
plaque.

Figure 14: Role of inflammation and liproteins in atherogenesis. Activated endothelial cells
express leukocyte adhesion molecules. Oxidized lipoproteins are also strong chemoattractants for
monocytes. After entry into the intima, monocytes differentiate into macrophages and express
scavenger receptors for the uptake of modified LDL particles. Inflammation is sustained by proinflammatory mediators, reactive oxygen species, and tissue factor. Macrophages ultimately
evolve into foam cells. In addition to modified LDL, triglyceride rich lipoproteins (VLDL) can
promote inflammation through Toll-like receptor 2. Cholesterol efflux from macrophages is
orchestrated by ATP-binding cassette transporters (ABCG1, ABCA1) toward HDL. Cholesteryl
ester transferase protein transfers cholesterol from VLDL/LDL to HDL and promote
atherogenesis. Reprinted by permission from Macmillan Publishers Ltd: Nature (Libby P, Ridker
PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature.
2011;473(7347):317–25.), copyright (2011).
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Smooth muscle cells proliferation and migration to the intima and subintima plays an
important role in the development of the atherosclerotic lesion (Figure 15). They are the main
cells synthesizing extracellular matrix constituents such as collagen, elastic fibers and
proteoglycans.(Wight 2005) It has been shown that the arterial wall reacts to experimental injury
by proliferation of smooth muscle cells from the media and migration into the subintimal space
where these cells are responsible for arterial healing and repair.(Cullen et al. 2005) Unlike most
experimental animals, intima of human arteries also contains resident smooth muscle
cells.(Libby et al. 2011; Stary et al. 1992) De-differentiation and phenotypic changes also occur
from a contractile to a synthetic state with production of extracellular matrix components
(proteoglycans, collagen).(George & Lyon 2010; Cullen et al. 2005; Coen & Bochaton-Piallot
2010) Smooth muscle cells also take up cholesterol and develop into foam cells and constitute a
significant proportion of foam cells. In advanced fibroatheromatous lesions, the fibrous cap is
composed of vascular smooth muscle cells. The formation of the fibrous cap and the phenotypic
modulation of intimal smooth muscle cells are stimulated by growth factors and cytokines such
as platelet-derived growth factor (PDGF), fibroblast growth factor (FGF-2) and transforming
growth factor β (TGF-β).(George & Lyon 2010; Wamhoff et al. 2005; Libby et al. 2011) The
origin of the smooth muscle cells implicated in atherosclerotic disease is still debated and a high
degree of monoclonality has been observed.(Cullen et al. 2005; Coen & Bochaton-Piallot 2010)
Bone marrow derived smooth muscle progenitor cells may also play a role in lesion
development.(Wamhoff et al. 2005) Further proliferation of smooth muscle cells and formation
of fibrous tissue lead to additional enlargement and restructuring of the lesions which becomes
covered by a fibrous cap that overlies the lipid and necrotic core (Figure 15).(Ross 1999; Libby
et al. 2011) Smooth muscle cells and their production of matrix constituents confer stability to
atheromatous plaques in an attempt to encapsulate the necrotic core.(Schwartz et al. 2000)
As the atherosclerotic lesion evolves, macrophages are joined by other inflammatory cells.
Lymphocytes participate in the immune modulation during the progression of atherosclerotic
lesions. Dendritic cells and mast cells are also present. Immune activation is mainly stimulated
by modified lipoproteins but also by microbial antigens and pro-inflammatory mediators.(Falk
2006) Natural killer T cells recognize lipid antigens and are especially present in early
lesions.(Hansson 2005) CD4 and CD8 T cells are also present and express a variety of cytokines,
cell surface molecules, and enzymes. In particular, Th1 effector cells activate macrophages and
produce interferon γ and it has been shown that atherosclerotic lesions contain cytokines that
promote a Th1 response rather than Th2 (Figure 14).(Hansson 2005) Mast cells play an
additional role in inflammatory cells recruitment and foam cell formation by increasing the
uptake of LDL by macrophages and smooth muscle cells.(Cullen et al. 2005) Histamine released
from mast cells may also enhance arterial permeability and increase the intimal accumulation of
LDL. Furthermore, heparin proteoglycans contained in mast cells granules bind LDL.(Lindstedt
et al. 1992)
Platelets adhere to the activated endothelium and further contribute to endothelial activation
by production of inflammatory and vasoactive molecules.(Hansson 2005; Harper et al. 2010) The
release of adhesion molecules, growth factors, chemokines, cytokines, and coagulation factors
enhances recruitment, adhesion, and diapedesis of monocytes into the intima.(Harper et al. 2010)
Furthermore, platelets along with macrophages produce the potent smooth muscle cell
chemoattractant PDGF.(Wamhoff et al. 2005)

42

Figure 15: Stages in the development of atherosclerotic lesions. A, the normal human artery
is composed of the intima presenting resident smooth muscle cells in contrast to animal models,
the media composed of layers of elastin and smooth muscle cells, and the adventitia containing
connective tissue and other cells. B, after endothelial activation, adherent monocytes migrate to
the intima and differentiate into macrophages which ultimately develop into foam cells. C,
smooth muscle cells migrate from the media into the intima and the resident intimal smooth
muscle cells proliferate and together produce extracellular matrix component and form the
fibrous cap overlying the lipid and necrotic atherosclerotic core. D, thrombosis is the ultimate
complication of human atherosclerotic lesions where the fibrous cap rupture exposing lipid core
constituents that are highly thrombogenic. Reprinted by permission from Macmillan Publishers
Ltd: Nature (Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the
biology of atherosclerosis. Nature. 2011;473(7347):317–25.), copyright (2011).
The vascular extracellular matrix is composed of collagen and elastic fibers embedded in
proteoglycans, hyaluronan, glycoproteins, and water and maintains vascular wall structure and
provide a biomechanically active scaffold.(Wight 2005) The extracellular matrix is modified by
macrophages and smooth muscle cells through secretion of both matrix constituents (collagen)
and various matrix-degrading proteolytic enzymes such as matrix metalloproteinases (MMP) and
tissue factor.(George & Lyon 2010; Cullen et al. 2005; Libby 2012) Type I collagen is mainly
deposited within the fibrous cap.(Wight 2005) Fragmentation and disruption of elastic fibers are
common in atherosclerotic lesions and are thought to be caused by released proteases.(Wight
2005) This causes a loss in arterial compliance and elasticity and exaggerated matrix deposition
contributes to arterial luminal narrowing. Proteoglycans are protein polysaccharides formed of
glycosaminoglycans (GAG) and a core glycoprotein and are predominant in the intima.(Wight et
al. 1991; Wight 2005) The amount of proteoglycans increases at the beginning of the lesions and
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decreases as lesions become more advanced and fibrotic. Changes in the proteoglycan
composition of the extracellular matrix affect vascular permeability and promote lipoproteins
binding.(Wight 2005; Williams & Tabas 1998) Calcification of atherosclerotic plaques is
common and resembles active calcification such as happening in bones.(Falk & Shah 2005)
iii. Atherothrombosis and complications
Complications and clinical signs are usually due to either severe stenosis from the
continuously growing atheromatous plaque or thrombosis and hamorrhage caused by plaque
disruption that can decrease or interrupt blood flow or provoke emboli. Atherosclerotic lesions
are silent and asymptomatic until such complications arise. Plaque disruption and smooth muscle
cell death are promoted by proteolytic enzymes (e.g. MMP) and inflammatory mediators
produced by macrophages, T cells, and mast cells.(Libby et al. 2011; Hansson 2005; Cullen et al.
2005) Variation in distribution of fibrillar collagen may create areas of the fibrous cap with
differences in susceptibility to plaque rupture.(Wight 2005) Neovascularization is frequently
present in advanced plaques and is associated with inflammatory cell infiltration, expression of
adhesion molecules (e.g. VCAM-1 and ICAM-1), and hemorrhage.(Falk & Shah 2005) Plaque
composition rather than plaque type plays a determinant role in rupture and complications. While
the exact pathophysiology of plaque rupture remains to be determined, it is associated with
specific features that include a large and soft lipid-rich atheromatous core, a thin and collagenpoor fibrous cap, lack of smooth muscle cells and accumulation of macrophages at rupture site,
extracellular matrix deterioration, neovascularisation, and arterial inflammation.(Falk & Shah
2005; Virmani et al. 2000) Fracture of the fibrous cap or endothelial erosion cause procoagulant
elements of the necrotic and lipid core (phospholipids, tissue factor, platelet-adhesive matrix
molecules) to be exposed to coagulation proteins in the arterial lumen triggering coagulation,
platelet adhesion, and thrombosis (Figure 15).(Libby et al. 2011; Hansson 2005; Harper et al.
2010; Virmani et al. 2000) Platelet aggregation may also be stimulated by exposed collagen
fibers, oxidized lipoproteins, and other plaque constituents as well as local flow disturbances and
systemic thrombotic propensity.(Falk & Shah 2005; Wight 2005) The thrombus composed of
platelets and fibrin evolves and may lead to flow obstruction and embolization.
B. Atherosclerotic lesions
Different types of atherosclerotic lesions have been described that reflect the pathophysiology
and progression of atherosclerosis. The old classification relies mainly on morphological gross
description and includes:(Stary 2003c; de Brue et al. 1958)
-Fatty dots/streaks: superficial yellow intimal lesions that stain positively with lipid stains
-Fibrous plaque: firm circumscribed and elevated intimal thickening
-Atheroma: atherosclerotic plaque with fatty softening
-Complicated lesions: lesions with additional changes or alterations such as hemorrhage,
thrombosis, ulceration, and calcification.
This gross classification has many limitations and precise lesion types cannot be determined
especially as it relates to the pathogenesis and pathways of development. More precise and
detailed histopathologic classification of atherosclerotic lesions based on large reviews of cases
in conjunction with experimental studies and clinical considerations have been developed since.
The reference classification is the one endorsed by the American Heart Association (AHA)
which includes 8 lesion types (Figures 16-17).(Stary et al. 1994; Stary et al. 1995; Stary 2005;
Stary et al. 1992; Stary 2000)
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Figure 16: American Heart Association (AHA) classification of human atherosclerotic lesion
types with their pathways of progression and regression. Thick and thin arrows differentiate
between the relative ease with which lesions develop in specific location, or they indicate the
relative frequency and importance of a specific pathway section. Reprinted with permission from
Wolkers Kluwer Health: (Stary HC, Natural history and histological classification of
atherosclerotic lesions: an update. Arteriocler Thromb Vasc Biol. 2000; 20:1177-1178).
Minimal atherosclerosis comprises type I and II lesions mainly formed of macrophages and
foam cells which never produce clinical manifestations or obstruct blood flow. Type III lesions
are intermediate between lesions with minimal changes and those with advanced atherosclerotic
changes and are characterized by extracellular lipid accumulation. Advanced lesions also known
as clinically important lesions include changes that produce clinical signs and silent ones that
have yet to obstruct blood flow, rupture, or lead to thromboembolism. These lesions include type
IV lesions composed of a lipid and necrotic core, type V lesions including a thick fibrous cap
over the lipid core, type VI lesions with added complications such as endothelial defects,
hematoma, and thrombus, type VII lesions which are mainly calcific with reduced presence of
fat, and type VIII lesions that are fibrotic without a lipid core. Type VI lesions are most
commonly associated with disease and fatalities. Type VII and VIII are regressive lesions with
minimal amount of fat and are sometimes referred to as type Vb and Vc lesions, respectively
(Figures 16-17).
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Figure 17: Diagrammatic representation of the main human atherosclerotic lesion types as
classified by the AHA. This illustrates the usual sequence in the development of atherosclerosis.
Modified and reprinted with permission from Wolkers Kluwer Health: (Koenig W, Khuseyima
N. Biomarkers of atherosclerotic plaque instability and rupture. Arteriocler Thromb Vasc Biol.
2007, 27: 15-26).
This classification system has been revised and modified by some authors. A modified
classification scheme has been proposed in which atherosclerotic lesion types have names
referring to clinically important morphological attributes without the use of roman numerals that
may imply a linear pattern of lesion progression (Figure 18).(Virmani et al. 2000) In this more
descriptive classification, initial xanthoma replaces fatty streak or initial lesion and describes
focal accumulation of fat-laden macrophages. Intimal thickening is another mechanism of the
initial lesion, which may be an adaptation to local hemodynamic constraints and these intimal
cell masses can progress to erosion and give rise to clinical signs. Fibrous cap atheroma accounts
for type IV and V lesions of the AHA classification. Since the thickness of the fibrous cap is an
important determinant of rupture and symptoms, thin and thick fibrous cap atheromas are
distinguished. Complicated lesions are further classified into 3 processes: rupture, erosion, and
calcified nodules. Thrombus can be seen either communicating with the lipid core through a
ruptured fibrous cap or overlying an eroded plaque. Finally, complex lesions are also described.
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Figure 18: Modified AHA classification based on lesion morphology and clinical outcome.
Boxed areas represent the 7 categories of lesions. This also shows processes of lesion
progression. Dotted lines represent the least established processes while thick lines represent
events with high strength of evidence. Reprinted with permission from Wolkers Kluwer Health:
(Virmani R, Kolodgie FD, Burke AP et al. Lessons from sudden coronary death: a
comprehensive morphological classification scheme for atherosclerotic lesions. Arteriocler
Thromb Vasc Biol. 2000, 20: 1262-1275).
C. Risk factors for atherosclerotic diseases
i. Overview
Risk factors are clearly defined by occurrence or characteristics that have been associated
with the increased rate of a subsequently occurring disease; causality may or may not be
implied.(Albert et al. 2012) Also risk factors usually refer to clinical diseases. As such, risk
factors have been characterized in humans for clinical atherosclerotic diseases such as coronary
heart disease, cerebrovascular accidents, and peripheral arterial disease but not for
atherosclerotic lesions themselves, which are present in almost everyone to some degree.
Atherosclerotic lesions and their characteristics are actually risk factors themselves for clinical
disease. In human epidemiology, risk factors are typically studied in prospective and clinical
studies. With atherosclerosis being the major cause of human death in the world, countless large
prospective studies, such as the pioneering Framingham study, have been conducted in an
attempt to identify risk factors for atherosclerotic diseases in various populations.(Abbott et al.
1983; Karim et al. 2008; D’Agostino et al. 2008; von Eckardstein 2005; Jousilahti et al. 1999)
Risk factors may be definitely modifiable (e.g. lifestyle, diet), potentially modifiable (e.g.
hematologic) or fixed (e.g. age, gender).(Wilson 2005) Also, some risk factors (e.g. obesity) may
not emerge in studies as statistically independent because they partially affect the pathogenesis
of atherosclerosis indirectly via other measurable risk factors. They are classified as underlying
risk factors but are still targets for intervention.(von Eckardstein 2005)
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Identifying and quantifying individual risk factors is an important aid in diagnosis and
prevention and specific guidelines have been developed by scientific groups such as the AHA,
World Health Organization (WHO), or the European Atherosclerosis Society (EAS).(Pearson
2002; Hirsch et al. 2006; Kavey et al. 2003; Reiner et al. 2011; WHO 2007) Global risk
assessment scores have been developed in which classical and independent risk factors are
combined in algorithms to estimate individual risks of developing atherosclerotic diseases.(von
Eckardstein 2005; Reiner et al. 2011; Kavey et al. 2003; Grundy et al. 1999; WHO 2007)
Apart from total cholesterol values, the leading risk factors globally according to the WHO in
the ascending order are increased blood pressure, tobacco use, increased blood glucose (diabetes
mellitus), physical inactivity, and obesity.(WHO 2011) Furthermore, according to a large
number of epidemiological studies, 80-90% of patients having coronary heart disease events
have at least one of the four classical risk factors including hypercholesterolemia, hypertension,
diabetes mellitus, or smoking.(von Eckardstein 2005) Risk factors can be classified into
biochemical, lifestyle, personal, and physiological (Table 18).(McGill & McMahan 2005;
George & Lyon 2010; Wilson 2005; von Eckardstein 2005; Pearson 2002; Smith, Blair, et al.
2001; WHO 2007)
Table 18: risk factors for coronary heart disease associated with atherosclerosis (*other than
dyslipidemia).
Biochemical*
Hyperglycemia
(diabetes)
Thrombogenic factors
Homocysteinemia
Inflammatory markers
(C-reactive protein,
fibrinogen)

Lifestyle
Dietary saturated fat
Dietary cholesterol
Dietary calories
Low intake of fruits
and vegetables
Alcohol
Tobacco smoking
Physical inactivity
Stress

Physiological
Elevated blood
pressure
Metabolic syndrome
Obesity

Personal
Age
Sex (male)
Family history
Genetic factors
Personal history

ii. Lipoproteins
1. Metabolism
Lipoproteins are a complex water-soluble transport system of lipids, cholesterol, triglycerides,
and phospholipids in the circulation. This transport system cycles lipid to muscle and adipose
tissue and cholesterol throughout the body that is used in cell membranes, bile acids, and steroid
hormone synthesis. Cholesterol synthesis is controlled by transcriptional regulation of 3hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and HMG-CoA synthetase which
are the rate-limiting enzymes in cholesterol biosynthesis.(Kane 2005) Retrieval of cholesterol
from target sources to the liver occurs through a reverse cholesterol transport pathway.
Lipoproteins are spherical or discoidal particles composed of a core of hydrophobic cholesteryl
esters and triglycerides surrounded by a coat of phospholipids, unesterified cholesterol and
proteins.(Zannis et al. 2005; Kane 2005) The proteins of the surface are known as the
apolipoproteins and have functions in structural integrity, enzyme activation, and receptor
binding.(Zannis et al. 2005) Apolipoproteins are grouped into several families depending on their
structure and size. A family of small apolipoproteins can move among the lipoprotein types and
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comprise apolipoproteins A-I, A-II, A-IV, A-V, C-I, C-II, C-III, C-IC, and E. The B
apolipoproteins are larger proteins that are inexchangeable between lipoprotein types and include
apoB-100 and apoB-48.(Kane 2005) Plasma lipoproteins are traditionally separated into
subclasses based on their density: chylomicrons, very low-density lipoproteins (VLDL),
intermediate-density lipoproteins (IDL), low-density lipoproteins (LDL), and high-density
lipoproteins (HDL). Lipoprotein (a) is part of the LDL group.(Zannis et al. 2005) Chylomicrons,
LDL, IDL, VLDL contain apoB (also called apoB-containing lipoproteins) and HDL contain
apoA-I as the main apolipoproteins.(Kwiterovitch 2000; Hoofnagle & Heinecke 2009)
Lipoprotein metabolism includes three different pathways: the chylomicron pathway, the
VLDL/IDL/LDL pathway, and the HDL pathway.(Zannis et al. 2005) Different protein receptors
and lipid transfer enzymes such as cholesteryl ester transfer protein (CETP), phospholipid
transfer protein (PLTP), and lecithin cholesterol acyltransferase (LCAT) have functions in lipid
exchange through these lipoproteins.(Kane 2005; Zannis et al. 2005)
The intestinal cells secrete chylomicrons in the lymph where dietary lipids assemble with
apoB-48 that requires the enzyme microsomal triglyceride transfer protein (MTP).(Kindel et al.
2010) In plasma, the triglycerides of the chylomicrons are hydrolyzed into free fatty acids and
glycerol by lipoprotein lipase at the surface of endothelial cells in a process requiring the
cofactor apoC-II which, as a result, produces chylomicron remnants rich in cholesteryl esters and
contain apoE. Free fatty acids, bound transiently to albumin, and glycerol are taken up by tissues.
Chylomicron remnants are removed from the blood by the liver through LDL-receptor related
protein and LDL receptors.(Zannis et al. 2005; Kwiterovitch 2000; Kane 2005) VLDL are
secreted by the liver with apoB-100 on their surface and function to transport endogenous
triglycerides along with LDL. VLDL also contains apoE. As for chylomicrons, the triglycerides
of the VLDL are broken down in plasma by lipoprotein lipase with its cofactor apoC-II leading
to the formation of smaller particles, the IDL rich in cholesteryl esters and other VLDL remnants
such as β-VLDL. IDL may be further converted into LDL by the action of hepatic lipase. Some
VLDL remnants and IDL are catabolized by the liver through the interaction between the LDL
receptor and apoE as a ligand or VLDL receptor. LDL is also taken up by the LDL receptor in
the liver with apoB as a ligand.(Zannis et al. 2005; Kwiterovitch 2000; Kane 2005) Small dense
LDL are a subpopulation of LDL that has a lower affinity for the LDL receptor and remains
longer in circulation. This subpopulation increases in the presence of hypertriglyceridemia.
Regulatory mechanisms in cholesterol homeostasis are regulated in part by hydrolysis of
cholesteryl esters contained in LDL subsequent to their binding with LDL receptors. This leads
to a downregulation of HMG-CoA reductase (cholesterol synthesis), LDL receptors expression
(entrance of cholesterol into cells), and upregulation of acyl-CoA cholesterol acyltransferasae
(ACAT2) which promotes intracellular cholesteryl ester storage.(Zannis et al. 2005) Lipoprotein
(a) is another apoB-containing lipoprotein and represents a distinct class of lipoprotein similar to
LDL but varying in density.(Zannis et al. 2005) Lipoprotein (a) contains apo(a), is secreted by
the liver, and participates in the endogenous cholesterol transport pathway. Apolipoprotein (a),
linked by a disulphite bond to apolipoprotein B-100, has a structure similar to
plasminogen.(McLean et al. 1987)
HDL are mainly synthetized in the liver and contained apoA-I as the main apolipoprotein and
small amounts of other apolipoproteins such as apoE and apoC proteins. HDL form a
heterogeneous group with different density subfractions, HDL1, HDL2, and HDL3. The latter is
the smallest particle and contains the least amount of lipid.(Rader 2005) HDL have functions in
the reverse cholesterol transport pathway where they acquire phospholipid and cholesterol
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through the action of ATP-binding cassette A1 (ABCA1) lipid transporters at the efflux
cells.(Rader 2005) LCAT participates also in HDL modification by esterification of free
cholesterol.(Zannis et al. 2005) Cholesteryl esters can be transferred to apoB-containing
lipoproteins, process notably mediated by CETP. Cholesterol can then be delivered to
hepatocytes by receptor-mediated endocytosis (LDL receptor).(Kane 2005) Transfer of
cholesterol from tissues to liver can also be mediated directly by the HDL through the activity of
SR-B1.(Rader 2005)
2. Lipoproteins and atherosclerosis
LDL, VLDL and its remnant IDL promote atherogenesis whereas HDL has
antiatherosclerosis properties. When the concentration of LDL and other apoB-containing
lipoproteins increase, they may penetrate the subendothelium. Modified LDL (by oxidation or
glycation (diabetes)) have an increased tendency to aggregate, adhere to arterial proteoglycans,
and get incorporated into immune complexes which may induce endothelial injury and promotes
endothelial dysfunction.(Ross 1999; Hessler et al. 1983) Oxidized lipoproteins may be the single
most important injurious agent leading to endothelial dysfunction and the discovery of their
cytotoxic effects has prompted a revision of the response to injury hypothesis.(Penn & Chisolm
2005) They upregulate the expression of adhesion molecules and the secretion of chemokines by
the endothelial cells.(Sitia et al. 2010) Increased oxidative stress and products of lipid
peroxidation stimulate the modification of LDL. Once trapped in the intima, LDL continue to
undergo oxidation and are taken up by macrophages via scavenger receptors such as SR-B1, SRA, or CD36 as a clearing mechanism. Internalized modified lipoproteins undergo modification
and esterification, and ultimately, macrophages become foam cells. Oxidized LDL also act as
auto-antigen stimulating the adaptive immune response, are strong chemotactic signals for
macrophages, have strong pro-inflammatory properties, can stimulate proliferation of smooth
muscle cells, and have procoagulant activities.(Ross 1999; Sitia et al. 2010; Penn & Chisolm
2005) Interaction between oxidized LDL and C-reactive protein (CRP) also promotes
autoimmunity.(Sitia et al. 2010) Small, dense LDL have a lower affinity for the LDL receptor
and have greater susceptibility to oxidation due to their longer half-life. (Zannis et al. 2005)
Furthermore, oxidized lipoproteins induce macrophages and smooth muscle cells apoptosis and
necrosis. Lipoprotein (a) also contributes to atherogenesis and thrombosis by interfering with
LDL metabolism and fibrinolysis and chemoattraction of monocytes.(Zannis et al. 2005) A
vicious circle of inflammation and further modification of these lipids perpetuates atherogenesis.
In addition, defects at any stage along the cholesterol transport pathway may increase the amount
of LDL/VLDL in the blood and predispose to the development of atherosclerosis. The most
common examples in humans include low activity of lipoprotein lipase, an overproduction of
VLDL (precursor of LDL) or chylomicrons, lipoprotein structure abnormalities, or defects in the
LDL receptor.(Kwiterovitch 2000)
Conversely, HDL protect against atherosclerosis through the reverse cholesterol transport
pathway by promoting cholesterol efflux from macrophages mediated by cholesterol transporters
such as ABCA1 and ABCG1.(Rader 2005; Cuchel et al. 2010; Van Eck et al. 2005) HDL allows
cholesterol to return to the liver through cholesterol transfer to LDL via CETP which can then be
excreted into the bile. Enhancement of this pathway through higher HDL concentration or
overexpression of apoA-I may decrease the occurrence of atherosclerosis and blood lipid levels.
The relation between the expression of LCAT and CETP and atherosclerosis in animal models
and humans is uncertain.(Rader 2005; Zannis et al. 2005) Additionally, HDL have antioxidant
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properties and prevents LDL oxidation, have anti-inflammatory properties by reduction in
cytokines and adhesion molecules expression, enhance NO production by endothelial cells, have
the ability to bind to SR-B1, and have anticoagulant properties.(Rader 2005; Mineo et al. 2003)
3. Dyslipidemia and risk factors
Dyslipidemia are alterations in normal lipid metabolism and blood values that can be initiated
by lifestyle, dietary, metabolic, and other underlying risk factors but also by genetic diseases
such as familial hypercholesterolemia (deficient LDL receptor) and type III
hyperlipoproteinemia (abnormal apoE).(Bersot & Mahley 2005) They are compelling evidence
linking specific types of dyslipidemia with atherosclerotic diseases. The magnitude and strength
of these associations have been reviewed in international guidelines such as those published by
the AHA, the WHO, the EAS, the international atherosclerosis society (IAS), and the American
Association of Clinical Endocrinologists (AACE) as well as the criteria for intervention defined
(Table 19).(Pearson 2002; Reiner et al. 2011; Kavey et al. 2003; Talayero & Sacks 2011; Miller
et al. 2011; WHO 2007; Smith, Blair, et al. 2001; Wood et al. 1998; Jellinger et al. 2012) Raised
total cholesterol is the most important lipid abnormality and one third of coronary heart disease
worldwide can be attributed to high blood total cholesterol.(WHO 2011)
Table 19: Dyslipidemic risk factors associated with human atherosclerotic diseases (*major
risk factors).
Dyslipidemic risk factors associated with
atherosclerotic diseases
Raised total cholesterol*
Raised LDL cholesterol*
Raised non-HDL cholesterol* (LDL+VLDL)
Low HDL cholesterol*
Raised triglycerides
Raised lipoprotein (a)
Raised apolipoprotein B
Increased ratio apo B/apoA1
Increased ratio non-HDL/HDL
Raised small, dense LDL
Increased LDL particle number
D. Diagnostic techniques
Diagnostic techniques for atherosclerosis are heavily based on imaging techniques to identify
and characterize atheromatous plaques and affected arteries. Functional tests aim to detect
abnormalities in blood pressure, cardiac function, and tolerance to exercise that are linked to
atherosclerotic diseases. They are also, in most cases, prognostic indicators. Furthermore
hematologic, inflammatory markers, and imaging diagnostic tests are used to detect preclinical
atherosclerosis, evaluate the risk to develop subsequent atherosclerotic problems, and for
designing prevention plans.
The ankle-brachial index (ABI) is the ratio between the indirect systolic blood pressure
measured at the ankle and at the arm. The ABI is used for detection of peripheral arterial disease
and is a simple, reproducible, and accurate method of determining, to some degree, the presence
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of arterial obstruction. The normal ABI is 1 and is considered abnormal below 0.9.(Feinstein
2008; Hirsch et al. 2006; Wennberg & Rooke 2005) Pre-exercise and post-exercise ABI can also
be compared. Segmental blood pressure measurements are indicated in the diagnosis and
localization of peripheral arterial disease. Other non-invasive methods used to assess peripheral
perfusion and pulse include pulse volume recording, continuous-wave Doppler ultrasound,
duplex ultrasound, standardized treadmill exercise.(Hirsch et al. 2006)
Diagnostic imaging of arterial luminal stenosis and atheromatous plaques is the cornerstone of
atherosclerosis diagnosis and management. Vascular imaging is evolving rapidly and the
principal techniques are presented in Table 20. The value, invasiveness, and indications of the
various diagnostic imaging technique vary with some aimed to detect luminal narrowing, others
to quantify plaque calcification (CT calcium scoring), and more advanced techniques being able
to provide information on plaque composition and characteristics.(Choudhury et al. 2005)
Table 20: Diagnostic imaging modalities used in human atherosclerotic diseases(Feinstein
2008; Choudhury et al. 2005; Budoff et al. 2008; Pakkal et al. 2011)
Technique
Arteriography

Stress
echocardiography
Transthoracic
Doppler ultrasound
Carotid ultrasound
Transesophageal
ultrasound

Multi-detector CT

Electron-beam CT
(ultrafast CT)

Intravascular
ultrasound

Comments
Gold standard and sensitive for stenosis
Needs arterial catheterization
No information on plaque composition
Used with dobutamine, with coronary heart disease, stress results in
myocardial ischemia manifested in regional wall motion abnormality.
Measurement of coronary flow velocity, ratio between hyperemic state
and baseline. This ratio is correlated to the degree of stenosis.
Correlated to coronary atherosclerosis
Measurement of carotid and aortic wall thickness. Echogenicity of the
plaque reflects its characteristics. Operator dependent and low
reproducibility. Carotid and aortic atherosclerosis are markers for
coronary atherothrombosis.
Cardiac CT with ECG gating, a low heart rate is needed and patients need
to breath-hold. Some patients are pretreated with beta-blockers. With
contrast: coronary angiography, assess the severity of stenosis.
The X-ray tube is large and stationary and the X-ray source point is swept
electronically along the anode in the tube, which is faster than
mechanically. Has been developped specifically for heart because it
moves and acquires information during the cardiac cycle. Calcification
occurs predominantly due to atherosclerosis and in certain arteries is
almost exclusively due to this disease. EBCT determines a calcium score.
Does not require contrast.
Invasive technique using a catheter with a miniaturized ultrasound
transducer. The arterial wall and its different layers are visualized.
Dynamic imaging histology has a high resolution especially in
combination with digital image analysis. Can detect fibrous cap, necrotic
core, and mineralization.
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(Table 20 continued)
Technique
Comments
Intravascular
Evaluation of arterial wall biomechanics, deformation with and without
ultrasound
application of stress. Plaque composition can be inferred from
elastography
biomechanical patterns (lipid rich, fibrous, mineralized).
Optical coherence
Uses back reflected infrared light. Samples with greater heterogeneity of
tomography
optical index of refraction exhibit stronger scattering and stronger OCT
signal. It is an intravascular technique.
Near infrared
Invasive method based on the absorbance of light by organic molecules.
spectroscopy
Can give insight into plaque chemical composition.
MRI
ECG gated. Plaques can be identified and measured. Thrombus can also
be imaged with specific sequences. MRI angiography. Stress MRI.
Molecular imaging
Imaging of plaques using radiolabeled molecules.
PET/SPECT-scan
Imaging agents can be detected at very low concentration. 18FDG, a
glucose analog accumulates in plaques in symptomatic patients.
E. Medical management and treatment
i. Reduction of risk factors and prevention
General guidelines for risk reduction have been proposed by the AHA, WHO, and EAS.
Guidelines are mainly based on lifestyle and dietary modifications combined with cardiovascular
risk reduction using therapeutic drugs for dyslipidemia and hypertension.(Hirsch et al. 2006;
Smith, Blair, et al. 2001; Pearson 2002; Kavey et al. 2003; Reiner et al. 2011; WHO 2007;
Weintraub et al. 2011; Smith et al. 2011) With the premise that atherosclerosis begins early in
life, the main targets for general and global prevention are the major risk factors and prevention
campaigns are primarily focused on smoking cessation, healthy dietary habits, reduction of blood
pressure and obesity, increased physical activity, and reduced sedentary lifestyle. For instance, at
least 30 minutes of moderate-intensity physical activity per day is recommended and dietary
measures include reduction in calories, overall fat, saturated fat, trans-fat, cholesterol, sodium,
alcohol and increased consumption of fruits, vegetables, whole grains, potassium, omega-3 fatty
acids, and fish. Target values for total, LDL, and HDL cholesterol as well as for blood pressure
have been determined. Aggressive risk reduction is recommended for secondary prevention after
a first cardiovascular event.
ii. Medical treatment
1. Statins
The statins are a homogenous group of lipid-lowering drugs. They inhibit the biosynthesis of
cholesterol by targeting the hepatic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA)
reductase that participates in a critical step in the mevalonate pathway.(Paoletti et al. 2005) They
are, in fact, HMG-CoA structural analog. Several statins are commercially available: lovastatin,
simvastatin, pravastatin, fluvastatin, atorvastatin, and rosuvastatin. Among these drugs, only
atorvastatin and rosuvastatin have a long half-life in humans of about 15-30h and are the most
used statins at the present time.(Paoletti et al. 2005) A comprehensive systematic review on the
use of statins in primary prevention concluded that statins reduced mortality and cardiovascular
events due to atherosclerosis and were associated with significant reduction in total and LDL
cholesterol.(Taylor et al. 2012) Multiple large scale studies and meta-analyses have also showed
the beneficial effect of statins in both primary and secondary prevention.(Reiner et al. 2011) The
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lipid effects of statins include lowering LDL by 18-55%, triglycerides by 7-30%, and increasing
HDL by 5-15%.(Pasternak et al. 2002) In addition, statins have other non-lipid beneficial effects
(Table 21). Side effects are uncommon and mainly muscular and include rhabdomyolysis and
myalgia.(Taylor et al. 2012; Pasternak et al. 2002; Paoletti et al. 2005) Some statins have
pharmacologic interactions, mainly with drugs metabolized by the cytochrome P450 pathway
such as antifungals.(Pasternak et al. 2002; Paoletti et al. 2005)
Table 21: Non lipid-effect of statins.(De Loecker & Preiser 2012; Paoletti et al. 2005; Pahan
2006)
Non lipid-effects of statins
Endothelial function
Attenuate endothelial monocyte adhesion
Up-regulation of endothelial NO synthase
Decrease in oxidative stress
Vascular inflammation
Reduction in CRP
Reduction in local inflammatory markers
(chemokines, adhesion molecules, cytokines)
Immunomodulatory
Decrease MHC-II expression and activity
Decrease TLR-4 expression
Decrease T-cell activation
Decrease monocyte/macrophage proliferation
Antioxidant
Decrease NADPH oxidase activity
Increase heme oxygenase activity
Antithrombotic
Decrease platelet activity
Decrease plasminogen activator
Increase tissue plasminogen activator
Increase thrombomodulin activity
Plaque stabilization
Inhibition of macrophage foam cell formation
Prevention of smooth muscle cell proliferation
Decrease in plaque thrombogenicity
2. Fibrates
Fibrates such as gemfibrozil or fenofibrate are hypolipidemic drugs used in the management of
hypertriglyceridemia and dyslipidemia, especially diabetic dyslipidemia. Fibrates are agonist of
the peroxisome proliferator-activated receptor alpha (PPARα) which stimulates β-oxidation of
fatty acids. PPARα is a transcription factor that modulates expression of specific target genes and
results in increased β-oxidation in the liver, decreased hepatic triglyceride secretion, increased
lipoprotein lipase activity, increased HDL, and increased clearance of remnant
particles.(Robillard et al. 2005; Chapman 2006; Pahan 2006) Elevated triglycerides level can
decrease by up to 50% and HDL can increase by up to 5-15%.(Chapman 2006) Fibrates also
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have non-lipid positive effects on atherogenesis prevention such as an influence on endothelial
dysfunction and monocytes adhesion and other steps of atherosclerotic lesion development such
as foam cell formation and fibrous plaque development.(Robillard et al. 2005) A number of
clinical trials have demonstrated a significant reduction of cardiovascular risks and beneficial
effects on atherosclerotic lesion progression.(Robillard et al. 2005; Jun et al. 2010) Fibrates can
also be used in combination with statins. Side effects appear to be uncommon as for statin drugs
and include myopathy and stomach upset especially when gemfibrozil is combined with a statin.
Long-term use of fibrates has been associated with peroxisome proliferation and hepatic tumors
in laboratory rodents.(Pahan 2006)
3. Others
Bile acid sequestrants (resins) such as colestipol are not systemically absorbed and prevent the
reabsorption of bile acids during the enterohepatic circulation of bile acids. Therefore, the liver
synthetizes bile acids from cholesterol stores which subsequently increases LDL receptor activity
and decreases LDL cholesterol blood levels. Reduction in LDL cholesterol is typically of a
magnitude of 15-30% with no effect on other lipid values.(Reiner et al. 2011; Gotto & Farmer
2005)
Ezetimibe is a relatively new cholesterol absorption inhibitor which acts at the level of the brush
border of the intestine. There is a subsequent decrease in the delivery of cholesterol to the liver
by the intestine. Ezetimibe is frequently used in combination with statins and further decreases
LDL cholesterol by 15-20%.(Reiner et al. 2011; Gotto & Farmer 2005)
Nicotinic acid has broad dyslipidemic indications and promotes HDL increase, LDL, VLDL, and
triglycerides decrease by a reduction in the flux of fatty acids from adipose tissue to the liver. It
also shows important decrease in lipoprotein(a).(Reiner et al. 2011; Gotto & Farmer 2005)
Patients with severe dyslipidemia may require low-density lipoprotein apheresis during which
LDL and lipoprotein(a) are removed from the blood during weekly extracorporal circulation
procedures.(Reiner et al. 2011)
Antihypertensive drugs such as ACE inhibitors and angiotensin II receptor antagonists (sartans
via AT1 receptor) are beneficial in atherosclerosis when hypertension is present.(Dendorfer et al.
2005) Angiotensin II aggravates hypertension, metabolic syndrome, dyslipidemia, oxidative
stress, inflammation, and endothelial dysfunction and has procoagulatory effects and promotes
plaques destabilization. Antihypertensive drugs improve prognosis and reduce overall mortality
after coronary disease events. Their actions are due to antihypertensive effects but they also
improve vascular function, decreased myocardial remodeling, and improved vascular neurohormonal regulation.(Dendorfer et al. 2005)
Beta blockers have been shown to reduce the progression of atherosclerotic lesions, recurrence of
myocardial infarction, and systemic blood pressure.(Sipahi et al. 2007; Bondjers 1994)
Platelets are involved in all stages of the pathogenesis of atherosclerosis and thrombosis and
thromboembolism are ultimately the factors leading to acute clinical signs. In addition, a
prothrombotic tendency is present in patients suffering from atherosclerotic diseases. Antiplatelet
therapy commonly involves the use of aspirin, cilostazol, and clopidrogel but a large number of
other compounds are also effective.(Ahrens et al. 2005) Aspirin, principally used in the treatment
of atherothrombosis and strokes, inhibits cyclooxygenases COX-1 (expressed by platelets) and
COX-2 thereby inhibiting the production of thromboxane TXA2. Cilostazol inhibits platelet
activation and increase vasodilation and is mainly used in the treatment of peripheral arterial
disease.(Ahrens et al. 2005; Hirsch et al. 2006) Clopidrogel is now the drug of choice in
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antiplatelet therapy because of excellent tolerability and low rate of side-effects. Clopidrogel is a
P2Y12 ADP receptor antagonist which is important in platelet aggregation and cross-linking of
platelets by fibrin.(Ahrens et al. 2005)
F. Mammal models of atherosclerosis
i. Generalities
Animals have been used to experimentally reproduce atherosclerosis for more than a
century.(Ignatowski 1908; Starokadomsky & Ssobolew 1909) Animal models provide the
necessary controlled conditions to study the pathogenesis, management, treatment, risk factors
while avoiding other confounding factors and approximating the naturally occurring disease of
humans. Even with the considerable growth of in vitro research and cell culture experiments in
atherosclerosis, animal models will still be useful in order to account for the complexity of real
disease processes and their pathophysiology. There is a wide diversity of animal models that
have been developed over the years with advantages and disadvantages inherent to each one. It is
also important to realize that these models have been designed to develop atherosclerotic lesions
in weeks to months, which normally take decades to develop in spontaneously occurring disease.
Animal models of atherosclerosis develop lesions spontaneously or induced by dietary
modifications, mechanical, chemical, immunological interventions, or by use of defective
animals or genetic manipulations.(Moghadasian 2002)
When interpreting study results obtained from animal models, one should bear in mind the
inherent limitations of such models and the difficulties in translating findings to the human
disease or among animal species.(Libby et al. 2011)
ii. Rabbits
The first experimental diet-induced atherosclerosis study was conducted in
rabbits.(Ignatowski 1908; Cullen et al. 2005; Moghadasian 2002) New Zealand White rabbits
develop atherosclerotic lesions when fed a diet modified with 0.5-2% cholesterol, which is
normally lacking from their herbivorous diet, for 4-16 weeks.(Cullen et al. 2005; Drew 2010)
Since then, it has been shown that lesions may develop with feeding cholesterol amount as low
as 0.1%.(Kolodgie et al. 1996). Rabbits absorb cholesterol efficiently and high plasma
cholesterol is achieved. Along with cholesterol supplementation, other dietary modifications
have also been implemented to induce lesions in rabbits using different types of oils and specific
proteins.(Yanni 2004) Rabbits are particularly sensitive to dietary cholesterol induction of
atherosclerosis due to their inability to increase sterol excretion in response to excess intake
which leads to increased liver export of cholesteryl ester-rich lipoproteins into the circulation
which subsequently accumulates in lesion-prone areas.(Thompson & Zilversmit 1983;
MacKinnon et al. 1985; Kolodgie et al. 1996) Lesions in diet-induced atherosclerosis are usually
localized in the aortic arch and ascending aorta.(Drew 2010; Moghadasian 2002; Yanni 2004)
Lesions are highly lipid filled and macrophage rich and different from spontaneous lesions in
humans.(Drew 2010; Cullen et al. 2005) However, feeding lower concentrations of cholesterol
for longer periods or altering the source of fat may produce lesions more closely resembling
those of humans.(Kolodgie et al. 1996; Kritchevsky et al. 1984; Yanni 2004) Dietary
modifications can also be combined with mechanical injuries, such as performed with balloon
injury, to accelerate lesion formation and stimulate the formation of a fibrous cap and a
neointima.(Yanni 2004; Worthley et al. 2000) Genetic variants of the rabbit such as the
Watanabe, St Thomas, and Houston RT present genetic abnormalities in lipid metabolism and
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may develop atherosclerosis faster and with minimal dietary modifications.(Yanni 2004)
Transgenic rabbits with altered gene expression have also been produced such as with increased
apoA-1 expression, overexpression of LCAT (involved in HDL metabolism), apolipoprotein(a),
or lipoprotein lipase which leads to a reduction in LDL and VLDL concentrations.(Yanni 2004;
Moghadasian et al. 2001) Plaque rupture has been induced in rabbits by balloon injury.(Vilahur
et al. 2011)
Rabbits possess similarities to humans in their lipoprotein metabolism: similar composition of
apolipoprotein B containing lipoproteins, production by the liver of apo B100-containing VLDL,
plasma cholesteryl ester transfer protein (CETP) activity, and efficient absorption of dietary
cholesterol.(Moghadasian et al. 2001) Watanabe heritable hyperlipidemic rabbit constitutes a
model for human familial hypercholesterolemia and have a defect in membranous LDL
receptor.(Drew 2010; Yanni 2004; Watanabe 1980)
Rabbits models have been used in studies investigating lesion characterization, pathogenesis,
therapeutics, mechanical injury, and arterial metabolism.(Drew 2010; Yanni 2004)
Disadvantages of rabbit models of atherosclerosis include differences in lesion location and
composition with humans, absence of spontaneous disease without experimental modification,
deficiency in hepatic lipase, cholesterol storage syndrome and that hepatotoxicity may develop
on prolonged cholesterol feeding.(Yanni 2004; Drew 2010; Moghadasian et al. 2001)
iii. Swine
Swine develop spontaneous atherosclerosis in the coronary arteries. They can develop fatty
streaks at 6 months and advanced lesions when older than a year.(Gottlieb & Lalich 1954; Drew
2010) Pig lesions show a high degree of similarity to human atherosclerosis but regular pigs do
not develop intralesional haemorrhage or thrombosis.(Drew 2010; L Badimon 2001) Lesions are
typically induced by cholesterol feeding but can occur when fed a normal porcine diet for a long
time.(Singh et al. 2009; Moghadasian 2002) Pigs may develop fibrofatty lesions in about 14
weeks and atheromatous plaques in 24 weeks.(Holvoet et al. 1998; Badimon 2001) A pig variety
(white Belgian) also experiences acute death from coronary disease when under stress.(Badimon
2001) Some lines of naturally defective pigs with apolipoprotein-associated mutations (Lpb5,
Lpr1, Lpu1) develop hypercholesterolemia and accelerated atherosclerosis without dietary
manipulation.(Prescott et al. 1991) Miniature swine are used preferentially for economic reasons
and some breeds are highly susceptible to diet-induce disease (e.g. Yucatan miniature pig).(Drew
2010; Reitman et al. 1982) Microminipigs have also been used recently.(Kawaguchi et al. 2011)
The IHLC (inherited hyperlipoproteinamia and hypercholesterolemia) pig is an inbreed strain
with reduced catabolism of LDL that develops advanced atherosclerosis at an accelerated
rate.(Rapacz & Hasler-Rapacz 1989)
Swine are popular models for atherosclerosis research because they develop spontaneous
lesions in similar locations (in particular the coronary arteries) and have similar cardiovascular
anatomy to humans, they are omnivorous with a tendency to overeat, they share similarities in
lipoprotein metabolism and atherogenic pathways with humans, and they are large enough for
cardiovascular surgery, angioplasty, and cardiac imaging.(Drew 2010; Moghadasian et al. 2001;
Paslawski et al. 2011; Singh et al. 2009; Vilahur et al. 2011) Disadvantages of pig models of
atherosclerosis include the cost and facilities for maintaining pigs in laboratories and
handling.(Cullen et al. 2005; Badimon 2001)
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iv. Guinea pigs
Guinea pigs develop diet-induced atherosclerosis and, as humans, transport the majority of
their cholesterol in LDL and possess plasma CETP activity, which is different from other rodent
models.(Fernandez & Volek 2006; West et al. 2003; Singh et al. 2009; Xiangdong et al. 2011)
They also show lecithin/cholesterol acyltransferase and lipoprotein lipase activities.(Fernandez &
Volek 2006; Singh et al. 2009) Ovariectomized guinea pigs have been used as animal models of
atherosclerosis in post-menopausal women because of similar plasma lipid profile.(Fernandez &
Volek 2006) Guinea pig models have been used to study diet intervention (fat saturation of the
diet, influence of fibers, dietary supplements) and drug investigations. Disadvantages are that
guinea pigs require constant supplementation with vitamin C which is an antioxidant and may
interfere with atherosclerosis induction, they do not develop advanced lesions, and there is a lack
of antibodies available for research.(Singh et al. 2009; Fernandez & Volek 2006)
v. Hamsters
Hamsters fed an atherogenic diet develop hypercholesterolemia and atherosclerosis. Dietary
manipulation causes a drastic increase in LDL / VLDL cholesterol and a decrease in HDL
cholesterol. In addition, golden-Syrian hamsters have plasma CETP activity and receptormediated uptake of LDL.(Moghadasian 2002; Dillard et al. 2010; Xiangdong et al. 2011; Singh
et al. 2009) Several strains, in particular the F1B, have been obtained to study diet-induced
atherosclerosis. They develop mild to moderate lesions in the ascending aorta after several
months of feeding.(Xiangdong et al. 2011; Dillard et al. 2010) However, hamster models are no
longer considered to be suitable to study experimentally-induced atherosclerosis due to
inconsistency in the development of lesions regardless of dietary modifications and the absence
of advanced lesions.(Dillard et al. 2010; Singh et al. 2009)
vi. Rats
Rats are highly resistant to atherosclerosis even with increased dietary cholesterol. Therefore
genetic manipulations are usually necessary to induce the lesions. Unlike humans, rats do not
have plasma CETP activity and most of the cholesterol is transported through HDL
particles.(Xiangdong et al. 2011) Atherosclerotic lesions present major differences with humans.
These major limitations hamper the use of rat models in atherosclerosis research. Nevertheless,
inbred strains of rats with inherited hypercholesterolemia are more prone to atherosclerosis and
consequently have been used in atherosclerosis research.(Xiangdong et al. 2011; Singh et al.
2009) Transgenic rats have been produced, notably the CETP transgenic Fisher rat which shows
a high increase in non-HDL cholesterol when fed atherogenic diets.(Singh et al. 2009) Rats have
been used to study vascular inflammation, hyperlipidemia, hypertension, and angioplasty.(Singh
et al. 2009) Sand rats have a propensity to become obese and insulin resistant and may be a good
model for atherosclerosis associated with type II diabetes.(Singh et al. 2009)
vii. Mice
Mice are undoubtedly the most widely used animal models in atherosclerosis research and
contemporary research is dominated by the use of murine models. Like rats, mice are naturally
resistant to atherosclerosis but the recent use of transgenic and knockout technology to create
various atherosclerosis-prone lines stimulated their use.(Xiao 2010; Daugherty & Rateri 2005)
Also similar to rats and unlike humans, mice do not have plasma CETP activity and most plasma
cholesterol is found in HDL.(Moghadasian et al. 2001) The small size of mice also limits
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frequent blood sampling and dissection of small arteries. Nevertheless, mice models of
atherosclerosis are popular because their genetic makeup ia well-defined, the low cost allows for
the use of a large number of animals, they breed and can be easily handled, and a large number
of transgenic lines are available.(Moghadasian et al. 2001; Xiangdong et al. 2011)
In some inbred strains of mice such as in the C57BL/6J, mild atherosclerosis can be induced
by dietary modification with a high fat / high cholesterol atherogenic diet that also typically
includes cholic acid and is referred to as the Paigen diet.(Nishina et al. 1990; Jawien et al. 2004;
Paigen et al. 1985) Cholic acid has the ability to induce inflammation, hence enhancing
atherogenesis. Lesions are usually confined to the aortic root and rarely progress to advanced
stages.(Jawien et al. 2004) In transgenic models, lesions are also frequently amplified by dietary
modifications with western-type diet (0.15% cholesterol, 21% fat), which is more physiological
than an atherogenic diet.(Xiao 2010; Daugherty & Rateri 2005) To investigate specific
atherogenesis pathways and given that atherosclerosis is strongly linked to dyslipidemia, various
models have been established by genetic manipulation of the lipid metabolism. The genetic
background of the transgenic mice also plays a significant role in atherosclerosis
susceptibility.(Dansky et al. 2002) Apolipoprotein E knockout mice (apoE-/-) was the first gene
deletion performed in murine models.(Jawien et al. 2004; Xiao 2010; Daugherty & Rateri 2005;
Xiangdong et al. 2011; Moghadasian et al. 2001; Piedrahita et al. 1992) This deficiency leads to
accumulation of atherogenic lipoprotein particles (apoE is a ligand of LDL receptor), lower HDL
concentration, elevated cholesterol and triglycerides levels in the blood, and apoE-/- mice
spontaneously develop reproducible and advanced atheromatous plaques even in the absence of
dietary modification. The characteristics of the lesions present in this model are relatively similar
to humans with the presence of fatty streaks that progress to advanced lesions with a lipid core
which frequently displays calcified areas covered by a fibrous cap.(Daugherty & Rateri 2005)
Plaque rupture is also seen in apoE-/- mice atherosclerotic lesions.(Johnson et al. 2005) ApoE-/mouse models have been used for experiments on atherogenesis, risk factors, and to assess and
screen for therapies.(Daugherty & Rateri 2005) LDL receptor deficient (LDLR-/-) mice are used
as a model of human familial hypercholesterolemia and atherosclerosis and need to be fed an
atherogenic diet to obtain advanced lesions.(Ishibashi et al. 1993; Daugherty & Rateri 2005;
Xiao 2010) ApoE/LDLR double knock-out mice have been created to develop both severe
hyperlipidemia and atherosclerosis.(Ishibashi et al. 1994) Transgenic mice expressing normal
(apoE2, apoE3) and defective variants (e.g. APOE*Leiden, APOE R142C) of the human
apolipoprotein E have also been produced to study inherited human dyslipidemia.(Xiao 2010)
These strains need additional dietary stimulation to develop significant lesions. A large number
of other transgenic variants (overexpression of apoB100, apo(a), apoC-III, Lp(a), CETP, LCAT,
knockout of CD36, SR-A) have been generated and have been used to understand further the
mechanism of the disease and screen newer drugs.(Singh et al. 2009; Xiao 2010; Moghadasian et
al. 2001; Penn & Chisolm 2005) Cross-breeding of different transgenic mice results in the
production of additional strains with specific characteristics. Experimental hypertension, one of
the major risk factor of atherosclerosis and plaque rupture has been induced in transgenic mice
using angiotensin II or deoxycortisone acetate salt administration.(Singh et al. 2009; Weiss et al.
2001; Weiss & Taylor 2008)
viii. Non-human primates
Non-human primates are phylogenetically close to humans and eat an omnivorous diet. They
have similarities in lipoprotein composition and metabolism. Mild lesions may develop
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spontaneously but feeding an atherogenic diet can induce advanced lesions. Lesions are similar
to humans, present plaque calcification, and can be complicated with thrombosis leading to
myocardial infarction.(Drew 2010; Singh et al. 2009) Therefore results obtained in these species
may be more directly applicable to humans. New world monkeys are of limited use in
atherosclerosis research due to severe complications such as chronic renal disease that are
associated with atherogenic diets, inconsistent development of lesions, and a different anatomical
distribution.(Clarkson 1998; Drew 2010) Old world monkeys such as rhesus and cynomolgus
monkeys developed more consistent lesions and show sex predilection similar to
humans.(Clarkson 1998; Drew 2010) Other old world primates that have been used include
baboon, pigtail, stumptail, green monkey, and chimpanzees.(Singh et al. 2009; Blaton & Peeters
1976; Rainwater et al. 2009) Familial LDL receptor deficiency has been reported in rhesus
monkey.(Scanu et al. 1988) Some laboratory assays designed for humans cross-react with
monkeys.(Vilahur et al. 2011) Non-human primates have been used to study thrombosis
associated with atherosclerosis, platelet function, pharmacokinetics of anti-atherosclerosis drugs,
risk factors, and vascular surgery.(Vilahur et al. 2011; Singh et al. 2009; Rainwater et al. 2009)
Disadvantages of the use of primates include expense, difficulties in maintenance and handling,
availability, endangered species, and ethical considerations.(Drew 2010)
ix. Dogs and cats
Dogs and cats are extremely resistant to atherosclerosis and spontaneous lesions are rare.
Dogs lack plasma CETP activity and HDL particles are their main cholesterol
transporters.(Xiangdong et al. 2011) Experimental diet-induced atherosclerosis is possible with
very high cholesterol content (5%) and saturated fat but advanced lesions are not
common.(Xiangdong et al. 2011; R.W. Mahley et al. 1974; Singh et al. 2009) Beagles have
similarities with humans in their lipid metabolism and have been used to study statin
therapy.(Singh et al. 2009) Due to their large size, dogs are used for imaging studies,
cardiovascular surgeries, atherothrombosis, and myocardial infarction.(Singh et al. 2009; Vilahur
et al. 2011) Limitations include poor response to dietary induction, large amount of experimental
agents needed, and ethical concerns.(Singh et al. 2009; Xiangdong et al. 2011; Moghadasian et
al. 2001)

III. Avian atherosclerosis
A. Peculiarities of avian lipoprotein metabolism
Lipids are present throughout the avian body but most significant deposits are found in
adipose tissues and, to a lesser extent, in the liver. Adipose tissues can be found in the abdomen
(mainly) and subcutaneous and intramuscular tissues. The capacity of birds for storing fat
exceeds that of any other class of vertebrates. Their lymphatic system is poorly developed and
they have differences in bile composition and anatomy of the pancreatic duct that enters the
distal portion of the duodenum.(Petzinger et al. 2010; King & McLelland 1984)
Triglycerides, cholesterol, and cholesteryl ester are present in the tissues and they are either
acquired through the diet or produced de novo. Triglycerides are produced in the liver and
lipogenesis is limited in the adipose tissue unlike in mammals.(Alvarenga et al. 2011) Similar
enzymatic pathways are present in avian tissues with for instance HMG-CoA reductase and
synthase. Also the large lipid deposits in the egg yolk have to be transported from the liver to the
oocyte. As in mammals, most lipids are transported in the form of lipoproteins in order to
solubilize lipids in the blood and interact with a variety of receptors in effector cells. The same
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VLDL, IDL, LDL, HDL fractions are present but lipoprotein (a) has not been described in avian
species yet. Similar HDL subfractions found in mammals are also present in birds.(Petzinger et
al. 2011; Langelier et al. 1976) Lipoproteins have been mostly studied in the domestic fowl for
commercial reasons and in avian models of atherosclerosis, notably the pigeon and the Japanese
quail.(Wu & Donaldson 1982; Nagata et al. 1997; Iwasaki et al. 2000; Hammad et al. 1998;
Alvarenga et al. 2011; Jones 1997; Langelier et al. 1976; Barakat & St Clair 1985; Schwenke &
St Clair 1993; Hermier 1997) The roles of the different classes of lipoproteins are similar to
mammals but a few differences exist. VLDL serve to transport endogenous lipids but also
exogenous lipids from the small intestines.(Stevens 1996) In addition, since birds do not have a
well-developed lymphatic system, triglycerides absorbed from gastrointestinal system are
transported directly to the liver via the liver portal system as portomicrons, chylomicrons are not
present.(Stevens 1996) Most birds transport the majority of their cholesterol as HDL.(Lizenko et
al. 2007; Langelier et al. 1976; Anderson et al. 2012; Barakat & St Clair 1985; Suckling &
Jackson 1993) Similar apolipoproteins are found in birds but some differences in structure and
repartition in the lipoproteins are present. No apoE and apoB-48 have been detected in avian
species.(Singh et al. 2009; Moghadasian et al. 2001; St Clair 1998) The avian apoA-I has some
homology with the mammalian apoA-I but is a monomer and possess activities similar to the
mammalian apoE. ApoB-100 is the main lipoprotein present in portomicrons, VLDL, IDL, and
LDL and apoA-I the main lipoprotein present in HDL. Avian LDL have the ability to bind
mammalian LDL receptors which demonstrates similarities in structure and function. Similar
important transfer proteins and enzymes are present in birds such as LCAT, CETP, lipoprotein
lipase, scavenger receptors, and ABCA-1.(Alvarenga et al. 2011; Anderson et al. 2012)
One major difference from mammals is that birds need to transport lipid synthetized in the
liver to the developing oocyte to form the future egg yolk. Lipoproteins responsible for this
process are VLDL and vitellogenin (VTG), a special type of lipoproteins, which are regulated by
estrogen secretion. Apo VLDL-II is a unique apolipoprotein present in yolk-labelled VLDLy and
induced by estrogens that have anti-lipoprotein lipase activities.(Alvarenga et al. 2011; Walzem
et al. 1999) VLDLy are smaller than standard VLDL to pass through the granulosa basal lamina
to reach receptors of the LDL family (LR8) located on the oocyte surface.(Schneider 2009)
ApoB of VLDLy binds to these receptors.(Alvarenga et al. 2011) VTG is a very high density
lipoprotein targeting exclusively the yolk via the same receptor-mediated endocytosis. During
the egg formation, total cholesterol, triglycerides, VLDL, total proteins, and protein-bound
calcium increase dramatically and may have some implications in the pathogenesis of
atherosclerosis in female birds.(Lumeij 2008; Alvarenga et al. 2011) Hematologic changes also
occur, including a slight increase in the total white blood cell and red blood cell counts.(Joyner
1994)
B. Avian models of atherosclerosis
i. Pigeons (Columbia livia)
The pigeon has been one of the most used animal models in atherosclerosis research since the
first demonstration of the lesion in 1959.(Clarkson et al. 1959) Its use is falling out of favor since
the emergence of transgenic animals, notably mice. One of the main features of avian models is
that they spontaneously develop atherosclerosis with aging. The White Carneau (WC) pigeon is
very susceptible to atherosclerosis even on standard grain diet while the show racer (SR) pigeon
is relatively resistant. This difference in susceptibility lies at the level of the aortic wall, is an
autosomal recessive genetic trait, and may be expressed by aortic SMC.(Smith, Smith, et al.
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2001; Anderson et al. 2012) On a standard grain diet (cholesterol-free), WC pigeons develop
lesions in 3-4 years, mainly in the thoracic aorta at the bifurcation of the celiac artery.(St Clair
1998; St Clair 1983; Santerre et al. 1972) When atherosclerosis developed in coronary arteries,
lesions involve mainly the intramyocardial coronary arteries and seem to occur independently
from aortic lesions.(St Clair 1998) Pigeons respond well to cholesterol feeding to accelerate
lesion formation typically at 0.5-1%. Also, pigeons are naturally hypercholesterolemic when
compared to humans.(Anderson et al. 2012) As in most birds, the majority of the cholesterol is
transported in HDL but β-VLDL and LDL are predominant in cholesterol-fed birds. However, in
less than 3 day old nestlings, cholesterol is mainly transported in the form of LDL.(Anderson et
al. 2012) WC pigeons have a higher plasma cholesterol levels than SR, a higher percentage of
plasma esterified cholesterol, and higher sterol and steryl ester arterial concentrations but these
differences are relatively mild and often not statistically different.(St Clair 1998; Subbiah et al.
1970; Langelier et al. 1976; Barakat & St Clair 1985; Anderson et al. 2012) When fed a
cholesterol rich diet, total cholesterol and LDL cholesterol increase by about 5-15 times.(Barakat
& St Clair 1985; Bavelaar & Beynen 2004b) Pigeons have been widely used to study the
pathogenesis of atherosclerosis and its genetic determinants.(St Clair 1998; Prichard et al. 1962;
Jerome & Lewis 1990; Schwenke & St Clair 1993; Lewis et al. 1985; Jerome & Lewis 1997;
Taylor & Lewis 1986) The histopathology and ultrastructure of the pigeon atherosclerotic lesions
are similar to humans with the presence of extra and intracellular fat and cholesterol, fibrous
tissues, SMC- and macrophages-derived foam cells.(St Clair 1998; Santerre et al. 1972; Lewis et
al. 1985; Barr et al. 1991; Hansen 1977) Furthermore, endothelial changes consistent with
endothelial activation and monocyte adhesion to the endothelium have been demonstrated by
electron microscopy.(Li 1989; Lewis & Kottke 1977; Taylor & Lewis 1986; Jerome & Lewis
1984) Macrophage foam cells appear early in the lesion formation and phenotypic switch of
SMC from a contractile to a synthetic phenotypes was observed.(Jerome & Lewis 1984; St Clair
1998; Wight et al. 1977; Li 1989) Complications are also encountered with advanced lesions
including hemorrhage, ulceration, mineralization, and thrombosis leading to myocardial
ischemia, which constitute a major advantage of pigeon models.(St Clair 1998; Anderson et al.
2012; Prichard et al. 1963) Comparative studies between the WC and SR pigeons have
demonstrated some constitutive differences in the arterial wall with a higher level of
glycosaminoglycans (in particular chondroitin-6-sulfate known to bind to LDL), lipid,
cholesterol esters, and metabolic differences.(Anderson et al. 2012; Santerre et al. 1972)
Furthermore, an in vitro proteomic experiment showed differential gene expression between
aortic SMC cultured from both breeds. In SR, genes expressed were more indicative of a
contractile phenotype whereas WC expressed proteins reflecting a synthetic phenotype as well as
the production of proteases and inflammatory signals.(Smith et al. 2008)
Unlike chickens, no relationship has been observed between columbid herpesvirus infection
and atherosclerosis. Main advantages of the pigeon model are that atherosclerotic lesions occur
spontaneously, complications and myocardial ischemia arise, and lesions are similar to humans.
Disadvantages are those shared by all avian models, the differences from mammals in
lipoproteins composition and metabolism, particularly in reproductively active females, and
differences in arterial microanatomy (no SMC in intima, fibroblast-like cells in the
media).(Anderson et al. 2012; Moghadasian 2002; Stout & Thorpe 1980)
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ii. Japanese quails (Coturnix coturnix japonica)
Japanese quails develop diet-induced atherosclerosis and myocardial infarction and were first
used as a model in 1972.(Ojerio et al. 1972) Susceptible and resistant strains are described.
Similar to pigeons, coronary atherosclerosis developed primarily in intramyocardial coronary
arteries. Lesions are similar to humans.(Bocan et al. 1994; Chapman et al. 1976) The SEA
(susceptible to experimental atherosclerosis) quail strain is highly susceptible to diet-induced
lesions and become hypercholesterolemic with a shift from HDL to VLDL and LDL as the main
lipoproteins in the blood.(Radcliffe & Liebsch 1985; Shih et al. 1983) Increased levels of dietary
cholesterol correlate with the severity of the lesions which can progress to stenosis and
infarction.(Shih et al. 1983) Depending on the strain and experimental protocol, quails typically
develop lesions from 10-15 weeks to 9-28 months.(Bavelaar & Beynen 2004b) Quails have been
extensively studied for therapy but also in studies on the role of viruses in lesion development.(St
Clair 1998; Day et al. 1977) Advanced atherosclerosis can take up to 2 years to occur with
cholesterol feeding. The main advantage of quails is their low cost and small size.
iii. Chickens (Gallus gallus domesticus)
Chickens develop atherosclerotic lesions naturally in the aorta and coronary arteries and
cholesterol feeding accelerates the development of lesions.(St Clair 1998; Dauber & Katz 1943)
Lesions are initially fibrous and can be induced in as little as 2 weeks.(Xiangdong et al. 2011) As
in women, estrogen reduced atherosclerosis in chickens, mainly in the coronary arteries.(Pick et
al. 1952) Chickens are naturally hypercholesterolemic but transport most of their cholesterol in
HDL. Addition of estradiol to the diet can stimulate the development of lesions in
chickens.(Toda et al. 1981) Some lines of chickens deficient in VLDL, LDL, or HDL have been
described.(Ayala et al. 2005) Marek’s disease, an herpesvirus, has also been shown to promote
atherosclerotic lesions in chickens. Mechanical denudation of the endothelium has been
performed in chickens to induce focal atherosclerotic lesions.(Lucas et al. 1996) Additional
advantages of chickens are that they are omnivorous and are cost effective to maintain.
iv. Others
Turkeys develop atherosclerosis naturally which can lead to aortic aneurysm.(Gresham &
Howard 1961) Atherosclerotic lesions have also been encountered in wild turkeys.(Manning &
Middleton 1972; Krista & McQuire 1988) Aortic aneurysm has been suggested to be related to
copper deficiency and hypertension. Turkeys have high systemic arterial blood pressure, the
highest recorded in vertebrates.(Smith et al. 2000)
Budgerigars have been used once in 1962 and developed severe atherosclerosis on a 2%
cholesterol diet with 15% lard after 2-6 months.(Finlayson & Hirchinson 1961) Budgerigars
have also been used for in vivo thrombosis assay.(Schmaier et al. 2011)
Several other avian species have been fed atherogenic diet anecdotally but these species have
many experiments.
C. Psittacine atherosclerosis
i. Epidemiology and risk factors
The prevalence of atherosclerosis has been documented in multiple sources and ranges from
1.9% to 91.8% (Table 22).(Bavelaar & Beynen 2004a; Garner & Raymond 2003; Johnson et al.
1992; Pilny 2004; Fricke et al. 2009; Krautwald-Junghanns et al. 2004; Pilny et al. 2012;
Bavelaar & Beynen 2003; Kellin 2009; Grunberg 1964; Finlayson 1965) The wide range of
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reported prevalence is likely due to reports varying in inclusion criteria, lesion severity,
geographical area, demographics and captive conditions of the studied population, psittacine
species, and retrospective or prospective nature of the work. In one study reporting a relatively
high number of psittacine cases, after review of the original database, the population was found
to be composed for the most part of neonates and juvenile birds.(Johnson et al. 1992) In a
prospective study, all types of atherosclerotic lesions also comprising early stages were included
in calculation of the prevalence which lead to the highest reported prevalence of atherosclerosis
in the literature (91.8%).(Fricke et al. 2009) While such a high variability in reported prevalence
precludes a correct appreciation of the true importance of atherosclerosis in the captive psittacine
population, previous investigations make clear that the condition can be frequent in some captive
psittacine bird populations. The main drawback of previous pathology surveys is the lack of
well-defined histopathologic inclusion criteria based on an established classification system of
psittacine atherosclerotic lesions. For instance, some authors established their own classification
system based on histopathology while others only used macroscopic criteria such as Sudan
staining of arteries.(Fricke et al. 2009; Schenker & Hoop 2007; Bavelaar & Beynen 2004a) Also,
the prevalence for pathologic lesions including early and mild lesions that seldom lead to clinical
signs is of suspect clinical use, especially since it can be expected to vary significantly with age
groups. Most studies focused on the pathologic lesions with little attention being drawn to
estimating the prevalence of atherosclerosis-induced diseases and the clinical aspects of
atherosclerosis. Finally, correct statistical analyses with at minima an estimation of the precision
of the prevalence being reported (e.g. confidence intervals) were not performed in any study
previously published which were most often limited to the documentation of raw percentages.
Table 22: Prevalence of atherosclerosis in Psittaciformes as reported in the literature sorted
by year of publication (methods, inclusion criteria, and population demographics varied
substantially between reports, %: raw prevalence, N: total number of birds investigated)
N
1157
97
126
72
1322
394

%
2.3
39.9
22
8.3
2.8
8.9

194

84.0

3678
107
912
97
1298

2.6
13
4.6
91.8
1.9

Genera
Unspecified
Unspecified
Unspecified
Unspecified
Multiple genera
Amazona, Psittacus,
Ara, Cacatua
Amazona, Psittacus,
Ara, Cacatu, Eclectus
Unspecified
22 genera
Unspecified
Amazona, Psittacus
Multiple genera

Country
USA
Belgium
UK
The Netherlands
USA
The Netherlands

Year
1933
1964
1965
1977
1983
1987

Reference
H. Fox 1933
Grunberg 1964
Finlayson 1962
Dorrestein 1977
Griner 1983
Kempeneers 1987

The Netherlands

2003

Bavelaar 2003

USA
Germany
USA
Germany
Spain

2003
2004
2004
2009
2009

Garner 2003
Krautwald 2004
Pilny 2004
Fricke 2009
Kellin 2009

Several risk factors have been suggested that may promote the development of atherosclerosis
in psittacine birds and include age, gender, species, increased plasma total cholesterol and
triglycerides, high energy and high fat diet, physical inactivity, thyroid disease, and co-infection
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with Chlamydophila psittaci.(Bavelaar & Beynen 2004a; Reavill & Dorrestein 2010; Fricke et al.
2009; Pilny et al. 2012; Johnson et al. 1992; Garner & Raymond 2003; Bavelaar & Beynen
2003) Unfortunately, a clear demonstration of a statistically significant effect from any of these
variables controlling for potential confounding factors such as age, gender, or species was often
not done or not performed on a large representative sample. While a higher prevalence or
severity of atherosclerotic lesions is often reported in older birds,(Bavelaar & Beynen 2004a;
Fricke et al. 2009; Bavelaar & Beynen 2003; Kellin 2009; Pilny et al. 2012; Garner & Raymond
2003) a clear quantification of magnitude of the effect of age on the prevalence is not available.
The influence of gender as a risk factor is also unclear from the literature with some studies
reporting a male predisposition,(Fox 1933; Griner 1983) others a female predisposition,(Garner
& Raymond 2003) and others no difference between genders.(Pilny et al. 2012; Johnson et al.
1992; Bavelaar & Beynen 2003) African grey parrots (Psittacus erithacus) and Amazon parrots
(Amazona spp.) usually show a higher prevalence of lesions than other psittacine species but
confounding effects of age and sex were usually not taken into consideration in these
reports.(Fricke et al. 2009; Bavelaar & Beynen 2004a; Bavelaar & Beynen 2003)
A possible association between Chlamydia pneumoniae infection and atherosclerosis has been
investigated in multiple studies in humans but remains controversial.(Dugan et al. 2002; Sessa et
al. 2009; Hoymans et al. 2007) Since avian chlamydiosis is a common infection in psittacine
species, this hypothesis was also explored in parrots but with mixed results. A study using PCR
and immunohistochemistry on arterial tissues did not conclude to a positive association between
atherosclerosis and avian chlamydiosis in psittacine birds.(Schenker & Hoop 2007) Pathologic
surveys rarely identified lesions consistent with avian chlamydiosis concurrently with
atherosclerosis.(Fricke et al. 2009) Conversely, a separate case-control study on 31 parrots
reported a significant association between atherosclerosis and positive immunohistochemical
(IHC) reaction for C. psittaci using specific anti-C. psittaci monoclonal antibodies in arterial
tissues.(Pilny et al. 2012) However, anti-Chlamydia antibodies including monoclonal antibodies
used in IHC are known to cross-react with atherosclerotic plaque constituents in human samples
such as ceroids.(Dowell et al. 2001; Hoymans et al. 2007; Hoymans et al. 2004) Poor correlation
has been observed between IHC, tissue PCR, and culture and the former usually leads to a higher
detection rate. For immunohistochemistry involving chlamydial antigens, one should carefully
select negative control tissues, use at least two negative control antibodies, and only
intracytoplasmic staining of macrophages, endothelial cells, and smooth muscle cells in a
granular pattern should be interpreted as true positive.(Dowell et al. 2001) In this psittacine
study, negative controls were avian tissues including blood vessel but negative control antibodies
were not used to assess background staining of atherosclerotic tissues and extracellular staining
in lipid and necrotic pools were interpreted as positive, thus increasing the possibilities of false
positives.(Pilny et al. 2012) Alternatively, C. psittaci PCR-negative psittacine atherosclerotic
tissue could have been used as negative control tissues.
Dyslipidemic changes with notably hypercholesterolemia are thought to predispose to the
development of atherosclerotic lesions as in other animal species. African grey and Amazon
parrots, which are thought to be predisposed to atherosclerosis, tend to have a higher plasma
cholesterol level than other psittacine species.(Bavelaar & Beynen 2004a) Total plasma
cholesterol correlates with the occurrence of atherosclerosis in psittacine birds but changes in
lipoproteins have not yet been investigated.(Pilny et al. 2012) In a case-control study on 22 birds,
parrots with atherosclerotic lesions had a significantly higher median (range) plasma cholesterol
based on their medical records at 421 (233-906) mg/dL than control birds at 223 (144-250)
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mg/dL.(Pilny et al. 2012) The impact of diet on atherosclerosis and dyslipidemia has been
investigated in a few studies. Atherosclerosis has been induced in budgerigars with 2% dietary
cholesterol but this amount is about 100-200 times higher than found in a normal diet.(Finlayson
& Hirchinson 1961; Petzinger et al. 2010) In a feed trial, African grey parrots fed a high-fat diet
rich in saturated fatty acids had significantly higher plasma cholesterol levels than parrots on a
low-fat diet or high-fat diet enriched in omega-6 unsaturated fatty acids (linoleic acid).(Bavelaar
& Beynen 2003) Another feed trial in African grey parrots did not demonstrate a significant
difference in cholesterol and lipoprotein plasma concentrations between groups on a pelletized or
seed diets.(Stanford 2005) The intake of unsaturated fatty acids, especially omega-3 fatty acids,
may protect against atherosclerosis in parrots.(Petzinger et al. 2010; Bavelaar & Beynen 2003)
The severity of atherosclerosis negatively correlates with muscle and adipose tissue content of αlinolenic acid in parrots.(Bavelaar & Beynen 2003) Feeding Quaker parrots (Myiopsitta
monachus) a diet rich in omega-3 unsaturated fatty acids caused a shift in the peak densities of
HDL subfractions but total plasma cholesterol was not altered whereas the same dietary changes
usually lower the cholesterol in mammals.(Petzinger 2012; Petzinger et al. 2011)
ii. Pathology
In parrots, atherosclerotic lesions are central and most commonly found in the great arteries at
the base of the heart, brachiocephalic arteries, ascending aorta, and pulmonary arteries.(Bavelaar
& Beynen 2004a; Garner & Raymond 2003; Krautwald-Junghanns et al. 2004; Lumeij & Ritchie
1994; Pees, Krautwald-Junghanns, et al. 2006; StLeger 2007; Reavill & Dorrestein 2010)
Lesions in the abdominal aorta and peripheral arteries appear less frequent. However, peripheral
lesions have been documented in the abdominal aorta, carotid, and coronary arteries in parrot
species.(Johnson et al. 1992; Mans & Brown 2007; Vink-Nooteboom et al. 1998; Finlayson &
Hirchinson 1961; Shivaprasad 1993; Finlayson 1965; Finlayson et al. 1962) In addition, a
retrospective survey revealed 35% of birds diagnosed with atherosclerosis had peripheral
lesions.(Garner & Raymond 2003) Atherosclerotic lesions are rarely complicated by thrombosis,
hemorrhage, and plaque ruptures in parrots and myocardial infarction is rare. While confirmation
is lacking, other histopathologic lesions are thought to occur in association with atherosclerosis
such as hepatic lipidosis/fibrosis and yolk coelomitis.(Garner & Raymond 2003) Furthermore a
recent study identified a correlation between atherosclerosis of the ascending aorta and organ
alterations such as myocardial hypertrophy, myocardial fibrosis, pulmonary congestion and
fibrosis.(Fricke et al. 2009)
In parrots, histologic lesions are reported to begin in the media and further extend in the media
and intima. Atherosclerotic lesions are characterized, depending on the stage, by foam cells,
presence of lipid, cholesterol clefts, chondroid metaplasia, fibrosis, and mineralization.(Fricke et
al. 2009; Garner & Raymond 2003; Reavill & Dorrestein 2010; Schmidt et al. 2003)
Macroscopically, fatty streaks and fibrous plaques are also recognized.(Bavelaar & Beynen
2003; Bavelaar & Beynen 2004a) Rupture of the fibrous cap and exposure of the lipid core
content to the lumen is rarely reported in birds which may explain why thromboembolic events
are uncommon. In two recent psittacine atherosclerosis pathology studies, atherosclerotic lesions
were classified into four stages, one of these studies was conducted on Amazon and African grey
parrots using histopathology, histochemistry, and immunohistochemistry.(Fricke et al. 2009;
Schenker & Hoop 2007) Stage 1 was characterized by the fragmentation of elastic layers and
increased extracellular matrix in the media, stage 2 by fat deposition in the intima and media,
stage 3 by an increased presence of collagen fibers, and stage 4 by a fibrous appearance of the
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plaque.(Fricke et al. 2009) This classification contrasts with those established in mammals,
humans, and other avian orders.(Fricke et al. 2009; Stary et al. 1994; Stary et al. 1995; Stary
2005; Santerre et al. 1972; Orita et al. 1994; He et al. 2005) In humans, the classification
accepted by the AHA divides lesions into 8 stages. The predominant cellular component of
human and animal lesions are macrophages, smooth muscle cells, and, in lesser number,
lymphocytes. Surprisingly, in the proposed classification of atherosclerosis in parrots,
macrophages and smooth muscle cells were not found based on histology and
immunohistochemistry in any stage.(Fricke et al. 2009) Moreover, the initiation and maintenance
of atherosclerotic lesion in parrots is believed to occur mainly in the media.(Fricke et al. 2009;
Schmidt et al. 2003) These observations contrast with what is known in other species and the
current widely-accepted theory that atherosclerosis is initiated by endothelial dysfunction and the
accumulation of oxidized lipoproteins in the intima and the chronic inflammatory response that
ensues.(Stary et al. 1994; Cullen et al. 2005; George & Lyon 2010) Although fat deposition
occurs in the tunica media and intima in several avian species, early lesions are found
predominantly in the intima and the atherosclerotic plaques contain macrophages and smooth
muscle cells.(Beaufrere, Holder, et al. 2011; Casale et al. 1992; Hansen 1977; Jerome & Lewis
1984; Simpson & Harms 1969; St Clair 1998) In an experimental induction of atherosclerosis in
budgerigars, atheromatous plaques formed in the intima and inner media of the
arteries.(Finlayson & Hirchinson 1961) It is possible that some lesions classified as stage I of the
parrot classification, which do not contain any lipid, may be attributable to aging of the vessels
or response of the media smooth muscles cells to arterial inflammation. Also, in more advanced
lesions, the disruption of normal intimal and medial architecture, the migration of cellular
elements into the intima, and the reorganization of the arterial wall may complicate one’s ability
to determine the origin of the lesions.(Stary et al. 1992; Stary et al. 1994; Nakamura & Ohtsubo
1992)
Clearly, there is a need for a better classification system in psittacine atherosclerotic lesions that
would better reflect the progression of the lesions, the pathways of development, the clinical
significance, and would be in accordance with the classification systems used in well-studied
species such as humans. This is a prerequisite to designing further observational and
experimental research projects as well as comparing the disease with other avian and mammalian
species.
iii. Clinical signs
Clinical signs are uncommonly reported with psittacine atherosclerosis but, when present,
consist of sudden death, congestive heart failure, dyspnea, neurologic signs, respiratory signs,
exercise intolerance, and ataxia.(Fricke et al. 2009; Bavelaar & Beynen 2004a; Johnson et al.
1992; Lumeij & Ritchie 1994; Phalen et al. 1996; Sedacca et al. 2009; StLeger 2007; VinkNooteboom et al. 1998; Beaufrere, Holder, et al. 2011; Beaufrère et al. 2011; Finlayson 1965)
Most clinical signs reported in parrots are associated with flow-limiting stenosis of the major
arteries or the carotid arteries while clinical signs of thrombosis and thromboemboli are rare (or
not diagnosed), unlike in humans. A recent experiment in budgerigars (Melopsittacus undulatus)
revealed that in vivo carotid artery injury did not lead to the formation of occlusive thrombi
contrary to mice in which carotid diameter and blood flow are similar to budgerigars.(Schmaier
et al. 2011) Avian thrombocytes seem less capable of forming shear-resistant arterial thrombi
and do not usually form 3-dimensional aggregates. The physiologic differences between avian
thrombocytes and mammalian platelets may partly explain the clinical differences observed in
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the nature and prevalence of atherothrombotic diseases. Also, the different pattern of coronary
circulation in the avian heart with the predominance of intramyocardial arteries and possible
increase in collateral circulation over humans may be responsible for the rarity of acute
myocardial ischemia.

Figure 19: Wedge section of the brachiocephalic trunk in a macaw with advanced
atherosclerosis. Note the severe luminal stenosis and extensive yellowish atheromatous plaque.
Courtesy of Drs. W. Michael Taylor and Marina Brash, Ontario Veterinary College, University
of Guelph, Canada.

Figure 20: Scanning electron microscopy of stenotic arteries due to atherosclerosis at the base
of the heart in a Quaker parrot. Note the severe stenosis with one artery almost completely
obstructed. (x 60)
The extent of stenosis needed to induce clinical signs in parrots is unknown. In humans, the
degree of luminal narrowing is correlated with sudden death. Clinical signs and >75% of luminal
narrowing is common in fatal lesions.(Virmani et al. 2000)
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Intermittent claudication, a clinical manifestation of peripheral arterial disease, was reported
in an Amazon parrot with severe atherosclerotic lesions of the abdominal aorta and ischiatic
arteries.(Beaufrere, Holder, et al. 2011) Cases of atherosclerosis have also been described in
conjunction with pelvic limb ataxia and clinical signs compatible with intermittent claudication
and peripheral arterial disease in parrots, especially in Amazon parrots.(Fricke et al. 2009;
Johnson et al. 1992; Simone-Freilicher 2007; Bennett 1994) A yellow-collared macaw (Ara
auricollis) had dry gangrene of the legs in conjunction with generalized
atherosclerosis.(Finlayson 1965) Atherosclerosis was suspected as the cause of distal extremity
necrosis in several zoo birds.(Calle et al. 1982)
Congestive heart failure and valvular insufficiency concurrent to atherosclerosis were also
reported in several parrots.(Phalen et al. 1996; Mans & Brown 2007; Sedacca et al. 2009) The
pathogenesis is unclear but chronic myocardial ischemia, systemic hypertension, and an increase
in the cardiac afterload associated with decreased arterial compliance and lumen may contribute
to this disease process. Also it can be postulated that the decreased myocardial oxygen supply
due to stenotic arteries coupled with the increased myocardial oxygen consumption due to the
increased afterload may lead to myocardial dysfunction such as reduced contractility,
dysrhythmias, reduction of the cardiac output and ultimately congestive heart failure. In one
study, severity of atherosclerotic lesions could be correlated with cardiac hypertrophy and
fibrosis.(Fricke et al. 2009)
Parrots also experience stroke events. An African grey parrot displayed chronic seizure
activity for at least 4 years following an acute ischemic cerebral stroke diagnosed on MRI, but,
while strongly suspected, atherosclerosis could not be confirmed ante-mortem in this
patient.(Beaufrère et al. 2011) A hemorrhagic stroke and brain infarct, diagnosed on MRI and
confirmed on histopathology, caused severe vestibular signs in a blue and gold macaw (Ara
ararauna) and was concurrent with advanced atherosclerosis.(Grosset et al. 2012) Hemorrhagic
strokes have also been reported in an Amazon parrot and in budgerigars but the presence of
atherosclerosis could not be confirmed or was not mentioned.(Shivaprasad 1993; Jenkins 1991)
In addition, carotid atherosclerosis was associated with seizures in an African grey parrot and an
aura-like behavior with altered consciousness in an Amazon parrot.(Shivaprasad 1993; Johnson
et al. 1992) A recent study showed an 8-time increase in odds for birds with atherosclerosis to
present with neurologic signs but this association was not statistically significant.(Pilny et al.
2012)
A coronary aneurysm developed secondary to coronary atherosclerosis in an umbrella
cockatoo (Cacatua alba).(Vink-Nooteboom et al. 1998) An aortic aneurysm with severe
atherosclerosis was reported in an alexandrine parakeet (Psittacula eupatria).(Finlayson 1965)
Aneurysms are suspected to form in atherosclerotic arteries because of their lower compliance
than healthy elastic arteries leading to limited and constant expansion of the arterial wall over a
range of distending pressures caused by the pulsatile cardiac output.(Smith et al. 2000)
Exercise intolerance and non-specific respiratory signs are also frequently reported but may
be caused by impaired cardiac function secondary to atherosclerotic lesions.(Johnson et al. 1992;
Fricke et al. 2009) Sudden death or non-specific clinical signs are generally acknowledged as the
most common presentation of clinical atherosclerosis and may be partially explained by the
relative inactivity of some captive parrots that allows severe subclinical atherosclerotic lesions to
develop without detection of clinical manifestations by their caretakers.(Bavelaar & Beynen
2004a; StLeger 2007) Finally, sudden death from lethal cardiac arrhythmia triggered by
myocardial ischemia or undetected cerebral emboli are possible.
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iv. Diagnostic tests
Currently, atherosclerosis is difficult to diagnose antemortem in birds and there are severe
limitations in knowledge and resolution of imaging equipment that seriously impair visualization
of lesions, their ischemic consequences, and the identification of avian patients at increased risk.
The lack of characterized clinical pathology markers and risk factors in birds and the drastic
changes in blood lipid and lipoproteins during the female reproductive cycle prevent the
identification of susceptible birds and the implementation of risk factor-targeted management.
While avian models of atherosclerosis consistently show an increased blood cholesterol and
LDL, the dyslipidemia is artificially induced by high cholesterol feeding and it is unclear if
similar dyslipidemic changes occur in patients with spontaneous atherosclerosis. As mentioned
previously, in a case-control study on 31 parrots, a total cholesterol median twice as high as in
control parrots was found in birds exhibiting atherosclerotic lesions.(Pilny et al. 2012) Also, Creactive protein which is an acute-phase protein that has diagnostic and prognostic value in
human coronary artery disease does not seem to be a major acute-phase protein in birds (Cray,
written communication, April 2012).
Blood pressure measurements could be useful in psittacine patients to detect chronic
hypertension, which is a risk factor for atherosclerosis in several species and a means to diagnose
certain clinical entities such as intermittent claudication (e.g. ankle-brachial index).
Unfortunately, indirect blood pressure measurements methods such the oscillometric and the
Doppler probe techniques are not reliable in parrots and direct arterial blood pressure
measurement is invasive and not clinically practical.(Acierno et al. 2008; Johnston et al. 2011)
Electrocardiographic changes have not been characterized with atherosclerosis but are
expected to occur in some cases due to cardiac consequences and ischemia.
Diagnostic imaging seems promising to assess the avian cardiovascular system but there is a
lack of standardization of vascular imaging protocols and the small size and fast heart rate of
birds provide limitations to the resolution of vascular structures that can reasonably be achieved.
Antemortem diagnosis of atherosclerosis is primarily obtained in advanced cases, with severe
calcification of the arteries, or in association with congestive heart failure.(Mans & Brown 2007;
Sedacca et al. 2009; Shrubsole-Cockwill et al. 2008) Atherosclerosis targets the major arteries in
birds and, fortunately, these arteries are the most accessible to diagnostic imaging. The two
brachiocephalic arteries, pulmonary arteries, and the ascending and abdominal aorta can be
visualized on plain radiographs and with advanced imaging techniques.(Beaufrere, Pariaut, et al.
2010) Smaller arteries such as the carotid arteries, visceral arteries, and branches of the
brachiocephalic arteries can also be observed on CT-scan.
Several authors claim that enlargement and opacification of the arteries are detectable on plain
radiographs and are suggestive of atherosclerotic changes.(Pees 2006) Considering the
variability in X-ray exposure, the fast heart rate of birds, and arterial motion artefacts that are
likely present on radiographs in addition to the subjectivity in interpreting such changes, it is
doubtful that this approach would have any clinical accuracy.(Pees, Krautwald-Junghanns, et al.
2006; Simone-Freilicher 2007; Krautwald-junghanns et al. 2011) Severe atherosclerosis may
also be present in the absence of vascular radiographic signs as documented in several case
reports.(Beaufrere, Holder, et al. 2011; Sedacca et al. 2009) Thus, radiographs should be
considered an insensitive method of detecting vascular diseases.(Beaufrere, Pariaut, et al. 2010)
However, arterial calcification is fairly specific to advanced atherosclerotic lesions and can be
detected on radiographs and CT-scan when severe.(Mans & Brown 2007; Krautwald-junghanns
et al. 2011)
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Figure 21: Computed tomography showing advanced aortic calcification of the ascending
aorta in a female African grey parrot. Mediastinal window. Courtesy of Drs. Yvonne van
Zeeland and Nico Shoemaker, Utrecht University, the Netherlands.
Since flow-limiting stenosis is the main mechanism leading to clinical signs in psittacine
birds, angiography could be useful to assess arterial luminal narrowing. Angiographic procedures
have also been described and can be expected to provide valuable information on arterial luminal
patency but there is a lack of standardization and reproducibility of the techniques and
measurements.(Krautwald-junghanns et al. 2011; Krautwald-junghanns et al. 2008; Beaufrere,
Pariaut, et al. 2010) Angiography has successfully been used to diagnose coronary aneurysm in a
single cockatoo.(Vink-Nooteboom et al. 1998) Digital subtraction angiography using
fluoroscopy consists of subtracting precontrast images from contrast images to increase the
outline of arteries in dense soft tissue and bone environment. This technique has been
investigated in birds and may increase the diagnostic sensitivity of arterial luminal stenosis but
has not been used in clinical cases.(Beaufrere, Pariaut, et al. 2010) Cardiac manifestations of
atherosclerosis (e.g. congestive heart failure, valvular insufficiency) can be diagnosed with
transcoelomic and transesophageal echocardiography but their association with atherosclerotic
lesions cannot be made using these techniques.(Pees, Krautwald-Junghanns, et al. 2006;
Beaufrere, Pariaut, et al. 2010) The aortic root can be imaged and measured by ultrasound, the
outflow aortic velocity estimated using spectral Doppler, and reference intervals have been
reported for aortic measurements.(Pees et al. 2004; Pees, Krautwald-Junghanns, et al. 2006;
Straub et al. 2004) Furthermore, transesophageal echocardiography allows M-mode imaging of
the aortic root.(Beaufrere, Pariaut, et al. 2010) Hyperechoic areas at the base of the aorta may
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sometimes be seen on echocardiography.(Krautwald-junghanns et al. 2011) Likewise cerebral
complications such as ischemic and hemorrhagic strokes can be diagnosed using CT-scan or
MRI but concurrent atherosclerosis cannot be detected when calcification of the lesions is not
severe.(Beaufrère et al. 2011; Grosset et al. 2012; Jenkins 1991) MRI was not a good diagnostic
value for the vascular system in pigeons because of the rapid circulation of contrast media
(gadolinium).(Romagnano et al. 1996) Organ perfusion imaging and radionucleotide-labelled
atherosclerotic markers have not been investigated in psittacine birds. Finally, endoscopy using
an interclavicular approach allows good and direct visualization of the base of the heart and the
major arteries but is impaired by area fat stores in overweight birds and is more
invasive.(Beaufrere, Pariaut, et al. 2010)
Therefore, the future of vascular imaging relies on the development and standardization of
advanced imaging techniques and improvement in equipment resolution.(Beaufrere, Pariaut, et
al. 2010) High quality angiographic techniques aiming to either diagnose arterial luminal
stenosis or detect atheromatous plaques are likely to become the diagnostic tests of choice when
limitations in resolution and motion artifacts are overcome.
v. Medical management and prevention
In the absence of well-characterized risk factors for prevention and pharmacologic
information to be used for therapeutics, the medical management and preventative approach are
largely empirical and based on information derived from human literature. While humans and
parrots may share major lifestyle and dietary risk factors, psittacine birds may have specific risk
factors that need to be explored for a more adapted approach. The treatment of atherosclerosis
can be divided into the reduction of risk factors and the treatment of cardiovascular and ischemic
consequences.
Lifestyle changes that could be implemented include increasing the physical activity of
captive parrots by providing more opportunities for locomotion and foraging behaviors and
decreasing the stress level in their captive environment. Parrots eat a cholesterol-free diet as
cholesterol is an animal compound for which ergosterol is the vegetal equivalent. Therefore,
animal products in the diet should be eliminated since they are a source of cholesterol and
saturated fat. A well balanced plant-based diet is primordial. Supplementation with omega-3
fatty acids such as α-linolenic acid that can be found in flaxseed oil has been shown to be
beneficial in improving lipid metabolism, minimizing inflammation, and minimizing
atherosclerosis in several avian species.(Petzinger et al. 2010; Bavelaar & Beynen 2003;
Bavelaar & Beynen 2004b) However, similar plasma lipid improvement than in mammals could
not be documented in normal parrots but were not investigated in dyslipidemic parrots.(Petzinger
2012; Petzinger et al. 2011; Bavelaar et al. 2005) Limiting dietary excess and obesity in captive
birds also appears to be a reasonable strategy but species-specific dietary needs should be
considered. For instance, macaws and palm cockatoos need a much higher dietary fat content
than other parrots.(Brightsmith et al. 2010)
Statins are employed in parrots but their use is controversial because no pharmacologic
information is available and target levels of blood cholesterol and LDL that would reduce
atherosclerosis risks are unknown in psittacine birds. Atorvastatin is the most commonly used
statin and has a long half-life in humans (15-30 hours) but it undergoes extensive hepatic
biotransformation and shows some pharmacologic interaction with itraconazole, an antifungal
drug frequently used in psittacine birds.(Paoletti et al. 2005) On the other hand, rosuvastatin has
a similar half-life, is not extensively metabolized by the liver and does not display problematic
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pharmacologic interactions.(Paoletti et al. 2005; White 2002) Other statins (e.g. lovastatin,
simvastatin, pravastatin) have short half-lives (1-4h). Therefore, if a statin is used empirically in
pet birds, we would recommend choosing rosuvastatin for its pharmacologic properties that may
be advantageous in avian patients.
Clinical signs of peripheral arterial disease have been treated with pentoxifylline or
isoxsuprine in Amazon parrots.(Beaufrere, Holder, et al. 2011; Simone-Freilicher 2007) Despite
the lack of evidence for efficacy in humans, isoxsuprine relieved signs of hindlimb weakness in
an Amazon parrots but atherosclerotic disease was not confirmed.(Simone-Freilicher 2007;
Hirsch et al. 2006) Likewise, the use of antihypertensive medications such as ACE-inhibitors and
β-blockers are not yet applicable in birds when there is no accurate and repeatable means of
measuring the arterial blood pressure in clinical cases for diagnosis and follow up.
Antithrombotic agents have not been investigated in psittacine birds but atherothrombotic
complications are rare. Medical management of congestive heart failure was described in a
previous section.
D. Atherosclerosis in non-domestic avian species
Atherosclerosis has been described in almost all orders of birds.(Finlayson et al. 1962;
StLeger 2007; Garner & Raymond 2003; Griner 1983; Bohorquez & C. Stout 1972) Three large
retrospective studies reported the prevalence of atherosclerosis in multiple avian orders on 9949,
7689, and 919 birds, respectively (Table 23).(Garner & Raymond 2003; Griner 1983; Finlayson
et al. 1962) Most lesions occurred in the major arteries as well as the carotid and coronary
arteries. However, these prevalences should be interpreted with caution as it is likely that not all
organs were reviewed in all cases when, for instance, biopsy cases were included in the
calculation of the prevalence and methods and inclusion criteria were different. In addition, avian
taxonomy is constantly changing and classifications used at the time may not directly relate to
today’s classification. For instance, prevalence reported in falconiformes actually included cases
in the orders falconiformes and accipitriformes, cases belonging to coraciformes included cases
from the orders of coraciformes and bucerotiformes, and struthioniformes only accounted for
ostriches.
One report from the Oklahoma City Zoo documented a prevalence of 90% (65/72) of exotic
birds with atherosclerosis with the most advanced lesions seen in galliformes and
ciconiiformes.(Bohorquez & Stout 1972) A survey in captive birds of prey from England
identified 5/66 diurnal birds of prey with atherosclerosis which was considered the cause of
death in two Bonelli’s eagle (Aquila fasciata).(Cooper & Pomerance 1982) A review of 57
penguin pathology records over 5 years at SeaWorld identified 25 birds with atherosclerosis
which was the attributable cause of death in 4 of them.(StLeger 2007) In a large raptor collection
in France in 2011-2012 (le parc du Puy du fou), a group of 80 black kites (Milvus migrans)
experienced severe loss due to atherosclerosis of the great vessels that primarily manifested as
acute deaths. (Facon & Beaufrère, in preparation)
Myocardial infarction in association with advanced atherosclerosis was diagnosed in several
individuals including a bald eagle (Halieetus leucoephalus), two white-backed vultures (Gyps
africanus), a Javan fishing owl (Scotopelia spp.), a concave-casqued hornbill (Buceros bicornis),
three pelicans (Pelecanus spp.), a tawny frogmouth (Podargus strigoides) (arterial thrombus as
well), and a Edward’s pheasant (Lophura edwardsi).(Griner 1983; Finlayson et al. 1962;
Finlayson 1965) Ischemic cardiomyopathy due to atherosclerosis was reported in a red-tailed
hawk (Buteo jamaicensis).(Knafo et al. 2011)
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Table 23: Prevalence of atherosclerosis in avian orders kept in zoological collections
(methods, inclusion criteria, and population demographics varied substantially between reports,
%: raw prevalence, N: total number of birds investigated)
Garner
2003
N %
Coraciformes
199 6.5
Struthioniformes
136 5.0
Falconiformes
282 4.2
Piciformes
205 3.4
Strigiformes
136 2.9
Ciconiformes
319 2.8
Psittaciformes
3678 2.6
Galliformes
812 2.1
Gruiiformes
258 1.9
Phoenicopteriformes 275 1.8
Columbiformes
305 1.6
Cuculiformes
64 1.5
Anseriformes
1062 0.9
Charadriformes
249 0.8
Sphenisciformes
212 0.5
Passeriformes
1495 0.1
Coliiformes
50 0.0
Pelecaniformes
60 0.0
Apodiiformes
20 0.0
Procellariformes
6 0.0
Gaviiformes
65 0.0
Caprimulgiformes
15 0.0
Unknown
46 2.0
Total
9949 2.1
Order

Griner
Finlayson
1983
1962, 1965
N
%
N %
110
8.0
19 31
78
1.3
129 10.8
30 53
138 12.3
23 22
87
1.1
208
2.9
63 13
1322
2.8
229 24
762
6.0
66 27
229
1.7
27 19
56
3.6
186 12.4
28
9
64
0.0
1047
3.1
131 19
256
1.6
40 12
118
0.8
36
0
1300
2.4
168
7
22
0.0
113
2.6
198
0.0
43
0.0
22
0.0
1 100.0
59 19
7689
3.0
919 21

Ruptured aortic aneurysm due to atherosclerosis has been diagnosed at least in a Sclater’s
crowned pigeon (Goura scheepmakeri), an Egyptian plover (Pluvianus aegyptius), a greywinged trumpeter (Psophia crepitans), a crowned hawk-eagle (Stephanoaetus coronatus), and a
maned goose (Chenonetta jubata).(Griner 1983; Finlayson 1965) A ruptured aortic aneurysm
with advanced atherosclerosis was the cause of death in a flamingo (Phoenicopterus spp.)
(Garner, written communication, May 2012). Likewise, several cases of aortic ruptures with
atherosclerosis were reported in Antarctic penguins.(StLeger 2003) Most cases of dissecting
aortic aneurysms in ostriches and turkeys are not due to atherosclerosis but are associated with
copper deficiencies.(Mitchinson & Keymer 1977; Vanhooser et al. 1994; Ferreras et al. 2001;
Baptiste et al. 1997; Gresham & Howard 1961)
Atherosclerosis is also diagnosed with some frequency in wild birds. Of 97 free-living birds
examined in the United Kingdom and East Africa, 32 had evidence of atherosclerotic lesions and
4 had evidence of advanced aortic lesions.(Finlayson 1965) An investigation on 157 wild male
turkeys collected by hunters in the United States found atherosclerosis in 49.5% of arteries
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evaluated with the greatest prevalence of lesions found in the ischiatic artery and aorta.(Krista &
McQuire 1988) A report from Iraq found 10% of a sample of 100 free-living pigeons with
atherosclerotic lesions.(Al-Sadi & Abdullah 2011) A retrospective survey from Northern
California found 6/409 free-living raptors with atherosclerosis, a frequency which is lower than
usually reported in captivity for these species.(Morishita et al. 1998) In addition, atherosclerotic
lesions were also found in a population of free-living Egyptian vultures (Neophron
percnopterus).(Grünberg & Kaiser 1966)
While much emphasis has been placed on psittacine atherosclerosis, it is also evident that
atherosclerosis is a major problem of other avian orders commonly seen by veterinarians,
especially falconiformes and accipitriformes.(Cooper & Pomerance 1982; Finlayson 1965;
Griner 1983; Garner & Raymond 2003) Some authors mention that atherosclerosis is uncommon
in carnivorous animals, but this does not seem to hold in Aves as birds of prey showed a
significant prevalence of lesions in captivity. Risk factors for atherosclerosis in non-psittacine
species are speculative and epidemiologicall unknown. The common practice of feeding day-old
chicks which have a large yolk sac rich in cholesterol may potentiate atherosclerosis in
susceptible raptorial species (e.g. insectivorous raptors, falcons). For instance, in a large
retrospective study in humans, consumption of egg yolk was strongly associated with an
increased atherosclerotic burden in the carotid arteries.(Spence et al. 2012)
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CHAPTER I:
CHARACTERIZATION AND CLASSIFICATION OF
PSITTACINE ATHEROSCLEROTIC LESIONS BY
HISTOPATHOLOGY, DIGITAL IMAGE ANALYSIS,
TRANSMISSION AND SCANNING ELECTRON
MICROSCOPY*
I. Introduction
Atherosclerosis is one of the leading causes of human deaths in the world and its pathologic
complications underlie coronary heart disease, stroke, and peripheral arterial disease.(Mathers et
al. 2004) Likewise, atherosclerosis is common in psittacine birds with the great vessels at the
base of the heart being affected most often. The prevalence of atherosclerosis in psittacines,
reported from post-mortem surveys, ranges from 2.6 to 91.8% depending on the geographical
areas, the time span of the study, the species, and the inclusion criteria.(Bavelaar & Beynen
2004a; Fricke et al. 2009; Garner & Raymond 2003; Krautwald-Junghanns et al. 2004)
Prevalences by age groups are unknown but the prevalence and severity of the lesions appear
increased in older psittacine birds.(Bavelaar & Beynen 2004a; Fricke et al. 2009) All psittacine
species appear susceptible but the disease is most frequently reported in Amazon parrots
(Amazona spp.), African grey parrots (Psittacus erithacus), macaws (Ara spp.), cockatoos
(Cacatua spp.) and cockatiels (Nymphicus hollandicus).(Bavelaar & Beynen 2004a; Fricke et al.
2009; Garner & Raymond 2003; Johnson et al. 1992; Krautwald-Junghanns et al. 2004; Pilny
2004; Schenker & Hoop 2007; StLeger 2007) Avian models, such as pigeons, Japanese quails,
turkeys, and chickens, are an integral and important part of the research conducted on
atherosclerosis and these models significantly contributed to the understanding of many aspects
of the disease.(Moghadasian 2002; St Clair 1998) Moreover, pigeons are considered one of the
best models for studying human atherosclerosis.(Moghadasian 2002; Moghadasian et al. 2001; St
Clair 1998) Despite the high incidence of atherosclerosis in parrots and the high number of
clinical case reports,(Beaufrere, Holder, et al. 2011; Johnson et al. 1992; Mans & Brown 2007;
Pees, Schmidt, et al. 2006; Pees et al. 2001; Phalen et al. 1996; Pilny 2004; Sedacca et al. 2009;
Simone-Freilicher 2007; Vink-Nooteboom et al. 1998) there are few pathologic investigations on
the lesions in this group of birds.(Bavelaar & Beynen 2003; Fricke et al. 2009; Schenker & Hoop
2007) Detailed pathological description and categorization of atherosclerotic lesions, as can be
found in the human literature and in reports from the Council on Arteriosclerosis of the
American Heart Association (AHA),(Nakamura & Ohtsubo 1992; Stary 2000; Stary 2003c; Stary
et al. 1992; Stary et al. 1995; Stary et al. 1994; Virmani et al. 2000) are a prerequisite to
understanding the pathogenesis of psittacine atherosclerosis and its clinical impact, designing
further experiments, and comparing the disease with other avian and mammalian species.
Atherosclerosis is a degenerative and inflammatory vascular disease characterized in
mammals and birds by the accumulation of inflammatory cells, lipids, lipoproteins, calcium, and
*
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formation of large fibrofatty lesions in the intima resulting in the disorganization of the arterial
wall, stenosis of the lumen, and potentially leading to thrombotic complications.(Cullen et al.
2005; George & Lyon 2010; St Clair 1998; Stary et al. 1995; Stary et al. 1994) Atherosclerotic
lesions are initiated by endothelial dysfunction associated with a variety of risk factors such as
smoking, dyslipidemia, diabetes mellitus, hypertension, aging, obesity, sex, genetic factors,
chronic systemic infections, lifestyle, hyperhomocysteinemia, and dietary factors.(Cullen et al.
2005; vonEckardstein 2005; George & Lyon 2010; McGill & McMahan 2005) Endothelial
dysfunction causes increased endothelial permeability to lipoproteins and adhesion and
recruitment of leukocytes, which set the stage for atherogenesis. In humans, the characteristics
and composition of atherosclerotic lesions have been investigated by histopathology,(Stary 2000;
Stary 2003c; C. Stary et al. 1995; Stary et al. 1994; Virmani et al. 2000)
immunohistochemistry,(Katsuda et al. 1992; Stary et al. 1995; Stary et al. 1994) transmission
electron microscopy,(Balakrishnan et al. 2007; Bocan & Guyton 1986; Nakamura & Ohtsubo
1992; Pasquinelli et al. 1989) scanning electron microscopy,(Congiu et al. 2010; Kamari et al.
2008; Walski et al. 2002) proteomics,(Duran et al. 2002) digital image analysis,(Dilley 2001;
Taatjes et al. 2000) and isolation and purification of their different biochemical
compounds.(Papakonstantinou et al. 2001) In birds, particularly the pigeon, similar pathological
and ultrastructural studies have been performed and lead to similar findings.(Barr et al. 1991;
Casale et al. 1992; Hansen 1977; Jerome & Lewis 1985; Lauper et al. 1975; Stout & Thorpe
1980) Recent studies have evaluated the characteristics of psittacine atherosclerosis using
histopathology and immunohistochemistry.(Bavelaar & Beynen 2003; Fricke et al. 2009;
Krautwald-Junghanns et al. 2004; Schenker & Hoop 2007) However, there are some limitations
to light microscopy alone in describing atherosclerotic lesions such as difficulties in
characterizing cell types, describing the fine structure of the atherosclerotic plaques, and
quantifying the lesion composition. Furthermore immunohistochemistry in parrots suffers from
the lack of sensitivity and standardization of protocols for the different species of interest.
Finally, some details of atherosclerotic lesions may not be appreciated on conventional 5 µm
thick histological sections.(Stary 2003a; Stary et al. 1992; Stary et al. 1995; Stary et al. 1994)
Lesion classification systems that reflect the progression of the lesions, the pathways of
development, and their clinical significance have been described in humans and in other
mammalian and avian species.(Santerre et al. 1972; Stary 2005; Virmani et al. 2000) The human
classification of atherosclerotic lesions published by the AHA defines eight types of lesions
based on histopathologic, ultrastructural, and biochemical criteria.(Stary 2003a; Stary 2005;
Stary et al. 1995; Stary et al. 1994) Type I-III constitutes early atherosclerotic changes. Both type
I and II are characterized by minimal lipid deposits in the tunica intima with macrophage foam
cells accumulated in layers in type II lesions.(Stary et al. 1994) Type III lesions (preatheroma)
are intermediate between early stages (type I-II) and advanced lesions (type IV-VI) and contain
histologically visible extracellular lipid deposits and cellular debris from foam cells.(Stary et al.
1994) Advanced lesions type IV-VIII are associated with intimal disorganization and thickening
and may produce clinical symptoms. In type IV lesions, extracellular lipids and debris converge
to form a well-delineated lipid core that contains calcium granules and is defined as an
atheroma.(Stary et al. 1995) The increase presence of fibromuscular tissue and calcium
characterizes type V lesions. Type VI lesions are lesions complicated by disruption of the
surface, hemorrhage, or thrombosis. Finally, type VII (calcific lesion) and VIII (fibrotic lesion)
are regarded as specific lesions that result from regression, repair, or changes in lipid
composition.(Stary et al. 1995) In birds, atherosclerotic lesion investigations have primarily
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utilized pigeons and quails with the progression of arterial lesion development being very similar
to atherosclerosis in humans with the presence of fibromuscular tissue, macrophage foam cells,
extracellular lipids, smooth muscles cells, and complications in advanced stages such as
thrombosis and mineral deposition.(Jerome & Lewis 1997; Moghadasian 2002; Santerre et al.
1972; Shih et al. 1983; St Clair 1998) Histopathologic classifications have been used in studies in
pigeons, quails, chickens, and parrots, sometimes with very specific objectives thereby allowing
this criteria to serve the study design.(Fricke et al. 2009; He et al. 2005; Orita et al. 1994;
Santerre et al. 1972; Siegel et al. 1995) Nevertheless, these findings propose that the progression
and the stages of the lesions are similar to humans with a few species variation. A staging system
has recently been suggested in parrot species in two studies and seems to bear fundamental
differences with other classifications in lesion description and interpretation.(Fricke et al. 2009;
Schenker & Hoop 2007) The staging system developed in these two studies was very similar.
Stage 1 was characterized by the fragmentation of elastic layers and increased extracellular
matrix in the media, stage 2 by fat deposition in the intima and media, stage 3 by an increased
presence of collagen fibers or the further development of the atherosclerotic plaque, and stage 4
by a fibrous appearance of the plaque with more calcification.(Fricke et al. 2009; Schenker &
Hoop 2007) This classification also suggests that the different stages are successive steps in the
development of the psittacine atherosclerotic lesion.
The objectives of our study were to further describe and quantify the microstructure and
ultrastructure of psittacine atherosclerotic lesions and characterize their cellular and extracellular
components. Our goals were also to propose a classification system that would adequately reflect
the lesion composition, progression, pathophysiology, and current atherogenesis theories. Our
hypothesis was that atherosclerosis in parrots showed similarities in composition and progression
with the lesions present in humans and other avian species.

II. Materials and Methods
A. Sample collection
Arteries were collected from psittacine birds submitted for necropsy to the Louisiana State
University School of Veterinary Medicine (LSU-SVM). A full necropsy was performed and the
brachiocephalic arteries, ascending aorta, and pulmonary arteries were harvested from each bird
when possible. Sections from the major arteries were fixed in 10% neutral formalin for
histopathology processing. Additional sections were fixed in 2% paraformaldehyde and 1.25%
glutaraldehyde in a 0.1 M sodium cacodylate buffer, with a pH of 7.3 and stored at 4°C for
transmission and scanning electron microscopy evaluation.
A total of 24 birds were collected: 5 African grey parrots (Psittacus erithacus), 3 yellownaped Amazon parrots (Amazona ochrocephala auropalliata), 1 double-yellow-headed Amazon
parrot (Amazona ochrocephala oratrix), 5 blue and gold macaws (Ara ararauna), 1 red-fronted
macaw (Ara rubrogenys), 3 cockatiels (Nymphicus hollandicus), 1 budgerigar (Melopsittacus
undulatus), 1 Goffin’s cockatoo (Cacatua goffini), 1 sun conure (Aratinga solstilialis), 1 green
cheeked conure (Pyrrhura molinae), 1 white-bellied caique (Pionites leucogaster), and 1 Quaker
parrot (Myiopsitta monachus). Ages ranged from 10 weeks to 48 years.
B. Histopathology
Formalin-fixed tissues were routinely processed into paraffin. Five micrometer sections were
cut and stained by hematoxylin and eosin (H&E), von Kossa for calcium salts, and Verhoeff von
Gieson for elastin fibers. Masson’s trichrome staining was also performed on a selected section
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for staining connective tissue. To reveal lipid, frozen formalin-fixed specimens were sectioned at
five micrometer thickness and stained with oil red O. In addition, 0.5 micrometer thick sections
obtained from the blocks used for transmission electron microscopy sections, as described below,
were stained with toluidine blue.
Immunohistochemistry (IHC) for CD68 (anti-human macrophages), anti-human
myeloid/histiocyte antigen, and anti-human lysozyme (all from DakoCytomation, Carpinteria,
CA) was attempted for psittacine macrophages using a parrot granuloma as a positive control.
The IHC for smooth muscle actin (DakoCytomation, Carpinteria, CA) was also performed on a
selected artery.
C. Digital image analysis
All slides were digitized using a slide scanner (NanoZoomer 2.0-HT Digital Pathology
System (NDP), Hamamatsu, Bridgewater, NJ, USA). The NDP can achieve a resolution of 0.23
microns per pixel using time-delay-and-integration charge-coupled technology. Slides were
acquired and processed using the manufacturer software (NanoZoomer Digital Pathology suite,
NDP.scan U10074-01 and NDP.view 1.1.27, Hamamatsu, Bridgewater, NJ, USA). Slides were
scanned at 40X using the semi-automatic and brightfield modes. Scanning time varied between
10 to 40 minutes per slide. Histopathology slides were then evaluated and the atherosclerotic
lesions were characterized.
For image processing, slides with appropriate cross-sectioning and staining quality were
selected. Images of areas of interest from each slide were exported at 10X in tagged image file
format (TIFF) in 24-bit RGB colors. TIFF was selected for its ability to store image data in a
lossless format.
Digital image analysis was performed using the public domain NIH software
ImageJ.(Rasband, 1997-2010) To improve visualization of the images, all images were initially
standardized to account for variation in staining quality, brightness, and uneven background
using the background correction plugin of the software (Figure 22.A-B).
For morphometric analysis, region of interests (ROI) were selected manually under 10X
magnification (arterial wall, lumen, atherosclerotic lesion) using the freehand, polygon, and
wand selection tools. The adventitia was not included in ROIs. Selections were saved in the ROI
manager module of the software. Areas of selected ROIs were measured using the measurement
analyzing tool and the atherosclerotic percentage area was subsequently determined. The degree
of stenosis and the ratio arterial wall/lumen were not calculated as such measurements would be
inaccurate in arteries not fixed under physiological pressure.
For staining quantification (Figure 22), color stains were first separated from the images using
the plugin ‘Colour Deconvolution” based on the color deconvolution method described by
Ruifrok et al.(Ruifrok et al, 2001) The plugin returns three 8-bit images for the three different
colors of a histochemical preparation. If the specimen is stained with only 2 colors, the third
image represents the complimentary image of the first two. Stains discrimination was based on
pre-set stain vectors. The stain vectors were determined for von Kossa (staining calcium),
Verhoeff von Gieson (staining elastin), and oil red O (staining lipid) using single stain
preparations of control slides processed, stained, and digitized using the same methods and the
same laboratory. Histologic sections of canine calcinosis cutis, penguin’s epicardial fat, and
psittacine arteries were used as positive controls respectively. The single stain images of the
arteries obtained were then used to delineate and measure the area containing the target
compound (calcium, lipid, and extracellular matrix) using thresholding segmentation and area
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analyses. As with the stain vectors, threshold levels for each stain that best discriminated the
stained target compound from surrounding counterstained tissues were determined on controlled
slides and advanced atherosclerotic lesions. These levels were then set in the software and
subsequently kept the same for all arterial images. Thresholding segmentation returns binarised
images (pixels are either white or black). Previously determined ROIs were then recovered from
the ROI manager module and applied on each of the segmented images. Percentage areas of the
stains were then measured using the measurement analyzing tool which gives the percentage of
black pixels in the selected areas. The image analysis protocol was slightly modified for
Verhoeff van Gieson stained slides as the areas of interest that would approximately represent
the extracellular matrix in the media would be the unstained and counterstained areas of the
media. The atherosclerotic lesion ROI was subtracted from the arterial wall ROI and the
percentage areas of extracellular matrix (percentage of white pixels) in the media was then
measured on the thresholded single stain images.

Figure 22: Digital image analysis process on a portion of a cross section of the ascending
aorta of an Amazon parrot stained with oil red O and performed with ImageJ. A. Acquisition of
the image, B. Standardization of the background, C. ROI is traced around the artery (green line).
D. Separation of the lipids stained with oil red by color deconvolution. E. thresholding
segmentation and binarization of D. Oil Red O, X 10.
D. Transmission and scanning electron microscopy
Selected arterial tissues fixed for electron microscopy were processed, sectioned and stained
using standard techniques. For TEM, materials were fixed in 2% paraformaldehyde and 1.25%
glutaraldehyde in a 0.1M sodium cacodylate buffer, then rinsed five times in 0.1M cacodylate
buffer containing 0.02M glycine over 12 hr period. Samples were post-fixed in 2% osmium
tetroxide for 1 hour, rinsed in water, en bloc stained in 0.5% uranyl acetate in the dark for 1 hour,
rinsed in water twice, dehydrated in ethanol series, infiltrated in ethanol with LR White resin
series for 12 hours periods, and embedded in LR White overnight at 60 ºC. Sections with 0.5
micrometer thickness were cut with a Dupont Sorvall MT-2 microtome and stained with 0.5%
toluidine blue O (TBO) in 2% sodium borate. The slides were examined and samples selected for
ultra-thin sections (70 nm thickness) for TEM study were sectioned using the same microtome.
Transmission electron microscopic sections were mounted on collodion-coated copper grids,
stained with Reynolds lead citrate, and imaged with a JEM-1011 Transmission Electron
Microscope (JEOL, Tokyo, Japan). For SEM, materials were fixed, rinsed and dehydrated as
described above. Then the half mount of the materials were critical point dried with liquid CO2
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in a Denton CPD, mounted on aluminum SEM stubs, coated with gold/palladium 60/40 in an
Edwards S150 sputter coater, and imaged with a Quanta 200 Scanning Electron Microscope
(FEI, Hillsboro, OR, USA).
Based on the assessment of the thin sections, 17 birds were selected for electron microscopic
evaluation representing a total of 43 arteries for TEM and 35 for scanning electron microscopy
(SEM).
E. Classification of atherosclerotic lesions
All sections were evaluated by light microscopy and a classification system was established to
evaluate the arterial pathology. The appropriateness of the AHA classification system for human
atherosclerotic lesions (Stary, 2000, Stary, et al., 1995, Stary, et al., 1994) was evaluated for
these psittacine lesions as it was the most comprehensive and detailed classification system
described for atherosclerotic lesions and encompassed information obtained from clinical signs,
histopathology, image analysis, electron microscopy, biochemical analysis, and animal
experiments. Lesions were also compared to classification systems proposed for parrots, pigeons,
quails, and chickens.(Fricke, et al., 2009, He, et al., 2005, Orita, et al., 1994, Santerre, et al.,
1972, Siegel, et al., 1995) Digital image analysis, and transmission and scanning electron
microscopy were used to further describe the lesion types and refine the classification system.
F. Statistical Analysis
Descriptive summary statistics were performed on the lesion types and digital image analysis
measurements. Normality was assessed using quantile plots and Shapiro-Wilk tests. Due to the
apparent non normality of the data distribution and the small number of arteries in some
categories, results were reported as median and range. Spearman rank correlation coefficients
were also computed between age, type of lesions, percentage areas of the lesions, lipid, calcium,
and extracellular matrix. Data were analyzed using SAS (SAS 9.1.3, SAS Institute Inc., Cary,
NC, USA). Correlation was considered significant for p<0.05.

III. Results
A total of 63 arteries were collected (24 brachiocephalic trunks, 23 ascending aortas, and 16
pulmonary arteries). Some of the arteries did not have the required cross-sectioning and staining
quality (complete circle of artery) for digital image analysis evaluation (n reported in Table 23).
Antibodies tested (CD68, myeloid/histiocyte antigen, and lysozyme) did not cross-react with
psittacine macrophages therefore the use of IHC for identifying macrophages was removed from
the study. The IHC for smooth muscle actin revealed intimal smooth muscle cells (SMCs) in an
examined section. The American Heart Association classification of atherosclerotic lesions was
found to appropriately reflect the different types of lesions identified in our sample of parrots and
the course of cellular and extracellular events observed on electron microscopy and was then
adapted for the classification of psittacine atherosclerotic lesions. Arteries were not fixed under
physiological pressure which, sometimes, made the interpretation of the anatomy of the intima
and luminal side of the media on contracted arteries difficult. Intimal changes representing
minimal atherosclerosis were more accurately identified on light microscopy of sections of 0.5
micrometer thickness stained with toluidine blue. Based on the 0.5 micrometer-thick sections, 43
arteries (16 brachiocephalic trunks, 16 ascending aortas, and 11 pulmonary arteries) with
different lesion types were selected for TEM and 35 for SEM evaluation. Mild degrees of
autolysis not visible on light microscopy could be seen at the ultrastructural level. These
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autolytic changes included mitochondrial swelling and degeneration in most cells, disruption of
cell-to-cell contact, and the presence of various degrees of vacuolation, cytoplasmic edema,
plasmalemmal disruption, and myelin figures in endothelial cells and, less commonly, in SMCs
and macrophages. Some ultrastructural autolytic changes and some features of cellular
degeneration induced by atherosclerosis were difficult to distinguish in several cases. It should
be noted that mitochondria and endothelial cells are known to deteriorate extremely rapidly after
death.(Cheville 1994a; Stary et al. 1992)
The different lesion types with their morphologic, histochemical, and ultrastructural
characteristics are described below, summarized in Table 24 and presented in Figure 23.
Moderate to advanced lesions were mainly identified in the aorta and brachiocephalic trunks
while the pulmonary arteries often exhibited mild lesions (15 type I and one type VII).
Digital image analysis results are reported in Table 25. The digital analysis of the extracellular
matrix was not considered reliable as there was a great variability in the morphometry of the
elastic laminae between arteries and the different sizes of arteries. Therefore, it was not included
in statistical calculation. There was a low correlation between age of the bird and type of lesions
(rho=0.38, p=0.03), lesion cross-sectional area (rho=0.47, p<0.01), percentage of lipid (rho=0.37,
p<0.01) and calcium (rho=0.4. p<0.01). There was a high correlation between type of lesions and
lesion cross-sectional area (rho=0.9, p<0.01), percentage of lipid (rho=0.96, p<0.01), and
calcium (rho=0.76, p<0.01).
Table 24: Classification of Psittacine Atherosclerotic Lesions (See also Figure 23)
Lesion Type
Description
Type I
Increased presence of macrophages and isolated foam cells, increased
extracellular matrix in the intima, vacuolation of endothelial cells, presence of
lipid in the intima, presence of RER-rich SMC.
Type II
Accumulation of macrophages and SMC foam cells in sheets, small pool of
extracellular lipid.
Type III
Preatheroma: increased extracellular lipid and cell remnant forming confluent
lipid areas, presence of calcium granules, mild disruption of arterial architecture.
Type IV

Type VI

Atheroma: large lipid area forming a lipid core, disruption of the arterial wall
architecture, atheromatous plaque bulging into the lumen, increased presence of
calcium, endothelial surface defects.
Fibroatheroma: increased presence of fibromuscular tissue forming a fibrous cap
over the lipid core. Mild to moderate plaque calcification. Significant luminal
stenosis and endothelial surface defects.
Complicated lesions: same as type IV, V but with hematoma or fissure.

Type VII

Calcific lesions, osseous metaplasia, large calcium plaques.

Type V
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Figure 23: Atherosclerotic lesions in arteries of psittacine birds. A. A cross section of an artery
showing Type V atherosclerotic changes. Expanding tunica intima consistent with a
fibroatheroma (double-head arrows), composed of a fibrous cap (arrow) and underlying lipid
core containing extracellular lipid (arrowhead), calcium deposits (open arrow), and extracellular
matrix. A square showing a representative area in B. Aorta. Hematoxylin and eosin. B.
Classification of psittacine atherosclerotic lesions described in Table 1 with normal artery (0),
early lesions (I and II), intermediate lesions (III), advanced lesions (IV and V), complicated
lesions (VI), and calcific lesions (VII). Hematoxylin and eosin.
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Table 25: Percentage areas obtained by digital image analysis of cross sections of psittacine
major arteries
Lesion Type
Normal
I
II
III
IV
V
VI
VII

Lesion
Lipid
Calcium
n median
range
n median
range
n median range
26
NA
NA
26
NA
NA
26
NA
NA
8
0.0
0.0-3.8
6
0.7
0.1-2.5 10
0.0
0.0-0.0
4
3.3
0.1-10.2 4
4.2
2.8-10.6 4
0.0
0.0-0.1
6
11.2
2.2-21.3 6
7.1
1.9-11.2 6
0.0
0.0-0.1
5
17.6
8.7-45.8 5
11.0
6.8-14.7 5
1.5
0.0-4.9
4
44.8 33.8-50.5 4
14.4
9.0-17.0 4
5.4
1.8-7.3
1
31.6
NA
2
30.65 29.5-31.8 1
1.8
NA
3
11.7
4.7-33.8 1
3.2
NA
3
7.2
1.5-8.3

A. The normal intima and arterial wall
No evidence of an atherosclerotic lesion was observed in 28 arteries (44%). The intima was
composed of a single layer of flattened elongated endothelial cells. The media was composed of
concentric lamellae of elastic fibers and spindle-shaped SMCs embedded in a ground substance
composed of collagen, elastic fibers, and extracellular matrix (Figure 24.E). A well-delineated
internal elastic lamina, which denotes the border between the intima and the luminal side of the
media and is considered part of the media,(H. C. Stary et al. 1992; L. C. Stout & Thorpe 1980)
was identified in several birds on Verhoeff van Gieson stain. No lipid or calcium deposits were
noted within the intima and media on the histological sections with H&E and histochemical
stains (Table 25).
As observed through TEM, endothelial cells measured about 2-4 μm at the level of the
nucleus and about 0.1-1 μm at the peripheral cytoplasm (Figure 25.A). The endothelial cells had
a limited number of organelles; free ribosome, rough endoplasmic reticulum (RER),
mitochondria, and Golgi complexes were rarely noted. Microfilaments measuring 5-7 nm were
abundant as well as plasmalemmal vesicles in the cytoplasm and at the luminal side of the cell
membrane (caveolae). Weibel-palate bodies were not observed. Microvilli were an infrequent
finding on the luminal side of the cellular membrane. A thin basal lamina was present in most
instances (Figure 25.A). The subendothelial space was limited to absent and the endothelium in
most cases was directly apposed to the media. Occasionally, isolated macrophages, identified by
the presence of a round to irregular shaped nucleus, pseudopodal projections, and frequent
electron-dense lysosomes, were found in the normal intima. The internal elastic lamina was
observed in several birds. In the media, SMCs measured approximately 2-4 μm in diameter and
frequently had an undulated nucleus, evidence of their contracted state (Figure 25.A). The SMCs
contained an abundant amount of myofilaments of 6-7 nm associated with electron-dense bodies
in the sarcoplasm and dense plaques on the inner side of the sarcolemma. Other organelles
identified included a few mitochondria preferentially located at the nuclear poles but also found
elsewhere in the sarcoplasm, uncommonly RERs, and, regularly, plasmalemmal vesicles and free
ribosomes. Smooth muscles cells were connected to each other via various junctional patterns
and also appeared anchored on the elastic fibers. A basal lamina was usually not observed on
normal SMCs. Ultrastructurally, lipid and calcium deposits were not observed. The endothelium
visualized with SEM was relatively smooth and was characterized by well-junctionned elongated
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endothelial cells that were orientated in the direction of the blood flow (Figure 26.A). There was
an inability to adequately characterize endothelial microvilli most likely due to autolytic
changes. On cross-sections, the concentric elastic lamellae were well visualized underneath the
endothelial layer (Figure 26.B).
B. Type I lesions
Ten arteries (16%) exhibited changes classified as type I lesions which represent the first
evidence of the presence of lipid deposits in the arterial intima and luminal side of the media and,
by definition, the first evidence of atherosclerosis. These lesions were difficult to identify
without the evaluation of toluidine-stained 0.5 micrometer-thick sections and TEM.
On light microscopy, initial changes were characterized by increased vacuolation of
endothelial cells, increased thickness of the intima in some cases as also evidenced through
Verhoeff van Gieson stain, mild to moderate fragmentation of elastic fibers, and the first
detectable presence of foam cells (Figure 24.A). The increased thickness of the intima was
mainly characterized by an increase presence of extracellular matrix and collagen fibers.
Macrophages were more numerous, generally isolated and rarely in groups of more than a few
cells. Extracellular lipid was not present and the extent of the lesions was minimal with no
plaque formation. Extracellular matrix was increased in the luminal side of the media. Mild and
scattered positive staining was observed on oil red O stain (Figure 24.B) but no calcium deposits
were detected (Table 25).
Ultrastructurally, endothelial cells had an increased numbers of caveolae and appeared more
vacuolated (Figure 25.F). As on light microscopy, TEM revealed an increased presence of
macrophages in the intima. They frequently contained lipid droplets of approximate 0.5-4 μm
diameter. In the intima and luminal side of the media, while most SMCs appeared normal, a
varying number of SMCs contained lipid droplets and an increased presence of smooth and
rough endoplasmic reticulum and plasmalemmal vesicles (Figure 25.C). A basal lamina was not
observed around the SMCs. Extracellular lipid was rare. Overall, when evaluated using the SEM,
endothelial architecture did not appear disrupted and was similar to normal endothelium.
C. Type II lesions
Type II lesions, observed in 4 arteries (6%), included the same changes as describe with type I
lesions but there was an increased number of foam cells arranged in groups and/or layers (Figure
24.C) and the atherosclerotic lesions occupied a significant portion of the arterial wall (Table
25). Foam cells were also found deeper into the media. Additionally, extracellular lipid droplets
were present in moderate quantity. A larger quantity of lipid (Table 25), as visualized by oil red
O staining, was present along the endothelium and the luminal side of the media (Figure 24.D).
No calcium deposition was detected in these arteries.
The foam cells were also visualized and characterized on TEM. Some cellular fragments and
myelin figures were also noted. As the intracellular lipid accumulation and the presence of foam
cells increased in the arterial wall, it became more challenging to differentiate macrophagederived from SMC-derived foam cells. However, the increased presence of myofilaments with
large numbers of dense bodies and dense plaques was more characteristic of SMCs and a large
number of lysosomes and cytoplasmic granules more compatible with macrophages (Figure
25.D-E). Endothelial changes were similar to type I lesions. On SEM examination, several
arteries exhibited mild endothelial changes characterized by an apparent increase in surface
roughness, small areas of endothelial denudation which left the basement membranes or the
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internal elastic lamina (elastic fibers) exposed, formation of “caves” in the endothelium, and the
presence of irregular shaped endothelial cells (Figure 26.C). No collagen fibers and significant
lipid and cellular debris deposition were noted in areas devoid of endothelial cells. In some areas,
the lack of overlapping and flattened endothelial cells was consistent with abnormal intercellular
junctional patterns. Clusters of red blood cells and occasional leukocytes were found adherent to
the arterial luminal surface in some arteries.
D. Type III lesions
The increased presence of extracellular lipid and cholesterol clefts formed large confluent
lipid areas in the subendothelium and adjacent media in type III lesions. Lipids and foam cells
accumulation disrupted the arterial architecture but deformation of the artery was still considered
mild. There was also an increased extracellular matrix between the elastic lamellae and an
increased fragmentation of the elastin fibers (Figure 24.F). This lesion type could be qualified as
preatheromas and was found in 7 arteries (11%). In one artery, lipid deposition was noted
primarily in the media. Two arteries had mild positive staining for calcium on von Kossa stain.
The preatheromatous lesion was positive for lipid on oil red O staining (Table 24).
Calcium granules were identified on TEM in several arteries (Figure 25.D). Higher degree of
cellular degeneration was also noticed along with an increased presence of extracellular lipids
and small and large cholesterol crystals measuring 0.1-2.5 μm in diameter. Compared to type II
lesions, type III lesions contained a larger proportion of foam cells (Figure 25.E) which appeared
to be derived from SMCs. On SEM, changes were similar but more severe to what was observed
in type II lesions with small to moderate areas of endothelial surface erosions and clusters of
blood cells adherent to the surface and, often, associated with the presence of fine fibrils
consistent with fibrin (Figure 26.D). Overall and similar to type II lesions, apart from these small
to moderate abnormal areas, the endothelial surface appeared minimally affected.
E. Advanced lesions: type IV and type V lesions
The accumulation of extracellular lipid, cellular debris, and calcium in the arterial wall leads
to the formation of the lipid core, that incorporates a significant portion of the arterial
circumference, disrupts the arterial architecture, protrudes in the lumen, and substantially
narrows it. This advanced type IV lesion is consistent with an atheroma and was seen in 5
arteries (8%). Cells were sparse in the lipid core and were found mainly along the periphery. An
increased presence of calcium granules and chondroid metaplasia was noted (Figure 24.G-H).
Increased extracellular matrix between elastic laminae was also present and accompanied, in
some cases, by lipid deposits.
Advanced lesions of type V, fibroatheromas encountered in four arteries (6%), were
characterized by the addition of a fibrous cap over the lipid core and increased disruption of the
arterial morphology and narrowing of the lumen (Figure 23.A, Figure 24.I). Extensive
calcification and chondroid metaplasia were also present. The cap over the lipid core was mainly
composed of collagen fibers. In one instance, a lesion was multilayered with two calcified lipid
cores separated by connective fibromuscular tissue. The arterial luminal stenosis became more
significant with this type of lesion and often more than 50% of the lumen was obstructed.
Calcification was prominent in advanced lesion types and only one artery was negative on
von Kossa stain. The percentage of lipid also continued to increase (Table 25).
Ultrastructurally, the lipid core was composed of a massive amount of extracellular lipid
droplets, cholesterol crystals, amorphous debris, disrupted collagen, and elastic fibers, dense
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calcium granules, and rare foam cells and degenerating cells (Figure 25.G). Occasionally, some
lipid-laden SMCs were found bordered by a thick basal lamina (Figure 25.B). Abundant collagen
fibers were observed in the fibrous cap of type V lesions. On SEM, advanced lesions were
characterized by wide surface defects and areas completely devoid of endothelial cells with,
occasionally, the presence of leukocytes (likely monocytes) and clusters of erythrocytes adherent
to the surface (Figure 26.E-F). The endothelial denudation revealed subendothelial structures
consistent, depending on the degree of ulceration, with collagen fibers of the fibrous cap and
lipid present within the lipid core (Figure 26.E-F).
F. Complicated lesions: type VI lesions
Two arteries (3%) were considered to have lesions complicated by fissures and hematomas
(Figure 24.J). In these areas, increased collagen and the presence of erythrocytes, thrombocytes,
and macrophages were noted on 0.5-micrometer thick sections and confirmed on TEM.
However, thrombus formation could not be clearly identified in any artery. Nevertheless, the
composition and organization of these lesions were very similar to type IV-V lesions. On SEM,
changes were comparable to what was observed in other advanced lesion types (IV-V) with the
presence of large number of fibrin fibers and blood cells in the fissure areas.
G. Type VII lesions
While all lesion types contain various amounts of calcium and chondroid metaplasia,
calcification was the predominant feature of 3 arteries (5%), classified as type VII lesions. Lipid
deposition was present but was minimal compared to advanced lesions and the amount of
calcium identified (Table 25). Calcification resembled calcification in bones rather than being
passive and dystrophic with the presence of chondrogenesis and osteogenesis. In one cockatiel,
bone marrow formation was observed in the arterial wall (Figure 24.K).
The TEM revealed large amounts of extracellular and occasional intracellular calcium
crystals, as well as some disrupted collagen and elastin fibers. Foam cells, extracellular lipids
and cholesterol crystals were found but in small quantity.
Only one artery was evaluated by SEM and showed changes similar to those observed in type
II-III lesions.
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Figure 24: Cross-section of arteries from psittacine birds. (The tops of the figures are the
luminal/endothelial sites. A. Type I. Polygonal and spindle cells with vacuolated cytoplasm
(foam cells) in the tunica intima. Pulmonary artery (PA). Toluidine blue (TB). Bar = 30 μm. B.
Type I. Cytoplasmic lipid, stained red, in the foam cells within the tunica intima. PA. Oil red O
(ORO). Bar = 30 μm. C. Type II. Large numbers of foam cells within the tunica intima with
overlying endothelial cells (arrow). Aorta (AO). TB. Bar = 30 μm. D. Type II. Extracellular and
intracellular lipid, stained red, within the tunica intima. AO. ORO. Bar = 30 μm. E. Type 0.
Normal media showing the regularly layered pattern of elastic fibers, stained black.
Brachiocephalic trunk (BT). Verhoeff van Gieson (VVG). Bar = 100 μm. F. Type III. Elastin
fragmentation and formation of areas devoid of elastin (*). BT. Bar = 100 μm. VVG. G. Type
IV. An atheroma containing necrosis (*) and lightly basophilic granules indicating calcium
deposits (arrow). AO. Bar = 50 μm. Hematoxylin and eosin (HE). H. Type IV. Calcium, stained
dark brown to black, within an intimal atheroma and the superficial tunica media. AO. Bar = 50
μm. von Kossa. I. Type V. A fibroatheroma consisting of a fibrous cap (arrows) and underlying
lipid core composed of lipid, cellular debris, cholesterol clefts (arrowheads) and extracellular
matrix. AO. Bar = 30 μm. TB. J. Type VI. A fissure with fibrous connective tissue (arrows)
dissecting an atheroma. AO. Bar = 50 μm. HE. K. Type VII. Ossifying metaplasia consisting of
bone with mineralization (arrows) and a marrow cavity (*). AO. Bar = 50 μm. HE. L. Type VII.
A fibrous cap (double-head arrows) containing collagen, stained blue, and subjacent extracellular
lipid and cartilage (*) indicating chondroid metaplasia. AO. Bar = 50 μm. Masson’s trichrome.
Insert: Positively stained cells (brown), indicating smooth muscle cells and/or myofibrocytes, in
a fibrous cap. Immunohistochemistry for smooth muscle actin. Hematoxylin counterstain.
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Figure 25: Transmission electronmicrograph of the major arteries of psittacine birds. A.
Normal arterial wall exhibiting no evidence of atherosclerosis and showing two endothelial cells
separated from the media by the internal elastic lamina. The media is composed of smooth
muscle cells, elastin, and collagen fibers. X 8 000. Insert : Magnified view of the basement
membrane of the endothelial cell (square). X 60 000. B. A smooth muscle cell is bordered by a
thick basal lamina and contained some lipid droplets. X 12 000. C. A SMC exhibiting
phenotypic changes with an increase presence of RER and lipid accumulation, X 10 000. Insert :
Magnified view of the RERs. X 20 000. Type I lesion. D. An active macrophage, with abundant
lyzosomes and a small number of lipid droplets in the cytoplasm and surrounded by a large
amount of extracellular lipid and extracellular matrix composed of various cellular debris,
collagen fibrils, and sparse calcium granules. X 10 000. Type III lesion. E. Two macrophagederived foam cells whose cytoplasm is filled with abundant lipid droplets and rare lysosomes. X
8 000. Type III lesion. F. A close-up view of the cytoplasmic membrane on the luminal side of
an endothelial cells presenting an increase number of caveolae, some of them being coated. X 60
000. Type II lesion. G. A large amount of extracellular lipid, cholesterol crystals, calcium
granules, and cellular debris with few cells are present. X 10 000. Type IV lesion. Ca, calcium
granule; Ch, cholesterol crystal; Co, collagen fibril; db, dense body; Exl, extracellular lipid; Ld,
lipid droplet; Ly, lysosome; Mf, microfilaments; My, myelin figure; N, nucleus; RER, rough
endoplasmic reticulum. Orcein-uranyl-lead stain.
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Figure 26: Scanning electronmicrograph of the major arteries of psittacine birds. A. Normal
endothelial surface of the aorta showing the organization of the endothelial cells oriented in the
direction of the blood flow. X 400. B. Cross section of a normal aorta where the endothelial cells
(En) are overlying the concentric elastic fibers (EF) of the media. X 2 500. C. Type II lesion
showing a demarcation area between normal endothelium (En) and endothelial denudation (*)
where the underlying elastic fibers are seen. X 300. D. Type III lesion showing some endothelial
cells (arrows) losing their intercellular junctions and detached from the arterial wall with
exposed underlying basement membranes (*). X 300. E. Type IV lesion depicting an extensive
area of endothelial denudation, a leukocyte (arrow) adhered to the surface in leukopedesis. X 2
000. Insert: A close-up view of this leukocyte. X 4 000. F. Type V lesion showing several
erythrocytes (arrowheads) and leukocytes (arrows) adherent to the luminal surface which is
devoid of endothelial cells, fine fibrils of fibrin seen on the surface. X 1 000.
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IV. Discussion
In this study, the different atherosclerotic lesions were described and classified based on light
microscopy, histochemistry, digital image analysis, and transmission and scanning electron
microscopy. While the disease is common in parrots, the description of the lesions including the
endothelial surface changes at the ultrastructural levels is presented here for the first time. With
light microscopy evaluation of 0.5 micrometer thick sections and the use of electron microscopy,
superior details of structure and detailed description of the cellular and extracellular components
of the psittacine lesions could be achieved. These results lead to a classification system that
better reflects the different steps or pathways of lesion progression, the pathogenesis of psittacine
atherosclerosis, and the composition of the atherosclerotic lesions. The AHA human
classification system was found to be suitable for the different lesion types found in parrots.
While the sample size was small (24 parrots, 63 arteries), the different lesion types could be
described in several arteries and the different morphologic variants were well represented. In our
report, several psittacine species (11) were used for the lesion description and classification. The
use of multiple species was not considered to be a limitation since the study was mainly
observational, the location and histopathology of psittacine atherosclerotic lesions are
homogenous, and veterinary pathologists do not usually focus on a single species.(Bavelaar &
Beynen 2004a; Fricke et al. 2009; Garner & Raymond 2003; Krautwald-Junghanns et al. 2004)
Furthermore, in recent studies, no difference was reported between species in lesion description
and location.(Bavelaar & Beynen 2004a; Fricke et al. 2009; Garner & Raymond 2003;
Krautwald-Junghanns et al. 2004; Pilny 2004) However, the use of different species should not
be encouraged in experimental studies when a specific hypothesis is to be tested. Birds were
obtained from a diagnostic pathology service and several limitations ensued. Variable degrees of
post-mortem autolytic changes were noted, and some changes not detectable on light microscopy
were observed at the ultrastructural level. Mitochondria, endothelial cells, and the endothelial
surface were primarily affected and some features of endothelial cells could not be thoroughly
evaluated. Weibel-palate bodies and anchoring fibrils to the subendothelial matrix were not
observed but could still be present in normal psittacine endothelial cells. Moreover, blood
monocytes adherent to the endothelium and/or their leukopedesis through endothelial
intercellular junctions could not be clearly identified, while suspected in some instances on
electron microscopy (Figure 26.E). Finally, mitochondrial swelling and disruption combined
with plasmalemmal disorganization can, in some instances, be confused with clear lipid droplets.
As mitochondria and endothelial cells deteriorate rapidly after death,(Cheville 1994a; Stary et al.
1992) they should be fixed immediately after death for best results, especially in species that
have a fast-metabolism such as birds. Additionally, arteries were not fixed under physiological
pressure which made the assessment of the thin intimal layer on light microscopy and the
morphology of the endothelial surface on SEM challenging. It is reported that collapse and
retraction of arteries can cause configurational distortions and tissue disruptions that can lead to
improper interpretation.(Stary et al. 1992)
Digital image analysis results show the progressive accumulation of lipid and calcium
deposits with the increase severity of the atherosclerotic lesion (Table 25) which presented high
correlations. In the proposed classification (Table 24 and Figure 23.B), type I and II lesions
constitute phases of minimal changes with an increased accumulation of foam cells but a limited
amount of extracellular lipids, calcium, and no disruption of the arterial architecture. Type III
lesions are intermediate between mild and advanced lesions and, while mild disruption of the
arterial wall is present, this type, with mild lesions, are likely to be clinically silent. Advanced
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type IV to VI lesions are characterized by the build-up of lipid and cellular debris forming a
fibroatheromatous plaque that can present complications such as fissures and hematoma.
Significant calcification begins to occur in advanced lesion types, which was also observed on
TEM (Table 25). These lesions are more likely to induce clinical signs and, in humans, are
referred to as clinically important lesions.(Stary 2003a; Stary 2005) Type VII lesions are mainly
calcific and do not contain a large amount of lipid. They may reflect lesion regression and repair
from more advanced lesion types after reduction of risk factors (Figure 23.L).(Stary 2003a; Stary
et al. 1995) In humans, calcification is a hallmark of advanced lesion types.(Stary 2003a)
Arterial calcification in parrots is almost always caused by atherosclerosis and, consequently
could be used as an imaging diagnostic marker and possibly quantified, as it is in human
medicine, for the detection of clinically important and advanced lesion types. Calcification in
atherosclerotic lesions involves the participation of osteoblasts and osteoclasts and a complex
interplay between chronic inflammation and bone biology.(Doherty et al. 2003) Calcification
usually progresses with the disease process and the development of complex lesions.(Doherty et
al. 2003) The different lesion types indicate the likely sequence of atherosclerosis stages until
the type IV lesion. After this stage, different pathways of progression are possible with different
morphologic outcomes and potential complications. The equivalent to the human type VIII
lesion characterized by reparative fibrotic tissue was not found in the arteries studied.(Stary et al.
1995)
In our study, a weak relationship was found between the age of the birds, the types of lesion,
and the lipid and calcium composition of the plaques. This may be due to the confounding effect
of other risk factors not evaluated in this observational study knowing that risk factors for
atherogenesis have not been clearly identified in parrots. Since the diet was extremely varied
across individuals, its relationship with the occurrence of atherosclerotic lesions could not be
assessed.
Other published classification systems in parrots, pigeons, quails, and chickens were
considered to less completely reflect the differences in lesions versus the AHA classification, as
characterized with light and electron microscopy in our study.(Fricke et al. 2009; He et al. 2005;
Orita et al. 1994; Santerre et al. 1972; Siegel et al. 1995) Classifications available in pigeons,
quails, and chickens were often designed to serve specific experimental objectives and without
the use of multiple modalities. Consequently, these classifications do not convey the same
information and may not apply readily to the variety of spontaneous lesion types that can be
encountered in diagnostic pathology. Nevertheless, these classifications were relatively close to
the one determined in this study with usually 3 to 6 stages showing the progressive accumulation
of macrophage foam cells and fat beginning in the intima, and ultimately resulting in a plaque
composed of a lipid core and a fibrous cap (Figure 23.A).(He et al. 2005; Orita et al. 1994;
Santerre et al. 1972) Two recent and comparable classifications of atherosclerotic lesions in
psittacine birds have been reported and, based on histochemical and immunohistochemical
methods, 4 stages of lesions were described.(Fricke et al. 2009; Schenker & Hoop 2007) In this
system, lesion classification was not based on the progressive accumulation of fat, calcification,
and cellular events, but was formulated on the successive occurrence of different extracellular
compounds. The stage I of this classification depicted lesions characterized by elastin
fragmentation but without the presence of fat. Since atherosclerosis is defined by the
accumulation of lipids in the arterial intima and, occasionally, the media, an initial lesion without
fat or foam cells cannot be considered to be part of this disease process. On the other hand, one
may speculate that this lesion type constitutes a pre-atherosclerosis stage. In our proposed
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classification and the AHA classification, the lesion type I constitutes the first evidence of
detectable lipid and, as such, the first evidence of atherosclerosis.(Stary et al. 1994) Furthermore,
in one of these previous studies, based on immunohistochemistry, macrophages could not be
demonstrated in psittacine lesions and the authors concluded that the current response-to-injury
hypothesis of atherogenesis was unlikely in parrots.(Fricke et al. 2009) However, these results
may rather be due to the challenges of immunochemistry in the avian species. The presence of
macrophages is the hallmark of atherosclerosis in all species studied and this cell type plays a
fundamental role in lesion initiation and progression.(Bobryshev 2006; Cullen et al. 2005; Libby
et al. 2002; Moore & Rayner 2010; Takahashi et al. 2002) In our study, macrophages were
demonstrated by electron microscopy but no immunohistochemical antibodies with crossreaction to psittacine macrophages could be found.
The use of TEM allowed the description of the ultrastructural characteristics of psittacine
atherosclerotic lesions in details. The ultrastructure of the different types of lesions was
invaluable in refining the classification criteria and gives an insight into the pathogenesis of the
disease in psittacine species. Lesions were ultrastructurally similar to what has been described in
other avian species (specifically the pigeon) and mammalian species including humans
suggesting common pathogenetic pathways.(Barr et al. 1991; Chamberlain & Belton 1987;
Hansen 1977; Lewis et al. 1985; Jerome & Lewis 1985; Nakamura & Ohtsubo 1992; Still 1963;
Toda 1988; Yamamoto & Igawa 1991) Early lesions were mainly characterized by isolated foam
cells, phenotypic changes of SMCs, increased extracellular matrix, and endothelial injury. As
lesions progressed, there was an increase amount of extracellular lipid droplets and cholesterol
crystals along with cellular debris, apoptotic cells, and calcium granules, particularly in the
forming atheromatous core (Figure 25.G). Some other cell types that are difficult to identify by
purely morphological criteria may also have been present. Foam cells appeared to be mainly
derived from macrophages, particularly in early lesions (types I-III). Smooth muscle cell-derived
foam cells appeared to increase in proportion with advanced (type IV-VII) lesions. However, the
identification of the origin of foam cells can be challenging, particularly in more advanced
lesions owing to the cellular degeneration and morphologic distortion caused by lipid
accumulation. In pigeons’ atherosclerotic lesions, foam cells are found to derive from both
macrophages and SMCs and there appears to be a shift in foam cell nature as lesion progresses
from macrophages in early lesions to SMCs in mature lesions.(Lewis et al. 1985) It is widely
accepted that the three major cell types involved in atherogenesis are the endothelial cell, the
SMC, and the macrophage.(Cullen et al. 2005; George & Lyon 2010; Nakamura & Ohtsubo
1992; Stary et al. 1994) Ultrastructural changes, which varied with the lesion types, were found
in these three cell types in parrots with vacuolation and edema of endothelial cells, apparition of
RER-rich SMCs (different form purely contractile SMCs) in early lesions suggesting an
increased metabolic and secretory activity (Figure 25.C), and foam cells formation from SMCs
and macrophages (Figure 25.E). Atherosclerosis is thought to be initiated by endothelial
activation and dysfunction which is characterized ultrastructurally by an increase in cytoplasmic
volume, pinocytotic vesicles (Figure 25.F), filopodia, vacuolation, and blood cells
attachment.(Cheville 1994b; Nakamura & Ohtsubo 1992) Changes observed early on in
psittacine endothelial cells could have been due to endothelial dysfunction but an accurate
interpretation was limited by post-mortem artifacts present at the ultrastructural level. Smooth
muscle cells associated with atherosclerosis are known to participate in the synthesis of
proteoglycans, collagen, and other components of the extracellular matrix.(Cullen et al. 2005)
The SMCs have also been found to proliferate and migrate into the intima, especially during
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initial phases.(Cullen et al. 2005) These findings were supported by the changes from a
contractile to a synthetic phenotype noted with a number of SMCs found in early lesions but
their proliferation and intimal migration could not be assessed.
The characteristics of the endothelial layer were also investigated by SEM. In humans and
other mammals, the endothelial surface changes characterized by SEM include surface
irregularities, due to the underlying accumulation of foam cells, erythrocytes, and platelets,
monocytes adhesion, endothelial cell proliferation, and endothelial erosions.(Terenzio Congiu et
al. 2010; Dell’Orbo et al. 2010; Davies et al. 1976; Goode et al. 1977; Kamari et al. 2008;
Pasquinelli et al. 1989; Song & Roach 1998; Walski et al. 2002; Weber et al. 1977; Zaikina et al.
1982) Similar changes have been observed in pigeons and Japanese quails.(Casale et al. 1992;
Taylor & Lewis 1986) In our study, various stages of surface defects, endothelium denudation,
and endothelial disorganization were observed in parrot arteries exhibiting atherosclerosis
(Figure 26). Occasionally, blood cells were observed to adhere to the endothelium (Figure 26.EF). Endothelial denudation was observed starting at type II lesions (Figure 26.C) and was severe
in advanced lesions (Figure 26.E-F). Various underlying structures such as the basement
membrane, collagen fibers of the fibrous cap, and the lipid core could often be observed
depending on the stage and depth of ulceration. Surface irregularities due to atherosclerosis were
likely present, but could not be accurately assessed because arteries were not fixed at
physiological pressure. It is to be noted that only small areas, corresponding to about 10-15% of
the arterial circumference, were evaluated on SEM and more severe endothelial lesions present
in other areas of the arterial endothelium may have been missed.
In conclusion, the classification system proposed in this study, adapted from the AHA
classification criteria, is supported by the different degrees of pathologic changes observed in the
arterial wall by light and electron microscopy and quantified by digital image analysis. It also
brings an insight into the pathogenesis of atherosclerosis in parrots and its comparison with other
species of animals for which there is a substantial scientific literature foundation. While some
mild differences with other species were present, our results suggest that the atherosclerotic
lesion composition and pathogenesis in parrots is similar to other species studied including
humans. Nevertheless, experimental studies in parrots would be the only means of studying the
pathogenesis, the chronology of molecular and cellular events, and the lesion progression
associated with psittacine atherosclerosis. Further studies are also needed to correlate the severity
of lesion type with clinical signs and diagnostic markers.
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CHAPTER II:
PREVALENCE AND RISK FACTORS IN PSITTACINE
ATHEROSCLEROSIS: A MULTICENTER CASECONTROL STUDY*
I. Introduction
Atherosclerosis is a chronic inflammatory fibroproliferative vascular disease characterized by
the buildup of atheromatous materials composed of numerous compounds including
inflammatory cells, lipid, calcium, and collagen in the luminal aspect of the arteries in response
to multiple forms of endothelial injuries. Complications of atherosclerotic lesions lead to wellcharacterized common diseases in humans, including coronary artery disease, ischemic stroke,
and peripheral arterial disease. As in humans, some species of birds seem extremely susceptible
to atherosclerosis, therefore, avian models including pigeons, quails, and chickens have been
extensively used. Studies on these species have elucidated some important aspects of the
pathogenesis and treatment of atherosclerosis.(Bavelaar & Beynen 2004b; Moghadasian 2002; St
Clair 1998) Among birds, psittacines seem particularly prone to developing spontaneous lesions
principally in the large arteries at the heart base.(Bavelaar & Beynen 2004a; Beaufrere, Nevarez,
et al. 2011; Fricke et al. 2009; Krautwald-Junghanns et al. 2004) However, scientific
investigations are scarce and certainly not of a scale in proportion to the importance of the
disease in this taxon. Most studies have focused on prevalence and histopathology.(Bavelaar &
Beynen 2004a; Beaufrere, Nevarez, et al. 2011; Fricke et al. 2009; Garner & Raymond 2003;
Johnson et al. 1992; Pilny 2004; Schenker & Hoop 2007; Krautwald-Junghanns et al. 2004)
The histologic lesions have been well described in psittacines and appear similar to humans
and compatible with the classification system developed by the American Heart Association
(AHA).(Beaufrere, Nevarez, et al. 2011; Fricke et al. 2009; Stary et al. 1994; Stary et al. 1995)
Psittacine atherosclerotic lesions consist of the progressive accumulation of inflammatory cells,
cholesterol, fat, and cellular debris in the intima and luminal side of the media. In advanced
lesions there is also formation of a lipid core (atheroma, type IV lesion) covered by a fibrous cap
(fibroatheroma, type V) and complications such as fissures, hematomas, and thrombosis (type
VI) may occur.(Beaufrere, Nevarez, et al. 2011) In humans, clinically important lesions are
defined as type IV-VI lesions based on reports from the AHA Committee on Vascular
Lesions.(Stary et al. 1995; Stary 2003b) Human post-mortem and clinical imaging studies have
shown that people with clinical signs of atherosclerosis had lesions of type IV or higher.(Stary et
al. 1995; Farb et al. 1995; Sanz & Fayad 2008)
The epidemiology of atherosclerotic diseases is well described in humans, but for the most
part, unknown in psittacine birds. Few studies have investigated the impact of dietary factors in
psittacine birds.(Bavelaar & Beynen 2003; Bavelaar et al. 2005; Bavelaar & Beynen 2003;
Petzinger et al. 2011; Bavelaar & Beynen 2003; Stanford 2005) Comparison of the epidemiology
of atherosclerosis in humans and psittacines is appropriate as they are both long-lived species
and may share common risk factors. The reported prevalence for atherosclerosis in
*
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psittaciformes varies widely from 1.9 to 92.4% depending on the study and species.(Bavelaar &
Beynen 2004a; Fricke et al. 2009; Krautwald-Junghanns et al. 2004; Johnson et al. 1992; Pilny
2004; Garner & Raymond 2003; Bavelaar & Beynen 2003; Kellin 2009) Post-mortem
retrospective and prospective studies on the prevalence of atherosclerosis in psittacines often
have variable study design, different and/or poorly defined inclusion criteria often encompassing
all lesion types, and do not control for confounding factors and covariables such as age and sex.
Furthermore, there is a need to model the prevalence of such slowly developing lesions as a
function of the age. The prevalence of atherosclerosis in psittacine birds based on age is
unknown but appears greater in older animals.(Bavelaar & Beynen 2004a; Fricke et al. 2009;
Beaufrere, Nevarez, et al. 2011) Knowing the prevalence of advanced and clinically important
atherosclerosis is crucial to the development and interpretation of diagnostic tests (positive and
negative predictive values) but also constitutes an invaluable aid in assessing and managing
psittacine patients based on their signalment and medical history.
Risk factors are an individual’s measurable characteristics which predict his or her probability
of developing clinical disease. This definition does not imply a causal relationship but entails
that risk factors must occur before the disease.(McGill & McMahan 2005) Risk factors for
atherosclerotic diseases in humans include lifestyle (smoking, diet, physical inactivity, stress,
alcohol, obesity), biochemical abnormalities (high cholesterol, triglyceride, LDL, low HDL, Creactive protein, thrombogenic factors, homocysteinemia, lipoprotein(a)), physiological
abnormalities (hypertension, diabetes mellitus, metabolic syndrome), and personal factors (age,
sex, genetic) categories.(McGill & McMahan 2005; von Eckardstein 2005) In birds, genetic risk
factors are present in White-Carneau pigeons and SEA (susceptible to experimental
atherosclerosis) quails.(Smith, Smith, et al. 2001; Shih et al. 1983) In psittacines, predisposed
species have been suggested and age, diet, and dyslipidemia are also frequently cited as potential
risk factors.(Fricke et al. 2009; Beaufrere, Nevarez, et al. 2011; Bavelaar & Beynen 2004a) But
to date these simple, yet primordial, potential risk factors have not been confirmed by studies
that used a large representative parrot sample and robust statistical methods.
Atherosclerotic lesions can remain silent for a long time until the accumulation of
atheromatous materials leads to pathologic complications and subsequent clinical signs in birds
caused by ischemia, arterial aneurysm, stenosis, and cardiac consequences.(Johnson et al. 1992;
Beaufrere, Holder, et al. 2011; Mans & Brown 2007; Phalen et al. 1996; Pilny 2004; Sedacca et
al. 2009; Shrubsole-Cockwill et al. 2008; Simone-Freilicher 2007; Vink-Nooteboom et al. 1998)
Therefore, the simple report of the prevalence of lesions of atherosclerosis and their associations
with several variables (that cannot be risk factors) is of modest immediate clinical interest.
Considering the implications in the definition of a risk factor, we suggest that veterinary
clinicians would be better served by knowing risk factors for advanced atherosclerotic lesions
rather than for lesions of various severities that may remain silent for decades. Atherosclerosisinduced avian diseases are challenging to diagnose and a better knowledge of their epidemiology
and association with other diseases in psittacine species would undoubtedly improve their
medical care in captivity.
With these goals in mind, we report a large multicenter retrospective case-control study on 5
psittacine genera aiming to determine associations between specific variables and advanced
atherosclerotic lesions. Our hypothesis was that the prevalence of atherosclerosis would increase
with age and that sex and some genera would show a higher prevalence than others. We also
hypothesize an association with cardiac, hepatic, reproductive, and renal diseases.
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II. Materials and methods
A. Study design and case-control selection
The available databases of 5 pathology centers were reviewed for all necropsy cases
(excluding biopsy and cytology cases) for which the heart was evaluated for the following five
genera of psittaciformes: Psittacus (African grey parrots), Amazona (Amazon parrots), Cacatua
(cockatoos), Ara (macaws), and Nymphicus (cockatiels). Databases included the School of
Veterinary Medicine at the Louisiana State University, Baton Rouge, LA, USA (2008-2010); the
Ontario Veterinary College at the University of Guelph, Guelph, ON, Canada (2001-2011); the
Schubot Center at the Texas A&M University, College Station, TX, USA (1988-1998); the
Zoo/Exotic Pathology Service, Sacramento, CA, USA (1998-2011); and Northwest ZooPath,
Monroe, WA, USA (1997-2012). Species, age, and sex were recorded for all subjects when
available. Information from all submissions was reviewed to ensure they were necropsy
submissions and not biopsy submissions.
Psittacine birds diagnosed with atherosclerosis were searched in the databases using the words
“atherosclerosis” or “arteriosclerosis” and their misspelled variants. All the histopathology slides
of these cases were retrieved and reviewed for the inclusion criteria. Only subjects presenting
advanced atherosclerotic lesions of type IV-VI, according to a previously described classification
system in psittacines (Table 24), in the brachiocephalic, pulmonary, carotid, coronary arteries or
the aorta were included as cases in the study.(Beaufrere, Nevarez, et al. 2011) These types of
lesions are defined as the clinically important lesions and prone to induce clinical signs in
humans.(Stary et al. 1995; Stary 2003b) Parrots presenting other types of atherosclerotic lesions
(I-III, VII) or in other locations were not included as cases.
For the second and third logistic models, a subset of the remaining birds was randomly
sampled using a statistical software (R, “sample” statement) and included as controls. The
number of controls selected was equal to the number of cases (ratio control/case=1). Criteria for
control selection were limited to the patient failing to exhibit advanced atherosclerotic lesions on
histopathology. Availability of patient information and completeness of pathology records were
not required for selection to prevent potential selection bias. Furthermore, to address bias
associated with centers, locations, databases, and pathologists, controls were matched with cases
at each institution.
A more detailed history was then recorded for all cases and controls including species, age,
sex, types of histologic lesions found (inflammatory, infectious, neoplastic, degenerative,
traumatic, metabolic, and other), and organ systems affected (hepatic, gastroenteral,
reproductive, musculoskeletal, respiratory, neurologic, cardiovascular (other than
atherosclerosis), integumentary, endocrine, systemic, lymphoid (splenic/bursal), and renal).
Lesions qualified as mild by the pathologists were not included in the analysis. The occurrence
of specific diseases, potentially associated or concomitant with atherosclerosis, was recorded and
comprised Chlamydophila psittaci infection, potential herpesvirus infection (internal
papillomatosis, Pacheco's disease), vacuolar hepatopathy, hepatic fibrosis, renal glomerulopathy,
nephrosis, myocardial fibrosis, myocardial degeneration, and myocarditis.
B. Statistical analysis
Missing data accounted for 26.6%, 25.2%, and 7.3% of age, sex, or both (unknown or
unreported on submission sheets), respectively, and was assumed to be missing at random. To
limit the loss of information and bias associated with list-wise deletion (default for statistical
software), the missing values were dealt with multiple imputations.(Honaker et al. 2011) A
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bootstrap based Expectation-Maximization-Bayesian (EMB) algorithm was used to perform 5
multiple imputations by missing value creating 5 different datasets.(Honaker et al. 2011) Age
was included in the imputation algorithm with a log transformation to achieve normality, one
assumption of the method.
Results were used to first construct a multiple logistic model to predict the prevalence of
advanced atherosclerosis based on age, sex, and genus and to quantify the effects of these
potential risk factors. This multiple logistic regression model was fitted simultaneously with the
combination of each of the 5 entire datasets corresponding to the 5 imputations with the presence
of severe atherosclerosis as the binary outcome variable with age, sex, and genera (dummy
variables) as explanatory variables. Final model parameters were combined using Rubin's rules
either manually or automatically by the statistical software.(Rubin 2004; Honaker et al. 2011) To
compare the difference in prevalence between genera, the reference level for genera was
accordingly changed in the model. To obtain odds ratio for each genus, a separate model with
only one of the 5 genera dummy variables was run for each genus. To assess the validity of the
imputation procedure, imputation diagnostics were performed by comparing the distribution of
the imputed data to the complete data and by comparing the odds ratio obtained using the model
with the complete-cases dataset (4264 birds) to the model using multiple imputations.
To investigate further associations, a more complex second multiple logistic model was
subsequently fitted with only the cases and randomly sampled controls and with the addition of
types of diseases and organ systems affected as explanatory variables. Only a few interaction
terms corresponding to specific research hypothesis were part of the models (e.g. degenerative x
cardiac). For this model, due to the high number of variables, a backward stepwise selection
process was performed to find the best model (alpha to drop=0.15, alpha to enter=0.10). This
was done manually not to remove variables that were part of an included interaction term.
Different models were compared using the Akaike information criterion. Multicollinearity was
checked with variance inflation factors prior to performing stepwise procedures.
Finally, a third logistic model investigating the association between severe atherosclerosis and
specific lesions or diseases [Chlamydophila psittaci infection, herpesvirus infection (internal
papillomatosis, Pacheco's disease), vacuolar hepatopathy, hepatic fibrosis, renal glomerulopathy,
nephrosis, myocardial fibrosis, myocardial degeneration, and myocarditis] was fitted controlling
for age, sex, and genus. The explanatory variables in the second and third models were not
combined as they were assumed to be multicollinear.
Assumptions of the models and the presence of outliers were checked based on model fit and
residual plots. Fit and predictive power of the models were assessed based on the area under the
receiver operator curve (ROC). Odds ratio were obtained by exponentiation of the parameter
estimates and were reported with their 95% confidence intervals (CI). A type I error rate of 0.05
was used for statistical significance. R (R development core team (2012). R foundation for
statistical computing, Vienna, Austria. http://www.R-project.org/) was used for statistical
analysis and the R-packages “Amelia II” (Honaker J, King G, Blackwell M (2011). Amelia II: a
program for missing data. R package version 1.5-4. http://CRAN.R-project.org/package=Amelia)
and “Zelig” (Imai K, King G, Lau O (2012). Zelig: everyone's statistical software. R package
version 3.5.5. http://CRAN.R-project.org/package=Zelig) were used for multiple imputations and
combinatory logistic models, respectively.
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III. Results
A total of 7683 parrots were included in this study with 525 confirmed advanced
atherosclerosis cases (IV-VI), which represented an overall prevalence of 6.8% (95% CI: 6.27.4) when not controlling for age, sex, and genus. Figure 27 shows the distribution of age in
birds with known age (5640 birds). Of the parrots with known sex (5750 birds), there was 51.5%
of females and 48.5% of males. The studied population included 17.9% of Psittacus, 14.9% of
Amazona, 26.4% of Nymphicus, 16.1% of Cacatua, and 24.7% of Ara. The control to case ratio
for the first logistic model was 13.6. There was only a mild difference in the point estimates of
the odds ratios between the analysis using complete information and the larger analysis using
multiple imputations (Table 26).

Figure 27: Distribution of ages of 5640 psittacine birds used in this study for which sex was
known. N: number of birds, Age is in years.

Age, sex, and genera had a significant association with the prevalence of advanced
atherosclerotic lesions on necropsy when holding other variables in the models constant (Figure
28, 29, 30, and Table 25). Older parrots and female parrots had increased odds of developing
advanced lesions (Figure 28 and 29, Table 26). Males showed an estimated 31% decrease in
odds compared to females.
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Figure 28: Estimated prevalence of advanced atherosclerotic lesions as a function of age from
a population of 7683 psittacine birds. Dotted lines represent 95% confidence bands. Age is in
years.

Figure 29: Estimated prevalence of advanced atherosclerotic lesions as a function of age and
sex from a population of 7683 psittacine birds. Dotted lines represent 95% confidence bands.
Age is in years.
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Table 26: Odds ratio of age, sex, and genus with the presence of advanced atherosclerosis on
necropsy in 7683 psittacine birds
Variable

OR 95% CI p-value ORcc

Age (1 year increase)

1.08 1.07-1.10 <0.001 1.10

Age (10-year increase) 2.22 1.93-2.57 <0.001 2.59
Sex (male/female)

0.69 0.56-0.85 0.007

0.66

Psittacus

2.75 2.23-3.45 <0.001 2.54

Amazona

1.83 1.45-2.30 <0.001 1.75

Nymphicus

1.46 1.14-1.87 <0.001 2.02

Cacatua

0.25 0.16-0.38 <0.001 0.20

Ara

0.13 0.08-0.20 <0.001 0.13

OR: odds ratio, CI: confidence interval, p-value for genera is for comparison with the overall mean response,
ORcc: odds ratio for complete-case dataset on 4264 birds (without use of multiple imputation procedures)

Among genera, in descending order, African grey parrots, Amazon parrots, and cockatiels
were particularly susceptible to atherosclerosis and had increased odds of having severe lesions
compared to the other genera in the model and had a higher prevalence than psittacines overall
(Table 25, Figure 28 and 30). Cockatoos and macaws seemed relatively less susceptible than
average with a decrease in odds by 75% and 87%, respectively. Genera differed significantly
from each other (Psittacus-Amazona comparison: p=0.017, all other p<0.01) except for Amazona
that did not differ significantly in prevalence from Nymphicus (p=0.38) as well as Cacatua from
Ara (p=0.11). The median effect level was reported as age for which a 50% probability of
experiencing advanced atherosclerosis was observed (50% prevalence), which is equal to (intercept – Σ dummy variables parameters) / age parameter (because logit[0.5]=0) (Table 26).
The area under the ROC was 0.83 for these models indicating a good fit. No outlying data were
detected and the interaction between sex and age was not significant.
The second logistic model investigating association with disease revealed that birds exhibiting
reproductive and/or hepatic disease were at increased odds of advanced atherosclerosis on postmortem examination when controlling for age, sex, and genus (Table 28). This association
appears to only be mild with hepatic disease. Most birds diagnosed with reproductive diseases
were females (49/50). Birds with cardiac degenerative disease were at increased odds but this
was not significant at the 0.05 level (but was at the 0.1 level of significance with a 90% CI of
1.06-5.90). The third logistic model showed only a significant increase in odds with myocardial
fibrosis diagnosed along with atherosclerosis controlling for age, sex, and genus (Table 28). Only
the odds ratio for positive parameter estimates with p<0.10 of the final selected models are
reported. The area under the ROC curve was 0.86 and 0.85 for the second and third logistic
models, respectively.
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Figure 30: Estimated prevalence of advanced atherosclerotic lesions as a function of age, sex,
and genus from a population of 7683 psittacine birds. Age is in years.
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Table 27: Median age effect level (50% prevalence) for genus and sex in years in 7683
psittacine birds.
Genus

Male Female

Psittacus

34.7

30.8

Amazona

40.3

36.0

Nymphicusa 40.6

36.7

Cacatua

60.5

56.4

Ara

63.5

59.8

a

the oldest cockatiel in the study was 30 year old but the median age effect level may still be a useful value to
report in this species for comparison purposes

Table 28: Odds ratio for presence of diseases and lesions association with the presence of
advanced atherosclerosis on necropsy in case-control logistic models with 525 cases controlling
for age, sex and genus
Variable

OR

95% CI p-value

Second logistic model
Reproductive diseases

3.09 1.39-6.88

0.007

Hepatic diseases

1.58 1.05-2.39

0.030

Degenerative cardiac diseases 2.62 0.90-6.95

0.080

Third logistic model
Myocardial fibrosis

4.68 1.83-12.00 0.001

Only variables with positive parameter estimates and p<0.10 are reported. See Table 2 for the remainder of the
keys

Atherothrombotic lesions, aortic rupture, aortic dissection, and plaque hemorrhage
(atherosclerotic lesion type VI) were rarely diagnosed, in only 1.9% (10/525) of cases but always
considered contributed to the death of the animal, based on pathologist comments (Figure 31.A).
While difficult to objectively assess due to post-mortem arterial collapse and contraction, severe
stenosis sometimes progressing to near complete occlusion seemed a relatively common finding
with advanced lesion types (Figure 31.B) and always contributed to the death of the animal based
on pathologists opinions. Only one case with advanced atherosclerosis was concomitantly
diagnosed with Chlamydophila psittaci infection.
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Figure 31: A: Atherosclerotic lesion type VI in a 13-year-old female African grey parrot
(Psittacus erithacus) in a longitudinal section of the aorta. The lesion is composed of a large
atheromatous plaque in the intima showing erosion and connected to an organized fibrin
thrombus nearly obstructing the lumen. B: Atherosclerotic lesion type IV in an Amazon parrot
(Amazona spp.) in a brachiocephalic artery in cross section. The lesion is composed of a large
circumferential atheromatous plaque nearly completely obstructing the arterial lumen. No fibrous
cap overlying the lesion is evident. (Hematoxylin and eosin, x100)
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IV. Discussion
This observational retrospective study reports the prevalence and association of advanced
lesions of atherosclerosis and selected epidemiological factors and concurrent diseases on
necropsy in a large sample of parrots from 5 centers and for 5 of the most commonly seen genera
by avian practitioners. This study is one of the largest epidemiological studies conducted in
psittacine birds to date and showed, through multiple logistic modeling, that age, female sex, and
Psittacus, Nymphicus, and Amazona genera were at increased odds of developing clinically
important atherosclerotic lesions. Our large sample size allowed us to estimate this prevalence by
age, sex, and genus with high precision. Atheromatous lesions were also found to be
significantly and positively associated with reproductive disease, and mildly associated with
hepatic disease, and concurrent myocardial fibrosis.
One can assert that the inclusion criteria for our cases were too stringent leaving some types
of atherosclerotic lesions in the control population, or that the association between advanced
lesion types and clinical signs remain to be proven in psittacine birds. While we concur with
these arguments, several factors support that our approach is valid. The advanced type lesions
(IV-VI) are qualified as clinically important in the AHA classification scheme and include
lesions that produce clinical signs and silent lesions that have not yet caused disease by vascular
occlusion or thromboemboli.(Stary 2003b; Stary et al. 1995) This lesion classification derived
from human pathology seems to be supported in avian patients based on our study findings;
stenosis was common, and also by a number of case reports where clinical signs could clearly be
associated with arterial luminal narrowing and ensuing tissue hypoperfusion but not with
atherothrombosis, plaque rupture, or pre-atheromatous lesions (type I-III).(Beaufrere, Holder, et
al. 2011; Phalen et al. 1996; Pilny 2004; Sedacca et al. 2009; Shrubsole-Cockwill et al. 2008;
Johnson et al. 1992) Complicated lesions (type VI) appeared rare in parrots as could be estimated
in our study (1.9% of advanced lesions, 0.1% overall raw prevalence), which is consistent with
previous reports.(Bavelaar & Beynen 2004a) However, clinical signs are not always caused by
atherothrombosis and, in fact, humans experience a high rate of lesions, up to 26% in one study,
associated with sudden coronary death for which thrombosis or other causes of death cannot be
found on autopsy.(Virmani et al. 2000) In these cases, symptoms and deaths are suspected to be
due to arterial stenosis leading to chronic myocardial ischemia and lethal arrhythmia.(Virmani et
al. 2000) Furthermore, atherosclerotic diseases are challenging to diagnose in birds and a
diagnosis is often, if not always, made on post-mortem examination.(Beaufrere, Pariaut, et al.
2010; Bavelaar & Beynen 2004a) Thus, in absence of a more valid and better alternative,
studying the prevalence of type IV-VI atherosclerotic lesions as a surrogate for estimating the
prevalence of atherosclerotic disease seems an acceptable strategy for parrots.
Our results must be interpreted in the context of the study limitations. The retrospective nature
of this work presents several drawbacks: incomplete information, difficulties in extraction of
valuable information from large databases, inability to show causal relationships, susceptibility
to bias, and assessment of risk factors after the outcome of interest has occurred.(Schulz &
Grimes 2002) The prevalence and severity found on necropsy may also be different from the true
prevalence of the live population and advanced atherosclerotic lesions may have still been
present but not represented in the available histopathologic sections. Sophisticated methods to
deal with missing values such as multiple imputations reduce bias and increase efficiency
compared to, for instance, performing statistical analysis on only complete data or imputing the
overall mean; imputations incorporate the uncertainty associated with the missing values and
limit information loss.(Donders et al. 2006; Harel & Zhou 2007; Honaker et al. 2011) In
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addition, all organs were not always assessed by histopathology, which may have introduced
some bias and limit the validity of our assessment on the association of general and specific
lesions of other organ systems with advanced atherosclerosis. Control selection and sampling are
important sources of bias and proper methods are crucial to interpret study results.(K. Schulz &
Grimes 2002) For this reason, investigation of age, sex, and genus risk factors was performed by
using the entire available population. Controls were sampled from this population for practical
reasons to investigate more specific associations and examination of new hypotheses to be
confirmed by future observations. Nevertheless, case-control studies are easier to perform than
cohort studies, are inexpensive, can be performed in a relatively short time period, and may
reveal important findings.(Schulz & Grimes 2002) The lengthy development of atherosclerotic
lesions in long lifespan species do not easily lend itself to cohort studies and case control studies
are an efficient alternative for such diseases with a long latency period.(Schulz & Grimes 2002)
Only five psittacine genera were included in this study and our results may not apply to other
psittacine species. There are roughly 84 genera including 353 species within the order
psittaciformes and it would have been challenging to account for all of them in a balanced and
meaningful statistical model especially since some species are kept in captivity in relatively low
numbers. For this reason, we decided to focus on only the most commonly seen genera by avian
practitioners and pathologists.
The prevalence of advanced atherosclerotic lesions in psittacine birds is comparable to the
human prevalence in North America keeping in mind the longer lifespan of humans with, for
instance, a 30-50% prevalence in 45-75 years old humans.(Roger et al. 2011)
Age was found to be a significant and important risk factor of advanced atherosclerosis in the
studied psittacine genera. This risk increases dramatically at about age 20-30 years (Figure 4).
While this effect was demonstrated in previous psittacine studies, our study provides a more
precise estimation of magnitude and a wider range of ages. A recent small case-control study
showed a significant effect of age in preliminary analysis that failed to be significant in a
multivariable model, but this may have been due to the small sample size.(Pilny et al. 2012)
Interestingly, the odds ratio for age, obtained on a smaller sample, was nearly identical to ours
(1.08 vs. 1.09 per year).(Pilny et al. 2012) Age is also an important predictor of atherosclerotic
diseases in humans.(Roger et al. 2011; von Eckardstein 2005) The effect of age is explained by
the increased exposure time to risk factors, the slow accumulation of atheromatous materials in
the arteries over time, the physiologic effects of aging, and the rising prevalence and severity of
specific cardiovascular risk factors with age such as dyslipidemias and hypertension.(von
Eckardstein 2005) The number of older psittacine birds seen by avian veterinarians is expected to
increase with the improvement of captive conditions and advancement of avian medicine, so the
number of parrots presented with disease processes linked to atherosclerosis will likely increase.
Another important finding of our models is the significant effect of female sex on the
probability of finding advanced lesions on necropsy. A female predisposition was noted by two
previous investigators based on raw percentages.(Garner & Raymond 2003; Nichols & Montali
1995) However, this effect was not detected in the majority of previous studies, probably based
on low sample size and statistical power.(Pilny et al. 2012; Fricke et al. 2009; Johnson et al.
1992; Bavelaar & Beynen 2004a; Bavelaar & Beynen 2003) In one report with over 1000
parrots, males had four times higher prevalence than females but the dataset was skewed toward
male sex and the analysis was not controlled for confounding variables.(Fox 1933) Interestingly,
SEA Japanese quails showed a male susceptibility for diet-induced atherosclerosis but this may
not be comparable to spontaneous lesions.(Godin et al. 1995) In our report, males seem to lag
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about 4 years behind females to reach similar prevalence (Figures 3 and 4, Table 2). This is a
reversal from mammals and humans for whom males less than 55 years have 2-3 times more
coronary heart disease events, strokes, or peripheral arterial disease than females and have a 50%
increased lifetime risk of developing coronary artery disease.(von Eckardstein 2005; Roger et al.
2011) This sex difference diminishes after menopause but the risk in women lags by 10-15 years
behind that of men.(von Eckardstein 2005; Roger et al. 2011) This effect is not completely
understood but is thought to be related to sex hormones and environmental/lifestyle factors that
varied between sexes.(von Eckardstein 2005; Mosca 2005) Protective action of estrogens may be
directed at the cardiac and vascular levels but also through beneficial effects on blood pressure,
hemostasis, inflammation and lipoprotein metabolism(Mosca 2005; Mendelsohn 2009) In fact,
these effects could well be reversed in female birds for which estrogens have tremendous
physiologic effects on lipid, protein, and calcium metabolism related to reproduction and egg
formation.(Alvarenga et al. 2011; St Clair 1998) In reproductively active females, estrogen
induce increases in plasma total calcium, proteins, cholesterol and triglycerides and hepatic
synthesis of two specific lipoproteins, vitellogenin and VLDLy (yolk labeled), which target the
developing oocyte and are protected against the normal degradation of plasma lipoprotein
lipase.(Alvarenga et al. 2011; Walzem et al. 1999) Increased plasma cholesterol, VLDL, VLDL
remnants, and non-HDL cholesterol promote atherogenesis, providing a plausible explanation for
the enhanced predisposition found in female psittacine birds.(von Eckardstein 2005; Zannis et al.
2005) Moreover, dietary supplementation of estrogens exacerbated lipid deposition in the aorta
of 5-day-old female chicks.(Toda et al. 1981)
The genera predisposition found here is a confirmation of previously suspected or
demonstrated species susceptibility.(Bavelaar & Beynen 2004a; Fricke et al. 2009; Pilny et al.
2012; Bavelaar & Beynen 2003) The reasons for this are unknown but one can speculate that
these genera may have physiological and genetic differences or different captive lifestyle and
stress levels that could influence atherogenesis. Also, these species have evolved with different
dietary and lifestyle habits which have changed drastically in captivity.(Cornejo et al. 2011)
In the model investigating organ system and types of diseases, the highest effect was observed
for reproductive disease, which further supports our finding of a female sex effect. These
findings may reflect a more general and frequent dysregulation of the reproductive system
occurring in captive psittacine birds which may subsequently promote chronic diseases in other
organ systems.(Van Sant 2006; Bowles 2006) Only a mild association was found with hepatic
disease and no association was found with vacuolar hepatopathy or hepatic fibrosis when
controlling for other variables. These lesions were prevalent in both cases and controls. Human
patients with hepatic lipidosis are at increased risk of cardiovascular diseases through a variety of
mechanisms.(Bhatia et al. 2012; Kim et al. 2012) Therefore, our findings may be explained by
differing pathophysiology of hepatic lipidosis in psittacine species than in humans, the
multiplicity of causes, an incorrect disease classification, or some unidentified bias affecting
these parameters such as incomplete histologic evaluation of all organs. Also, only moderate to
severe lesions were included in the study. A previous study failed to find any association
between atherosclerosis and illness types but some psittacine cases were concurrently reported
with hepatic lipidosis and fibrosis.(Pilny et al. 2012; Phalen et al. 1996; Shrubsole-Cockwill et
al. 2008)
Contrary to a recent case-control study using immunohistochemistry on arteries from 62
psittacine birds and in accordance with another report using PCR and immunohistochemistry in
103 birds, we did not find any association between avian chlamydiosis and atherosclerosis as
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only 1/525 cases was confirmed to be infected on necropsy.(Pilny et al. 2012; Schenker & Hoop
2007) However, we did not attempt to detect C. psittaci antigens in arteries. Association with C.
pneumoniae infection in humans remains controversial after decades of research.(Dugan et al.
2002; Hoymans et al. 2007; Sessa et al. 2009; C. Watson & Alp 2008)
Myocardial fibrosis was significantly related to the presence of advanced atherosclerotic
lesions suggesting that these vascular lesions may induce cardiac pathologic changes that could
lead to myocardial dysfunction, cardiac arrhythmia, or further degenerative changes. Myocardial
fibrosis is a frequent finding in humans with coronary artery disease, is caused by chronic
myocardial ischemia and systemic hypertension, and can lead to congestive heart failure and
sudden death.(Wheeler & McNally 2005; Frohlich 2001; Liebson 2008) Severe myocardial
fibrosis was diagnosed in several avian case reports diagnosed with advanced atherosclerotic
lesions and in a high percentage of Amazon and African grey parrots in a previous study.(Fricke
et al. 2009; Shrubsole-Cockwill et al. 2008; Sedacca et al. 2009)
Several major risk factors could not be assessed retrospectively. The diet, which is probably
one of the most important modifiable risk factors, could not be investigated because it was rarely
reported on submission sheets or the information was too scant to be of use. Clinicopathologic
parameters could not be investigated. Total cholesterol was significantly higher in parrots
diagnosed with atherosclerosis in a previous retrospective study.(Pilny et al. 2012) Total
cholesterol and LDL rise in response to 1-2% cholesterol feeding and experimental induction of
atherosclerosis in Quaker parrots (Myiopsitta monachus), budgerigars (Melopsittacus undulatus),
and other avian models.(Pilny et al. 2012; Bavelaar & Beynen 2004b; Pilny 2004; Finlayson &
Hirchinson 1961) (Beaufrère et al, in preparation) Moreover, Amazon and African grey parrots
have higher plasma levels of cholesterol and the latter showed an increased plasma cholesterol
when fed high-fat diet in feed trials.(Bavelaar & Beynen 2004a; Bavelaar & Beynen 2003;
Bavelaar & A. Beynen 2003)
In conclusion, this large multicenter study provides avian veterinarians with useful
information on prevalence and risk factors for advanced lesions of atherosclerosis in captive
psittacine birds, and these may be of value in cardiovascular disease assessment and patient
management. Reproductive diseases were the only identified potentially modifiable risk factor.
There is no prospective information to definitely confirm this association, we suspect that
reproductive diseases are likely to be true risk factors based on three elements: presence of a
significant female susceptibility, significant association found with reproductive diseases, and
the common occurrence of chronic reproductive disorders in captive psittacine pets. Therefore,
prevention and management of reproduction dysfunction in captivity and salpingohysterectomy
in females may show some benefit in lowering the prevalence of atherosclerosis in psittacine
birds.
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CHAPTER III:
EXPERIMENTAL DIET-INDUCED
ATHEROSCLEROSIS IN QUAKER PARROTS
(MYIOPSITTA MONACHUS)*
I. Introduction
Similar to humans, birds have a high susceptibility to atherosclerosis and probably show the
highest prevalence and severity of atherosclerotic lesions among vertebrate animals under
standard captive conditions.(F. J. Bavelaar & A. C. Beynen 2004a; Beaufrere et al. in press)
Non-psittacine avian models have been extensively used for the experimental investigations of
atherosclerotic lesions and their associated physiologic complications in species such as the
white Carneau pigeon, Japanese quail, and chicken.(Xiangdong et al. 2011; St Clair 1998; Singh
et al. 2009; Shih et al. 1983)
Birds of the order psittaciformes (e.g. parrots, cockatoos) are long-lived species and seem
especially prone to atherosclerosis with a high prevalence of lesions in the captive
population.(Bavelaar & Beynen 2004a; Beaufrere, Nevarez, et al. 2011; Beaufrere et al. in press;
Fricke et al. 2009) In psittacines, atherosclerotic lesions occur spontaneously and on cholesterolfree diet but, unlike in pigeons, which develop them in the thoracic aorta, they are predominantly
located in the main elastic arteries at the base of the heart and in the carotid arteries. Although
identified less often in psittacine species than in humans, coronary and other peripheral arterial
lesions are also diagnosed on a regular basis through histopathologic examination. In addition,
parrots show clinical manifestations of advanced atherosclerotic lesions caused mainly by
arterial luminal stenosis (e.g. ischemia, claudication, stroke) with the histologic characteristics of
the lesions being similar to those associated with human disease.(Sedacca et al. 2009; Beaufrere,
Holder, et al. 2011; Bavelaar & Beynen 2004a; Vink-Nooteboom et al. 1998; Phalen et al. 1996;
Simone-Freilicher 2007; Mans & Brown 2007; Beaufrère et al. 2011) However,
atherothrombosis, plaque rupture, and myocardial infarction are considered infrequent in
psittaciformes. A recent large multicenter case-control study on over 7600 captive psittacine
patients has shown that age, female sex, some genera, and concurrent reproductive diseases were
potential risk factors for the development of advanced atherosclerotic lesions of type IV-VI of
the American Heart Association (AHA) classification.(Beaufrere et al. in press) Furthermore, the
prevalence of atherosclerotic lesions by age groups was comparable to humans. The
pathophysiology and risk factors of psittacine atherosclerosis are still poorly understood. Also,
the ante-mortem diagnosis is challenging and the correlation between clinical signs and the
degree of histological changes is unclear with current scientific knowledge.(Beaufrere, Pariaut, et
al. 2010; Beaufrere et al. in press) Therefore, a psittacine model is highly needed to investigate
diagnostic tests, explore pathogenesis and risk factors, and test potential treatments of this
common disease of parrots. One report published in 1962 documented significant atherosclerosis
and hypercholesterolemia in budgerigars (Melopsittacus undulatus) fed a diet composed of 2%
cholesterol and 15% lard, but since that study, an experimental psittacine model of
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atherosclerosis has not been established and used for atherosclerosis research
investigation.(Finlayson & Hirchinson 1961)
Other atherosclerosis animal models involve mainly mammalian species such as mice, rats,
hamsters, rabbits, swines, guinea pigs, dogs, and non-human primates.(Xiangdong et al. 2011;
Singh et al. 2009) Among these, genetically engineered mice are currently the most
popular.(Xiangdong et al. 2011; Singh et al. 2009) While mammals share similar lipid
physiology and are closer to humans than birds, mammalian species used as models rarely
develop spontaneous advanced lesions under normal circumstances while being fed a standard
diet with the exception of primates. Therefore, the results obtained from experiments using
inbred and genetically modified animals cannot easily be translated to spontaneous-occurring
lesions in the same species.
Here, we report the experimental dietary induction of advanced atherosclerotic lesions in
Quaker parrots (Myiopsitta monachus), a small psittacine species susceptible to spontaneous
atherosclerosis.

II. Materials and methods
A. Experimental design
Sixteen captive-bred Quaker parrots (Myiopsitta monachus) of unknown sex ranging in age
from 6 months to 2 years were used in this study. The birds were housed in pairs and kept in
stainless steel cages in a laboratory animal facility. The research protocol was approved by the
Louisiana State University – Institutional Animal Care and Use Committee. The parrots were
acclimatized for 6 months and converted to a commercial pelletized psittacine diet (Kaytee Exact
Natural, Kaytee). The birds were randomized to one control group of 4 birds and one treatment
group of 12 birds with differing lengths of treatment using statistical software (R). A psittacine
atherogenic diet was formulated and manufactured by Kaytee from the company's maintenance
parrot pellets formula (Exact Natural) with the addition of 1% cholesterol keeping a similar
calorie and micronutrients to protein ratio with the control diet to obtain similar daily caloric and
protein intake among groups. The cholesterol was obtained as 92.5% cholesterol from sheep
wool (Sigma, C8503). Both the atherogenic and control diets were submitted for nutritional
analysis to an independent A2LA accredited laboratory (Eurofins Scientific Inc., Nutrition
Analysis Center, Des Moines, IA) (Table 29). The atherogenic diet was fed for 2, 4, 6, 8 months
with 3 birds allotted to each time period. Each group of birds was euthanized at the end of their
specific period by intravenous injection of potassium chloride under isoflurane anesthesia. The
control group was fed the control diet. Two birds from the control group were euthanized before
the study was initiated to ensure the lack of any detectable atherosclerotic lesions and the 2
remaining birds at the end of the study period at 8 months. Food consumption was monitored
daily by providing 18g of pellets per bird per day and weighing unconsumed food and food
waste at the cage bottom before the subsequent feeding. All birds were weighted on a monthly
basis until they were euthanized.
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Table 29: Nutritional analysis on the atherogenic and control diets used in an experiment on
diet-induced atherosclerosis in Quaker parrots (% dry weight).
Nutrient

Atherogenic diet Control diet

Moisture (%)

11.77

10.65

Protein (%)

17.17

15.70

Calories (kcal/100g) 455

435

Protein/calorie ratio

0.038

0.036

Ash (%)

4.13

4.44

Crude fiber (%)

2.72

2.69

Calcium (%)

0.35

0.35

Chloride (%)

0.31

0.47

Potassium (%)

2.49

2.43

Sodium (%)

<0.025

<0.025

Crude fat (%)

14.17

10.63

Cholesterol (%)

0.9951

0.0036

Fatty acids (%)

10.68

8.70

Caprylic acid (%)

<0.01

<0.01

Capric acid (%)

<0.01

<0.01

Lauric acid (%)

0.01

0.02

Myristic acid (%)

0.02

0.02

Palmitic acid (%)

1.37

1.15

Margaric acid (%)

0.01

<0.01

Stearic acid (%)

0.36

0.29

Oleic acid (%)

2.47

2.05

Linoleic acid (%)

5.60

4.52

Linolenic acid (%)

0.60

0.46

Arachidic acid (%)

0.03

0.03

Arachidonic acid (%) <0.01

<0.01

B. Samples collection and analysis
A 1 mL blood sample was obtained monthly from each bird and was used to measure packed
cell volume, avian plasma biochemistry profile (Avian/Reptile rotor, Abaxis Vetscan),
cholesterol, triglycerides, total cholesterol and HDL (Ortho Vitros 250 Chemistry Analyzer). The
VLDL and LDL were obtained using the Friedewald formula.(Friedewald et al. 1972) A larger
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blood sample (3 mL) was obtained under anesthesia prior to euthanasia. Plasma cholesteryl ester
transfer protein (CETP) activity was measured using a commercial assay according to the
manufacturer instructions (ab65383, Abcam Inc.) and a complete blood count performed using
the Leukopette technique. Plasma was stored at -80 C until analysis.
The ascending aorta, brachiocephalic and pulmonary arteries were collected within 15
minutes of euthanasia and sections were fixed in 10% neutral formalin for histopathology and in
2% paraformaldehyde and 1.25% glutaraldehyde in a 0.1 M cacodylate buffer for transmission
electron microscopy (TEM). The heart and liver were also collected and fixed in formalin.
Additional fresh sections were stored at -80ºC for cholesterol measurement. Sex was determined
at necropsy. Formalin-fixed tissues were routinely processed into paraffin. Five-micrometer
sections were cut and stained with hematoxylin and eosin, von Kossa for calcium salts, and
Masson's trichrome for collagen. Frozen formalin-fixed sections were also stained with oil red O
(ORO) for lipid. Arterial tissues fixed for electron microscopy were processed, sectioned, and
stained using standard techniques. They were rinsed 5 times in 0.1 M cacodylate buffer
containing 0.02 M glycine over a 12h period. Samples were post-fixed in 2% osmium tetroxide
for 1h, rinsed in water, en bloc stained in 0.5% uranyl acetate in the dark for 1h, rinsed in water
twice, dehydrated in ethanol series, infiltrated with LR White (Electron Microscopy Sciences,
Hatfield, PA, USA) resin series for 12h periods, and embedded in LR White overnight at 60ºC.
Sections with 0.5 µm thickness were cut with a Dupont Sorvall MT-2 microtome and stained
with 0.5% toluidine blue O in 2% sodium borate. Samples were then sectioned at 70 nm
thickness for transmission electron microscopy (TEM) using the same microtome. TEM sections
were mounted on collodion-coated copper grids, stained with Reynolds lead citrate, and imaged
with a JEM-1011 transmission electron microscope (JEOL, Tokyo, Japan). Atherosclerotic
lesion types were categorized according to a published classification system in parrots that
mirrors the AHA classification.(Beaufrere, J G Nevarez, et al. 2011) Total cholesterol was
measured in fresh arterial samples using a commercial assay according to the manufacturer
instructions (ab65359, Abcam Inc.).
Lesions were also qualitatively compared to spontaneous lesions in 16 Quaker parrots
obtained from a veterinary pathology laboratory (Zoo/Exotic Pathology Service, Sacramento).
C. Statistical analysis
Hepatic cholesterol content and CETP plasma activity between groups were compared using a
Kruskall-Wallis test. Repeated measures over time were analyzed using linear mixed models
with parrots as random variable and treatment, time, and polynomial terms as fixed variables
when appropriate. Arterial cholesterol content was similarly analyzed but with time and artery as
fixed effects. Variance heterogeneity and dependence among observations were modeled using
variance functions and serial correlation structures when appropriate. Competing models were
evaluated based on Aikaike information criterion and model assumptions were evaluated on
residual and quantile plots. Parametric and non-parametric post-hoc comparisons were
performed with a Tukey adjustment. Correlations between lesion types in aorta and
brachiocephalic arteries and plasma cholesterol at euthanasia or arterial cholesterol were
assessed using a Kendall tau correlation coefficient. Correlations between plasma cholesterol at
euthanasia and arterial and liver cholesterol concentrations were assessed using a Spearman
correlation coefficient. A p<0.05 was used for statistical significance. R (R development core
team (2012). R foundation for statistical computing, Vienna, Austria. http://www.R-project.org/)
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was used for statistical analysis and the R package “nlme” for mixed modeling.(Pinheiro & Bates
2000)

III. Results
Four out of sixteen Quaker parrots were females and one female was in each group except for
the 8 months group. The Quaker parrots consumed an average of 9.9 g (95% CI: 9.4-10.3) of
pellets daily (intercept only mixed models). There was a significant time*treatment interaction
effect on the daily food consumption (t=15.6, p<0.001). The control parrots had a food
consumption that increased with time (approximately 20% in 8 months, t=17.5, p<0.001) and
was, overall, greater than the parrots in the treatment groups (approximately 15%, t=2.55,
p=0.025). Parrots in the treatment groups had a stable food consumption over time of 9.6 g (95%
CI: 9.5-9.6) daily corresponding to 84.3 mg (788.6mg/kg) of cholesterol daily. The mean±SD
weight of the parrots was 106.9±10.1 g, which did not change over time (t=-0.6, p=0.55) or with
treatments (t=-0.8, p=0.86). No bird displayed any abnormal clinical signs during the study.
Overall there was a high interindividual variability for all measurements that frequently
accounted for close to 70% of the total variance of the mixed models.
The mean plasma total cholesterol concentration in control birds was constant over time with
a mean±SD of 6.5 ± 1.6 mmol/L and overall lower than the treatment group parrots (p<0.001).
The mean plasma cholesterol concentration in treatment groups increased significantly overtime
as well as the variance. It was best modeled using a cubic polynomial
(cholesterol(mmol/L)=3.3+27.3*time-5.9*time2+0.4*time3, p<0.001, p<0.001, p=0.03, p=0.19,
respectively) with a power of variance covariate for the variance structure (Var=σ2(time)2*0.87).
Even if the cubic term was not significant, it brought substantial smoothing of the curve and an
overall better fit to the data. The mean cholesterol concentration reached a plateau at about 3-4
months (Figure 32).

Figure 32: Plasma cholesterol concentration over time with a polynomial regression line.
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The mean plasma LDL cholesterol concentration in control birds was constant over time with
a mean±SD of 0.5 ± 0.4 mmol/L and overall lower than in parrots in treatment groups (p<0.001).
The rising total cholesterol concentrations in treatment groups was explained by the LDL
cholesterol, thus it followed a similar trend (LDL(mmol/L)=-0.6+22.6*time4.0*time2+0.2*time3, p=0.3, p<0.001, p=0.04, p=0.34, respectively, variance structure:
Var=σ2(time)2*0.89). Likewise, the mean LDL concentration reached a plateau at about 3-4
months (Figure 33).

Figure 33: LDL cholesterol concentration over time with a polynomial regression line.
The HDL cholesterol plasma concentrations did not change significantly over time (t=-0.5,
p=0.61) or between treatment and control groups (t=0.19, p=0.85) with a median (interquartile
range) of 3.8 (2.7) mmol/L (Figure 34). Mean triglycerides and VLDL cholesterol plasma
concentrations did not change significantly between treatment and control groups (t=-4.8,
p=0.39) but slightly decreased overtime (triglycerides(mmol/L)=1.58-0.05*time, all p<0.001)
(Figure 35). HDL was the predominant cholesterol type in plasma before starting the feed trial
but LDL became preponderant on the atherogenic diet.
No other biochemical and hematologic parameters showed any significant difference over
time between control and treatment groups (all p>0.05).
Cholesteryl ester transfer protein activity was detected in all Quaker parrots' plasma samples.
While CETP activity was generally greater in parrots on the atherogenic diet than on the control
diet, the difference was not significant (Kruskall Wallis test, p=0.298) (Figure 36). The median
(interquartile range) was 45.80 (38.9-65.0) nmol/mL/h and 99.40 (46.10-148) nmol/mL/h in the
control and treatment groups, respectively.
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Figure 34: HDL cholesterol concentration over time.

Figure 35: Triglycerides concentration over time with a linear regression line.
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Figure 36: Plasma CETP activity over time.

Figure 37: Hepatic cholesterol concentration over time, 4-8 months group significantly
differed from controls (*).
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For hepatic cholesterol concentrations, there were only significant differences between the
control group and 4-8 months groups (Kruskal-Wallis test, p<0.001) (Figure 37). Arterial
cholesterol concentrations linearly increased from control birds to the 8-month group (Figure 38)
with a significant treatment effect (F=31.74, p<0.001) but no difference between arteries
(F=0.72, p=0.41). One outlier was removed to have an adequate fit and validate model
assumptions. The outlier was an aortic sample in the 6-month group that differed markedly from
the brachiocephalic sample within the same bird (Figure 38). The variability in the pulmonary
arterial samples was high due to the small quantity of artery that could be harvested and used in
the assay and the values were not considered reliable, thus not included in the analysis. However,
pulmonary arterial samples appeared to have less cholesterol than other elastic arteries with a
median (interquartile range) of 23.17 (18.16) µmol/g. There was a significant moderate
correlation between plasma cholesterol at euthanasia and atherosclerotic lesion type (τ=0.50,
p<0.001), arterial cholesterol (ρ=0.64, p<0.001) and a high correlation with liver cholesterol
(ρ=0.81, p<0.001). Arterial cholesterol was highly correlated to the type of lesions (τ=0.80,
p<0.001).

Figure 38: Arterial cholesterol concentration over time with a linear regression line (arrow:
outlier).
On histopathologic examination of harvested arterial samples, the 4 control birds did not have
any evidence of atherosclerotic changes in any artery. At 2 months on 1% cholesterol diet, one
bird had atherosclerotic lesions of type III in the aorta and brachiocephalic arteries and type I
lesion in the pulmonary arteries. The type III lesions were extensive, proliferative, diffuse,
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encompassed the full circumference of the arteries, and displayed significant fibrosis as
evidenced by the trichrome stain (Figure 39.A). The 2 remaining birds had type I lesions in the
aorta and brachiocephalic arteries mainly characterized by mild ORO positive staining and
scattered lipid vacuoles on toluidine blue stain but no evidence of lesion or lipid in the
pulmonary arteries. At 4 months, all birds exhibited advanced lesions of type IV extending on
the whole circumference of the aorta and brachiocephalic arteries and characterized by fatty
proliferation, intense ORO staining, stenosis of the lumen, mild calcification (on von Kossa
stain), and high but diffuse collagen expression (Figure 39.B and 39.C). Pulmonary arteries only
displayed none to mild lesions of type 0-II. At 6 months, all birds had type IV-V lesions in the
aorta and brachiocephalic arteries with a well-delimited lipid core, mild calcification, and the
presence of a thin fibrous cap overlying the atheroma in one bird. Pulmonary arteries exhibited
type II lesions in two birds and type I in one bird. At 8 months, 2 birds developed advanced
lesions of type V with a fibrous cap and moderate calcification in some areas of the atheroma
(Figure 39.D). Only the pulmonary arteries had mild lesions of type II. However, one bird only
developed mild lesions despite 8 months on the atherogenic diet with type I-II lesions in the aorta
and brachiocephalic arteries and no lesion in the pulmonary arteries.
Spontaneously-occurring lesions in 16 other Quaker parrots appeared more organized and the
different areas of the fibroatheromas were better defined when compared to experimental lesions.
Also, experimental lesions of type III-IV were more diffuse, vacuolated, and typically involved
the entire circumference of the arteries whereas spontaneous lesions of these types were usually
more circumscribed and less vacuolated. Finally, calcification was often more advanced in
spontaneous lesions than in experimental lesions and chrondroid metaplasia and ossification
were not observed in the latter. Advanced lesions characterized as type V appeared histologically
similar between spontaneous and experimental atherosclerosis in Quaker parrots.
No histological abnormalities, except coronary atherosclerotic lesions, were evident in the
hearts of all 16 birds. Intramyocardial coronary arteries (15-20 per heart of approximately 40-250
μm in diameter) were evaluated. The birds in the control and 2 month groups did not develop any
atherosclerosis in the coronary arteries. At 4 months, all birds had atherosclerotic changes mainly
type III lesions but with complete obstruction of the arterial lumen in some coronary arteries by
some type III-IV lesions. At 6 months, 2 birds had advanced type IV lesions, characterized by
segmental arterial walls almost transmurally replaced by foamy cells and extracellular lipid, but
no atherosclerotic lesions were observed in one bird. At 8 months, only one bird demonstrated
coronary atherosclerotic lesions of type III. In the hepatic sections, prominent hepatocellular
vacuolization was observed in two birds, one at 6 and one at 8 months.
On transmission electron microscopy, the normal intima showed a single layer of endothelial
cells with various organelles, plasmalemmal vesicles, and short microvilli. The media was
mainly composed of two types of cells: smooth muscle cells and fibroblast-like cells with an
interlaminar location. Overall, extracellular fat accumulation seemed to precede the presence of
foam cells. In type I lesions, foam cells were rare but extracellular lipid vacuoles were present
throughout the intima and media. Some endothelial cells seemed to have more cytoplasm,
filopodia, vacuoles, and Weibel-Palate bodies (that are spherical and granular in birds) than in
control birds (Figure 40.A). In addition, a few monocytes were seen to adhere to endothelial cells
in some sections. Some smooth muscle cells (SMC) showed phenotypic changes to a more
synthetic state. There also seemed to be an increased number of fibroblasts. In type II-III lesions,
there were moderate to large pools of extracellular lipid containing small and large lipid droplets,
cholesterol crystals, cellular debris, myelin figures with disorganization of elastin and collagen
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fibers and increased extracellular matrix. While lipid remained primarily extracellular,
characteristic foam cells were present, mainly in type III lesions (Figure 40.B). The cellular
origin of foam cells was difficult to determine based on morphology alone but both SMC and
macrophage-derived foam cells were present. In the type IV-V atherosclerotic lesions, there was
major disorganization of the arterial ultrastructure with large areas devoid of cells filled with
lipid and extracellular matrix components, cellular debris and foam cells (Figure 40.C). The
fibrous cap was composed of collagen, elastin fibers, and fibroblast-like cells (Figure 40.D).
Large numbers of foam cells were present immediately underneath the fibrous cap.

Figure 39: A. Photomicrograph of diet-induced atherosclerotic lesions in the brachiocephalic
arteries in Quaker parrots. Proliferative type III lesions at 2 months (Hematoxylin and eosin, X
100). B. type IV lesion exhibiting a lipid core but not covered by a fibrous cap at 4 months.
(Hematoxylin and eosin, X 100). C. type IV lesion showing blue staining for collagen (*) in the
lipid core (Masson's trichrome, X 100). D. type V lesion similar to B and C but covered by a
fibrous cap (double-headed arrow), cholesterol clefts are visible as well as foam cells (arrow)
(Toluidine blue, X 100).
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Figure 40: A. Electron-micrographs (Orcein-uranyl-lead stain). Cytoplasm of an endothelial
cell exhibiting an increased number of Weibel-Palate bodies (arrows) and pinocytic vesicles
(arrowheads), type I lesion at 2 months. N, nucleus (X 80000). B. macrophage-derived foam
cells with a few lysosomes (arrows), type V lesion at 6 months (X 9400). C. lipid core of a type
IV lesion at 4 months composed of extracellular lipid (ExL), cholesterol crystals (Ch), and small
calcium granules (arrows) (X 29000). D. fibrous cap in a type V lesion at 6 months composed of
elongated smooth muscle cells (SMC), collagen (Co) and elastin (El) fibers, a fibroblast-like cell
(Fi) is also visible (X 14000).

IV. Discussion
This study showed that atherosclerosis could be induced in Quaker parrots as early as 2
months with a 1% cholesterol diet. Moreover, advanced atherosclerotic lesions developed at 4
months and were characterized by a large circumferential lipid core and a fibrous cap. At 6
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months, lesions appeared histologically analogous to spontaneous advanced lesions in the same
parrot species and showed significant luminal stenosis. The chronology of lesion progression in
the aorta and brachiocephalic arteries seemed to follow the previously established psittacine
classification system with the type V lesions being only present at 6 and 8 months.(Beaufrere,
Nevarez, et al. 2011) Coronary lesions also developed at 4 months but owing to the small sizes
of these arteries (about 40-250 µm) in Quaker parrots, categorization of the lesions was less
precise. Lesion severity and arterial cholesterol content increased linearly with time and both
were significantly correlated to plasma cholesterol concentration. Pulmonary arteries displayed
only mild to moderate lesions that never progressed to advanced lesions. This may have been
influenced by the lower blood pressure of the vascular pulmonary system, but severe pulmonary
lesions have been described in association with clinical signs in psittacine birds.(Sedacca et al.
2009) Spontaneous lesions appeared more organized, more calcified, and less diffuse than
experimental lesions possibly reflecting the slow development of spontaneous lesions compared
to the accelerated rate of experimental lesion formation. Different appearance of atherosclerotic
lesions have also been noted in pigeons fed with different concentration of cholesterol.(Jerome &
Lewis 1984) Atherothombosis, plaque rupture, and cardiac ischemia were not encountered but it
is possible that complicated lesions would have developed several months later. On the other
hand, these complications are common in White Carneau pigeons.(Prichard et al. 1964; St Clair
1998) A recent experiment in budgerigars (Melopsittacus undulatus) revealed that in vivo carotid
artery injury did not lead to the formation of occlusive thrombi contrary to mice in which carotid
diameter and blood flow are similar to budgerigars.(Schmaier et al. 2011) Avian thrombocytes
seem less capable of forming shear-resistant arterial thrombi and do not usually form 3dimensional aggregates. The physiologic differences between avian thrombocytes and
mammalian platelets may partly explain the clinical differences observed in the nature and
prevalence of atherothrombotic diseases.
During this research investigation, the Quaker parrots also exhibited dyslipidemia with a shift
from HDL to LDL as their main cholesterol-carrier lipoproteins. The dyslipidemia developed
quickly and stabilized at about 3-4 months at which total and LDL cholesterol reached a plateau.
This shift from lipoprotein profiles and similar levels of cholesterol were also observed in quails
and pigeons after cholesterol feeding.(Ojerio et al. 1972; Barakat & St Clair 1985; Bavelaar &
Beynen 2004b; Hammad et al. 1998; Inoue et al. 1995; Morrissey & Donaldson 1977) As with
these parrots, change in plasma HDL is usually not observed in birds during cholesterol
feeding.(Bavelaar & Beynen 2004b; Hammad et al. 1998; Barakat & St Clair 1985; Hermier &
Dillon 1992; Radcliffe & Liebsch 1985; Jerome & Lewis 1985) Furthermore, the Quaker parrots
displayed a high plasma CETP activity which, while not statistically significant, increased on the
atherogenic diet. This enzyme transfers cholesteryl esters to LDL from HDL and an increase in
its activity has been described with atherogenic dyslipidemia both in humans and animal
experimental models.(Tall et al. 1987) The response to dietary cholesterol varies among species
and individuals and different concentrations of this compound have been used (0.05-5%) in
formulated bird diets to induce atherosclerotic lesions with variable severity, prevalence, and rate
of development.(Bavelaar & Beynen 2004b; Inoue et al. 1995; Prichard et al. 1962; Shih et al.
1983) Within a same species, the induction of atherosclerosis depends on the line of birds, the
level of dietary cholesterol, and the duration of the feeding period.(Shih et al. 1983; Bavelaar &
Beynen 2004b; Inoue et al. 1995; Prichard et al. 1962) It appears from our study that advanced
atherosclerotic lesions can be induced relatively quickly in Quaker parrots with 1% dietary
cholesterol as all birds in the 2 months group had significant arterial lesions. In a previous study
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in which another psittacine species was used, the budgerigar, significant atherosclerotic lesions
were induced by feeding a diet that contained 2% cholesterol and 15% lard for 6 months. Not
only did the budgerigar plasma cholesterol increase, but there was concurrent development of
hepatic lipidosis.(Finlayson & Hirchinson 1961) A concentration of 0.5-1% is usually required to
generate significant atherosclerotic lesions in a short timespan (months) but more physiological
levels (0.15% cholesterol, Western-type diet) are also being used to better mimic the slow
progression of the disease when time is not a constraint. Japanese quails have been particularly
bred and selected to produce atherosclerosis rapidly with less dietary cholesterol.(Bavelaar &
Beynen 2004b; Radcliffe & Liebsch 1985; Shih et al. 1983) Similar results may be achievable in
Quaker parrots through selection to obtain a more homogenous population (variability was high
here) which would allow the investigator to reduce the number of animals required to achieve
statistically relevant results, cholesterol level, and time to induce atherosclerotic lesions. Other
dietary modifications have been used in conjunction to cholesterol in avian models including
increased saturated fat level and cholic acid supplementation, which induces an inflammatory
state and aids in cholesterol absorption.(Bavelaar & Beynen 2004b; Radcliffe & Liebsch 1985)
In our study, only the cholesterol content of the diet was altered and the formula was controlled
for caloric and micronutrients intake to limit potential confounding factors of increased weight
and fat reserve on metabolism, dilution of other nutrients, and to provide more reproducible
dietary modifications. In addition, the inflammation induced by cholic acid can also be a
confounding factor in itself.
Among avian models of atherosclerosis, histopathology and ultrastructural pathology have
mainly been reported in white-Carneau pigeons and Japanese quails.(Jerome & Lewis 1984;
Jerome & Lewis 1985; Lewis et al. 1985; Barr et al. 1991; Hansen 1977; Inoue et al. 1995; Shih
et al. 1983) While parrots and quails principally develop lesions in the ascending aorta and
brachiocephalic arteries, pigeons preferentially acquire lesions in the lower thoracic aorta,
especially at the celiac bifurcation.(Bavelaar & Beynen 2004a; Jerome & Lewis 1984; Inoue et
al. 1995) Spontaneous and experimental lesions in parrots, pigeons, and quails are similar to
human lesions with the presence of foam cells, extra and intracellular lipid, a lipid core, a fibrous
cap, and calcification.(Beaufrere, Nevarez, et al. 2011; St Clair 1998) Early lesions in pigeons
are characterized by endothelial activation and monocyte adherence to the endothelium.(Jerome
& Lewis 1984; Lewis et al. 1982; Lewis & Kottke 1977; Taylor & Lewis 1986) Endothelial
changes noted in this study suggested endothelial activation and degeneration with adherent
monocytes being observed in a few instances. In parrots, as in pigeons, SMC- and macrophagederived foam cells are present in spontaneous and experimental lesions.(Beaufrere, Nevarez, et
al. 2011; Hansen 1977; Lewis et al. 1985; Jerome & Lewis 1985) The large amount of
extracellular lipid present in early lesions (type I-II) in the Quaker parrots contrasts with
spontaneous early lesions in the same species of parrots that are primarily characterized by foam
cells and intracellular lipids.(Beaufrere, Nevarez, et al. 2011) More characteristic foam cells
were present in more advanced experimental lesions. Similar to pigeons, quails, and other birds
but in contrast to mammalian species, interlaminar fibroblast-like cells were present in the media
and may actively participate in fibrosis and synthesis of constituents of the extracellular matrix
during atherogenesis.(Hansen 1977; Lauper et al. 1975; Yamamoto & Igawa 1991; Moss &
Benditt 1970; Toda et al. 1984) As evidenced in lesions from parrots, remodeling with increased
deposition of collagen is a hallmark of atherosclerotic lesion maturation and fibrous cap
formation and is similar to other avian models.(Velleman et al. 2001; McCullagh & Ehrhart
1977)
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Even if the advanced lesions seem identical between diet-induced and spontaneous
atherosclerosis, the mechanisms of lesion formation and progression may differ owing to the
compressed experimental time frame. Birds also have major differences in lipoprotein
metabolism (absence of apolipoprotein B48, E, and chylomicrons, HDL as the main carrier
lipoprotein, drastic changes during egg laying) and arterial microanatomy (no SMC in the intima,
fibroblasts in the media) than humans.(Anderson et al. 2012) Nevertheless, all experimental
models have limitations and even with animals more closely related to humans, some findings
may not translate well to the human disease.(Libby et al. 2011) An example of this discrepancy,
as observed in parrots, transgenic mice primarily develop lesions in the proximal great vessels
and rarely get lesion complications.(Libby et al. 2011) Similarities in plasma biochemical
changes, lesions composition, pathology, ultrastructure, and progression suggest that the
pathogenesis of atherosclerosis in Quaker parrots is comparable to other avian models
investigated and humans. Therefore, Quaker parrots could be used to study some aspects of the
pathogenesis and therapeutics of atherosclerosis. The Quaker parrot is certainly a good model to
study spontaneous atherosclerosis in psittaciformes which commonly develop atherosclerosisrelated diseases under standard captive conditions and may share common risk factors with
humans.
In conclusion, Quaker parrots may be a useful model of atherosclerosis for parrots and
humans as this species is small, has low food consumption (10 g/day), and rapidly develops
advanced atherosclerotic lesions with cholesterol feeding that resemble lesions found both in
humans and other avian models. In addition, advanced lesions induced experimentally are similar
to spontaneous-developing lesions within the same species.
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CHAPTER IV:
ESTIMATION OF INTRATHORACIC ARTERIAL
DIAMETER BY MEANS OF COMPUTED
TOMOGRAPHIC ANGIOGRAPHY IN HISPANIOLAN
AMAZON PARROTS*
I. Introduction
Atherosclerosis is a common disease of aging parrots as suggested by results of retrospective
pathologic surveys.(Braun et al. 2002; Krautwald-Junghanns et al. 2004; Bohorquez & C. Stout
1972; Pilny 2004; Garner & Raymond 2003; Fricke et al. 2009) The disease is characterized by
the thickening of arterial walls through lipid accumulation and plaque formation in the tunica
intima, ultimately resulting in arterial luminal stenosis of the great vessels.(Fricke et al. 2009;
Bavelaar & A. C. Beynen 2004a) Atherosclerosis can also lead to arterial aneurysms in pet
birds.(Vink-Nooteboom et al. 1998)
Birds are susceptible to diet-induced and spontaneous atherosclerosis.(Bavelaar & Beynen
2004a) Spontaneous atherosclerosis in pet psittacine birds typically develops in older birds fed a
nutritionally unbalanced diet, with risk factors similar to those described for human
atherosclerosis.(Krautwald-Junghanns et al. 2004; Bavelaar & Beynen 2004a) Parrots can
develop a central form of atherosclerosis, in which the great vessels at the base of the heart are
most commonly affected.(Krautwald-Junghanns et al. 2004; Fricke et al. 2009; Bavelaar &
Beynen 2004a; Oglesbee & Oglesbee 1998) Antemortem diagnosis of atherosclerosis in these
birds has been considered difficult and remains one of the challenges of avian medicine. Only
advanced cases of disease with considerable calcification of the great vessels or with secondary
heart changes can be diagnosed.(Mans & Brown 2007; Phalen et al. 1996; Sedacca et al. 2009;
Shrubsole-Cockwill et al. 2008)
Clinical antemortem diagnostic imaging of atherosclerosis in humans includes the use of
various modalities of vascular imaging that mainly involve angiographic techniques through the
use of high-speed CT scan and magnetic resonance imaging.(Sanz & Fayad 2008) The main site
of arterial stenosis in people is the carotid arteries, and CTA is the principal imaging method to
measure carotid diameters and quantify stenosis.(Bartlett et al. 2007) Whereas angiography
appears to be used in birds, no studies have been conducted to evaluate an angiography protocol
in detail and to determine the apparent diameter of intrathoracic arteries in healthy companion
birds. The purpose of the study reported here was to establish a CT angiography protocol and
provide reference limits for cross-sectional measurements of the great arteries in Hispaniolan
Amazon parrots (Amazona ventralis).

*

This chapter originally appeared as Beaufrere, H. et al., 2011. Estimation of intrathoracic arterial diameter by
means of computed tomography angiography in Hispaniolan Amazon parrots. Am J Vet Res, 72(2), pp 210-218.
Reprinted with permission of the American Veterinary Medical Association.

128

II. Materials and methods
A. Animals
Thirteen Hispaniolan Amazon parrots were included in the study. Birds were considered
healthy on the basis of results of physical examination and a recent CBC. The parrots did not
have any clinical signs of cardiovascular disease such as lethargy, anorexia, abdominal
distention, or dyspnea prior to the study. They were obtained from a research colony maintained
at the Louisiana State University and were fed a pelleted diet (Kaytee Exact Rainbow, Chilton,
WI). The study protocol was approved by the Louisiana State University Institutional Animal
Care and Use Committee.
B. Cardiological evaluation
All birds were screened for cardiac diseases, with echocardiography performed and ECGs
obtained while birds were anesthetized with isoflurane. Echocardiography was performed
following the transcoelomic approach,(Pees & Krautwaldjunghanns 2005; Pees, KrautwaldJunghanns, et al. 2006; Pees et al. 2004) with an ultrasonographic probe (S12-4 sector array
transducer, Philips Healthcare, Andover, MA) connected to an ultrasonography system (IE 33,
Philips Healthcare, Andover, MA). Morphometric measurements of the left ventricles were
obtained with the inner edges method in the vertical view and aortic diameter in the longitudinal
view; aortic outflow velocity was measured by use of spectral Doppler technology. All
measurements were compared with published reference limits for Amazon parrots. (Pees &
Krautwald-junghanns 2005; Pees, Krautwald-Junghanns, et al. 2006; Pees et al. 2004) The right
ventricle was not measured in consideration of its relatively small size in this smaller species of
Amazon parrots, lack of detail, and inability to obtain accurate measurements.
Electrocardiograms were obtained via an anesthetic monitor (Vetspecs VMS7, VetSpecs Inc,
Canton, GA), recorded at 100 mm/s with a gain of 10 mm equal to 0.5 mV, and printed via
manufacturer software. Measurements were obtained from the recordings and compared with
published reference limits for Amazon parrots.(Nap et al. 1992)
C. CTA procedures
Each parrot was positioned in dorsal recumbency, and anesthesia was induced via face mask
with 5% isoflurane in oxygen at an oxygen flow rate of 0.8 L/min. The parrot was then intubated
with an uncuffed endotracheal tube, and anesthesia was maintained with 2% to 3% isoflurane.
Supplemental heat was provided by a heating pad and forced warm air (Bair Hugger, Arizant
Inc, Prairie, MN). A 24- or 26-gauge catheter was placed in the left ulnar vein (n = 10 parrots),
right ulnar vein (2), or medial metatarsal vein (1). An injection plug was placed at the end of the
catheter, and the catheter was secured in place with an adhesive bandage. A 1-mL syringe
containing the contrast medium was connected to the catheter by a 22-gauge butterfly catheter.
The CTA examinations were performed with a 16-detector-row CT scanner (Light Speed GE
Healthcare, Milwaukee, WI). Whole-body scout scans were performed in orthogonal planes. A
survey examination was performed before contrast medium administration (precontrast) by use
of a built-in abdominal scan protocol with the following parameters: standard algorithm in
helical scan mode, 1.25-mm slice thickness, 1.375 pitch, 100 kVp, and 150 mA. The scan area
of interest extended from the last cervical vertebra just cranial to the coracoid bone and
continued caudally to the coxofemoral joint. A dynamic CT scan was performed at the level of
the abdominal aorta dorsal to the proventriculus and began 3 seconds before an initial manual
bolus injection of iohexol (Omnipaque 240 mg/ml, GE Healthcare Inc, Princeton, NJ) (1 mL/kg),
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which was administered over 1 second. The person manually injecting the contrast medium was
positioned behind a mobile lead x-ray shield.
When precontrast survey scans were completed, CTA was performed with the same scan
parameters but with a manual injection of 3 mL of iohexol/kg over 3 seconds, administered 3
seconds prior to initiation of CTA. Additional reconstruction series at 0.625 mm and bone
algorithm were performed. Dynamic scans allowed time of arrival of contrast medium to the
abdominal aorta (time to enhancement peak) to be determined.
D. ROI measurements
The attenuation coefficient (in HU) was obtained for each vessel including the 2
brachiocephalic trunks, the aorta, and the 2 pulmonary arteries to quantify the amount of contrast
medium present in these arteries. Circular ROIs corresponding to the cross-sectional area of all
the major arteries before and after contrast administration were obtained. The circular
measurement tool gave the area of the ROI from which the diameter (D) was calculated with the
following formula:
D = 2(area/π)1/2
A pulmonary window (width, 1,400 HU; level, –500 HU) was used for pre- and postcontrast
measurements (Figure 41). Additional windows used for ROI measurements made after contrast
agent administration (postcontrast) included a mediastinal window (width, 350; level, 50) and an
angiography window, with the window level determined from the mean contrast attenuation
coefficient in the 6 measured arteries and the window width determined by calculating the
following ratio: window width/window level = 2. The ratio used was derived from the following
formula:
W/AC = (3.3 X L/AC) – 1.3
in which W is the window width, AC is the attenuation coefficient, and L is the window level
used (L = mean AC of vessels for this protocol). This formula was obtained from a previously
reported CTA study(Liu et al. 2000) on phantom arteries of various sizes, which was conducted
to determine optimum CT levels and windows. Regions of interest were obtained as the largest
circle that would encompass the outermost outline of the arteries before contrast medium
administration and the outermost outline of the contrast boundary after administration (Figure
42). For precontrast measurements, the unsharp edges of the arteries were included in the
measurements, whereas for postcontrast measurements, such edges were not included to obtain
luminal diameters and minimize inaccuracy due to blooming and penumbra artifacts caused by
the contrast medium and algorithm used, respectively. The left and right brachiocephalic trunks
were measured at the same level as they laterally crossed the cranial thoracic cavity. The
ascending aorta was measured at the middle of its ascending course. The abdominal aorta was
measured prior to the bifurcation of the mesenteric artery. The left and right pulmonary arteries
were measured at the middle of their ascending course to the lungs.
Ratios were also calculated with the length of the keel bone and length of the vertebral body
at the coracoid-keel junction as obtained via a bone window. Two observers participated in ROI
measurements. Observer 1 (the radiologist) obtained all measurements twice on different days to
evaluate intraobserver agreement (reproducibility) of the measurement techniques. Additionally,
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observer 2 (the clinician) obtained measurements to evaluate interobserver agreement. Outlining
of ROIs, linear measurements, and 3-D reconstruction (segmentation and volume rendering) of
the heart and great vessels were performed with a commonly used and calibrated imaging
program (OsiriX Imaging Software, version 3.5.1, OsiriX Foundation, Geneva, Switzerland.
Available at: www.osirix-viewer.com). Cross-sectional images were magnified at 300% to
improve accuracy of measurements.

Figure 41: Computed tomography angiography scan of a healthy Hispaniolan Amazon parrot
obtained at the level of the brachiocephalic trunks in a pulmonary window (A) before contrast
medium administration and in a pulmonary window (B), mediastinal window (C), and manually
selected angiography window (D) after administration.
E. Statistical analysis
Analyses were performed by use of the same computer software (SAS, version 9.1.3, SAS
Institute Inc, Cary, NC), except where indicated. Data were tested for normality with a ShapiroWilk test, with a value of P < 0.05 indicating a nonnormal distribution. Results are reported as
mean ± SD when the data were normally distributed and as median (range) when they were not.
Univariate summary statistics were calculated to report echocardiographic measurements, CT
artery diameters, and ratios. Reference limits were determined as the central 95% of the values
(ie, the mean ± 2 SD) for normally distributed data and the interval between the 2.5th and 97.5th
percentiles for non-normally distributed data.
For CTA measurements, with measurements of the various arteries considered dependent
variables, differences between the means of these measurements with and without contrast
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medium administration, with the various CT windows, and between observers were assessed by
means of ANOVA on the ranked value blocked for individual birds. Multiple post hoc
comparisons were performed with the Tukey and the least squares means methods. The
Wilcoxon matched-pairs signed rank test was used to assess differences between the means of
the diameters of the 2 brachiocephalic trunks, the 2 pulmonary arteries, and the 2 consecutive
measurements by the same observer (the radiologist).
Spearman rank correlation coefficients () were calculated to assess the correlation between
the sizes of the various arteries and with the parrot body weight overall and for each CT window.
A correlation was considered strong when the coefficient was > 0.5 and weak when ≤0.5.
Intraobserver agreement (reproducibility) between 2 consecutive measurements was evaluated
by calculating concordance correlation coefficients for each artery.(Lin 1989) Reproducibility
was considered high when the coefficient value was ≥0.76, medium when between 0.40 and
0.75, and low when ≤0.39. Interobserver agreement between the radiologist and clinician was
evaluated by calculating ICC coefficients (SPSS, version 16.0, SPSS Inc, Chicago, IL).(Shrout &
Fleiss 1979) The 2-way, random, single-measure reliability ICC for absolute agreement and 95%
CIs were determined for each artery. Interobserver agreement was considered high when the
coefficient value was ≥ 0.76, medium when between 0.40 and 0.75, and low when ≤ 0.39. Values
of P < 0.05 were considered significant for all analyses.

Figure 42: Computed tomography angiography scan of a Hispaniolan Amazon parrot
obtained at the level of the brachiocephalic trunks in a mediastinal window. Circular ROIs
(circles) were used to measure the diameters of the right and left brachiocephalic trunks.

III. Results
A. Cardiological evaluation
The 13 Hispaniolan Amazon parrots had a mean ± SD body weight of 290.5 ± 21.2 g. No
cardiac abnormalities were detected nor were any clinically important arrhythmias identified on
ECGs. All ECG measurements were within reference limits reported for Amazon parrots.(Nap et
al. 1992) No echocardiographic reference limits are available for the A ventralis, which is a
smaller species of the genus Amazona, so published reference limits were used for the genus
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Amazona, which were obtained from 4 larger species of Amazon parrots (Amazona amazonica,
Amazona aestiva, Amazona ochrocephala, and Amazona viridigenalis).(Pees et al. 2004)
Compared with those reference limits, some echocardiographic measurements (left ventricular
width in diastole, left ventricular width in systole, and left ventricular length in systole) were
slightly lower. No abnormalities in cardiac shape and function were detected via
echocardiography. Therefore, on the basis of aforementioned results, the 13 parrots were
considered free of detectable cardiovascular diseases.
Mean ± SD echocardiographic measurements were as follows: left ventricular width in
diastole, 5.60 ± 1.21 mm; left ventricular length in diastole, 20.1 ± 2.46 mm; left ventricular
width in systole, 4.22 ± 0.93 mm; left ventricular length in systole, 18.26 ± 2.82 mm; aortic root
diameter, 3.35 ± 0.39 mm; aortic outflow velocity, 75.46 ± 15.75 cm/s; left ventricular width-tolength ratio in diastole, 0.28 ± 0.08; left ventricular width-to-length ratio in systole, 0.23 ± 0.05;
and left ventricular fractional shortening, 24.03 ± 12.79%.
B. CTA
With the dynamic axial CT, the enhancement peak in the abdominal aorta ranged from 0.5 to
2 seconds after contrast medium administration (Figure 43). The CTA scans obtained through
helical CT acquisition were of good quality and diagnostic value. The mean ± SD attenuation
coefficients of the left and right brachiocephalic trunks, the ascending aorta, and the abdominal
aorta were 366 ± 129 HU, 404 ± 193 HU, 332 ± 101 HU, and 253 ± 123 HU, respectively.
Median (range) attenuation coefficients in the left and right pulmonary arteries were 260 (89 to
849) HU and 259 (103 to 847) HU, respectively. For comparison, the attenuation coefficient of
soft tissue is 20 to 50 HU.
Administration of contrast medium considerably enhanced visualization of the major arteries
in various window settings (Figures 41 and 44), particularly the smaller diameter arteries such as
the carotid arteries and the abdominal aorta. Three-dimensional reconstruction of the heart and
central vasculature by means of segmentation and volume rendering techniques was also possible
with CTA (Figure 45). No adverse effects were observed in the parrots during or after contrast
administration.
C. ROI measurements
All arterial diameters were considered as apparent arterial diameters because of the lack of
gold standard for arterial diameter measurements in birds and the likelihood of motion artifacts.
All measurements made before and after contrast medium administration at the various window
settings (pulmonary, mediastinal, and angiography) were normally distributed with the exception
of the measurements of the left brachiocephalic trunk via the angiography window. Reference
limits for the length of the 6 measured arteries were summarized (Table 30). For these arteries,
there were significant (all P < 0.005) differences between the means of arterial measurements
made before (precontrast) and after (postcontrast) contrast medium administration and via the
various windows. In descending order, the largest apparent arterial diameters were observed
precontrast, postcontrast via the pulmonary window, postcontrast via the mediastinal window,
and postcontrast via the angiography window.
Ratios between the diameters of the major arteries with the keel length and with the vertebral
body length were also determined (Tables 31 and 32).
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Figure 43: Dynamic axial CTA scan of a Hispaniolan Amazon parrot obtained at the level of
the abdominal aorta at various points after administration of contrast medium. The contrast
enhancement of the abdominal aorta (arrows) is seen over time with the enhancement peak at 1
second.

Figure 44: Computed tomography angiography scan of a Hispaniolan Amazon parrot
showing the ascending aorta (arrow; A), abdominal aorta (arrow; B), left pulmonary artery
(arrow; C), and right pulmonary artery (arrow; D).
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Figure 45: Diagram of the 3D segmentation of the heart of a Hispaniolan Amazon parrot as
obtained via segmentation and volume rendering techniques made possible by CTA. The image
is oriented to display a cranial view of the base. 1, right brachiocephalic trunk; 2, left
brachiocephalic trunk; 3, carotid arteries; 4, ascending aorta; 5, right pulmonary artery; 6, left
pulmonary artery; 7, pulmonary veins.
Table 30: Reference limits for apparent diameters (mm) of the major arteries of 13
Hispaniolan Amazon parrots as measured via CTA before and after contrast medium
administration and via various windows. PreC, pre-contrast measurements; PostC, post-contrast
measurement; RI, reference interval; LB, left brachiocephalic trunk; RB, right brachiocephalic
trunk; AO, ascending aorta; AA, abdominal aorta; LP, left pulmonary artery; RP, right
pulmonary artery.
Pre- and post-contrast values are reported as mean±SD. *Data for this circumstance were not
normally distributed; therefore, median is reported.
Reference intervals for normally distributed data were calculated as mean±2SD. Intervals for
nonnormally distributed data represent the 2.5th and 97.5th percentiles.
Pulmonary window
Mediastinal window Angiography window
Artery PreC
RI
PostC
RI
PostC
RI
PostC
RI
LB
3.2±0.3 2.5-3.8 2.7±0.4 2.0-3.5 2.4±0.3
1.8-3.1
2*
1.7-2.9
RB
3.5±0.3 3.0-4.0 2.9±0.4 2.1-3.6 2.5±0.3
1.8-3.1
2.2±0.3
1.5-2.7
AO
2.5±0.2 2.0-2.9 2.2±0.4 1.3-3.4 1.9±0.3
1.3-2.5
1.7±0.3
0.9-2.3
AA
2.3±0.2 1.8-2.7 1.9±0.3 1.4-2.5 1.5±0.4
0.8-2.2
1.3±0.1
1.0-1.6
LP
2.5±0.3 1.7-3.2 2.4±0.3 1.9-3.0 1.9±0.2
1.4-2.3
1.6±0.3
1.0-2.1
RP
2.3±0.3 1.7-2.9 2.4±0.2 2.0-2.8 1.9±0.3
1.3-2.5
1.6±0.4
0.9-2.3
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Table 31: Reference limits for keel-to-apparent arterial diameter ratio of the major arteries of
13 healthy Hispaniolan Amazon parrots as measured via CTA before and after contrast medium
administration and via various windows. KL, keel length. See table 30 for remainder of key.
Pulmonary window
Artery
PreC
LB:KL 0.13±0.01
RB:KL

0.14*

AO:KL

0.10*

AA:KL

0.09*

LP:KL

0.10±0.02

RP:KL

0.10±0.01

RI
0.100.16
0.130.17
0.080.11
0.080.10
0.060.13
0.070.12

PostC
0.11±0.02
0.08±0.15
0.05±0.12
0.08*
0.10±0.01
0.10±0.01

RI
0.080.14
0.080.15
0.050.12
0.060.09
0.070.12
0.070.12

Mediastinal
window
PostC
RI
0.10±0.01 0.070.13
0.07±0.13 0.070.13
0.05±0.10 0.050.10
0.06*
0.040.08
0.07*
0.070.09
0.08±0.01 0.050.10

Angiography
window
PostC
RI
0.08*
0.070.12
0.08*
0.070.11
0.07±0.01
0.040.09
0.06*
0.040.06
0.06±0.01
0.040.09
0.07±0.01
0.040.09

Table 32: Reference limits for vertebral body-to-apparent arterial diameter ratio of the major
arteries of 13 healthy Hispaniolan Amazon parrots as measured via CTA before and after
contrast medium administration and via various windows. VL, vertebral body length. See table
30 for remainder of key.
Pulmonary window
Artery
PreC
LB:VL 0.67±0.07
RB:VL 0.75±0.07
AO:VL 0.52±0.06
AA:VL 0.49±0.05
LP:VL

0.50±0.07

RP:VL

0.49*

RI
0.530.82
0.600.90
0.410.64
0.400.58
0.370.68
0.420.67

PostC
0.58±0.09
0.61±0.08
0.47±0.09
0.42±0.06
0.51±0.07
0.51±0.07

RI
0.400.76
0.440.78
0.280.66
0.300.54
0.350.68
0.360.65

Mediastinal
window
PostC
RI
0.52±0.07 0.370.66
0.53±0.08 0.370.68
0.40±0.07 0.250.55
0.33±0.08 0.160.49
0.41±0.06 0.300.49
0.41±0.06 0.280.53

Angiography
window
PostC
RI
0.41*
0.360.63
0.46±0.07
0.320.61
0.35±0.08
0.190.50
0.27±0.04
0.200.35
0.35±0.06
0.220.46
0.35±0.06
0.220.48

For the 13 parrots, internal marker lengths were normally distributed and were 24.6 ± 0.5 mm
for the keel and 4.6 ± 0.3 mm for the vertebral body. When the effects of contrast medium
administration and window settings were not considered, there was no significant (P = 0.219)
difference between the diameters of the left and right pulmonary arteries but there was a
significant (P < 0.001) difference between the diameters of the left and right brachiocephalic
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trunks, with the right being larger. When controlling for the effect of contrast medium
administration and window settings, there was no difference between the left and right
pulmonary arteries (all P > 0.096). There was also no difference between the diameters of the left
and right brachiocephalic trunks (all P > 0.088) except for the precontrast diameter values, with
values for the right being significantly (P = 0.002) larger than for the left. Body weight was not
correlated with diameter of the major arteries overall and within window settings (all P > 0.05).
However, when the presence of contrast medium and the window settings were not taken into
account, strong associations were detected between the diameters of the major arteries (all P <
0.001; all ρ > 0.65). When considering the presence of contrast medium and the window settings,
there was a strong correlation between the diameters of the 2 brachiocephalic trunks and between
both brachiocephalic trunks and the ascending aorta in the pulmonary (P < 0.014; ρ > 0.66) and
mediastinal windows (P < 0.023; ρ > 0.62) and only between the diameters of the 2
brachiocephalic trunks but not between both brachiocephalic trunks and the ascending aorta in
the precontrast (P = 0.029; ρ = 0.6) and angiography (P = 0.007; ρ = 0.7) windows. The
diameters of the left and right pulmonary arteries were strongly correlated in all settings except
the mediastinal window (P < 0.037; ρ > 0.6). Correlation patterns were similar for the calculated
ratios. The means of measurements made by 2 observers (the radiologist and clinician) did not
differ significantly (all P > 0.072), except for those of the left brachiocephalic trunk (P = 0.047)
in which the clinician had larger values than the radiologist. Similarly, no significant (all P >
0.588) differences were evident between the means of 2 consecutive measurements by the same
observer (the radiologist). Intraobserver agreement (reproducibility) was high, with all
concordance correlation coefficients > 0.95 (Table 33). Interobserver agreement was high for
measuring diameters of the brachiocephalic trunks, the ascending aorta, and the abdominal aorta
and was medium for the pulmonary arteries. Results of the reliability assessment were similar for
the calculated ratios.
Table 33: Intraobserver agreement (reproducibility) for a clinician and interobserver
agreement between a radiologist and clinician for arterial CTA measurements in 13 Hispaniolan
Amazon parrots. CCC, concordance correlation coefficient; ICC(2,1), 2-way, random, singlemeasure reliability ICC coefficient for absolute agreement comparing the clinician’s
measurements with those of the radiologist.
CCC
ICC (2,1)
Artery Correlation 95% CI Correlation 95% CI P value
LB
0.98
0.97-0.99
0.75
0.58-0.86 <0.001
RB
0.99
0.98-0.99
0.89
0.81-0.93 <0.001
AO
0.96
0.93-0.98
0.76
0.62-0.86 <0.001
AA
0.95
0.93-0.98
0.84
0.73-0.90 <0.001
LP
0.97
0.95-0.99
0.65
0.46-0.78 <0.001
RP
0.99
0.98-1.00
0.71
0.56-0.83 <0.001

IV. Discussion
In the study reported here, a protocol for CTA and reference limits for apparent luminal
arterial diameters and ratios were developed for Hispaniolan Amazon parrots. On the basis of our
findings, we recommend performing a dynamic axial CT with a test bolus consisting of 25% of
the total contrast medium dose (ie, 1 mL/kg of a total dose of 4 mL/kg) to ensure the catheter is
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correctly located and determine the time delay to be used during angiographic scanning. A
helical CT angiography scan can then be performed with the time delay obtained from the
previous test bolus technique, and the remaining dose of contrast medium (ie, 75% or 3 mL/kg)
can be administered. We chose manual injections rather than an automated injection
synchronized with the CT machine because of poor results obtained with previous attempts,
which were probably attributable to the small injection volume and the 3-second delay between
activation of the pump and the start of the scan.
The CTA method described here appears safe and of potential diagnostic value as
demonstrated by the adequate amount of contrast present in the major arteries. Although
adequate visualization of the major arteries was obtained with nonenhanced CT, in particular for
the brachiocephalic trunks with a pulmonary or bone window, visualization was greatly
improved with the angiography procedure in several window settings. Furthermore, CTA
allowed evaluation of smaller diameter arteries, assessment and measurement of the apparent
arterial lumens, and 3-D reconstruction and segmentation of the heart and central vasculature,
thereby enhancing its diagnostic value.
The interval to enhancement peak in the aorta was fast and just a few seconds from the
initiation of contrast medium administration. This interval is considerably longer in humans and
dogs, with means varying between 25 to 45 seconds.(Awai et al. 2004; Lee et al. 2007) It
depends on many factors such as the type of contrast medium and the duration and rate of
injection. (Awai et al. 2004; Lee et al. 2007) However, considering the fast circulation of
contrast medium in the avian vascular system, it would be difficult to confirm the influence of
any of these factors.
Arterial measurements were window-dependent in the present study; therefore, we
recommend using window-specific reference limits when evaluating the apparent luminal
diameter of the major arteries in Hispaniolan Amazon parrots. We recommend measuring the
arteries via a mediastinal or angiography window, which eliminates penumbra and blooming
(blurring) of the arteries and provides better delineation of the contrast medium. Overall, the
diameters of the brachiocephalic trunks and pulmonary arteries on one side were not
significantly different than those on the other side, and there was a positive correlation between
the arterial diameters of both sides. Use of ratios may prove beneficial in the extrapolation of
these results to psittacine
species of various sizes, particularly other Amazon parrot species. The measurement method
involving circular ROI measurements at the described arterial locations had medium to high
reliability as suggested by high intra-observer agreement and medium to high interobserver
agreement.
The accuracy of CTA is considerably affected by the attenuation coefficient of contrast
material within the vessel, the window settings used for measurement, and the arterial inner
diameter.(Liu et al. 2000; Claves et al. 1997; Suzuki et al. 2004) Several studies have involved
use of vascular models (phantoms) to determine the most accurate settings for measuring arterial
luminal diameters and subsequently quantifying degrees of arterial stenosis. For example, the
angiography window formula used in our study yielded the most accurate CTA measurements on
phantom arteries of various diameters.(Liu et al. 2000) In another phantom study,(Claves et al.
1997) results suggested that measurement inaccuracy increases with attenuation coefficients <
150 or > 250 HU. However, a different phantom study (Suzuki et al. 2004) involving automated
software revealed that measurement errors decrease as densities of intravascular contrast medium
increase, with the least measurement error obtained when a high-density vascular model of 460
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HU is used. In the study reported here, attenuation coefficients for the arteries after contrast
administration were high (overall mean ± SD, 333 ± 167 HU). The fast heart rate and circulation
of contrast medium in the vascular system of birds might limit the ability to obtain a
predetermined attenuation coefficient in the selected arteries. Moreover, greater contrast
enhancement may be needed to adequately visualize the small arteries of psittacine species. Our
study has some limitations. First, the major arteries at the base of the heart move with heart beat,
which may induce considerable motion artifacts during sequence acquisition, possibly decreasing
accuracy of the diameter measurements. Changes in arterial diameters and positions likely occur
during the cardiac cycle and could potentially lead to differences in measurements performed in
the present study. In addition, the small size of the study birds limited visualization of the smaller
arteries such as the carotid arteries cranially, the mesenteric artery, and other branches of the
brachial arteries and the abdominal aorta. Furthermore, all manual measurements involved some
degree of subjectivity. Automated software for CTA is available and may provide more
objectivity in arterial measurements. Its usefulness has been investigated in a phantom
study.(Suzuki et al. 2004) Finally, the reference limits created through our study have not been
evaluated in diseased birds; therefore, the potential of CTA in the diagnosis of vascular
conditions remains unknown. Several case reports of birds with central atherosclerosis have
described the presence of stenosis or narrowing of arterial lumens. A substantial luminal
narrowing (approx 50%) of the ascending aorta and pulmonary arteries was detected through
gross examination and histologic analysis in an African grey parrot.(Sedacca et al. 2009) A blue
and gold macaw that was suspected to have narrowing of the aorta and brachiocephalic arteries
on angiography was found at necropsy to have narrowed arterial lumens.(Phalen et al. 1996) A
blue-fronted Amazon parrot was also found to have a 60% to 95% reduction in lumen diameter
of the carotid arteries caused by atherosclerosis.(Johnson et al. 1992) Furthermore, several
examples of arterial luminal stenosis are cited in reviews on atherosclerosis in birds.(StLeger
2007; Bavelaar & Beynen 2004a) These reports support CTA as potentially useful in the
evaluation of birds with suspected vascular stenosis. Additionally, a phantom study (Suzuki et al.
2004) of the effect of vascular inner diameter on measurement accuracy showed similar
measurement errors existed among the 3-, 4-, and 6-mm-diameter vascular models through
use of a standard algorithm. The results of the present study suggested that CTA may be of
value in assessing the major arteries of psittacine species that are of sizes similar to the small
vascular models. However, given the small size of the species evaluated, it is possible that
arterial lumens cannot be measured accurately and that quantification of the amount of stenosis
may not be achievable. To further determine the accuracy of CTA measurements in birds, such
measurements will need to be confirmed at necropsy on healthy birds and birds with
cardiovascular diseases, including atherosclerosis. Arterial luminal stenosis is a consequence of
atherosclerosis in psittacine birds and is believed to be a contributing factor to clinical signs,
tissue ischemia, or acute death in affected birds. However, the degree and clinical importance of
arterial luminal stenosis has not been properly characterized. More studies are needed to
investigate the relationship between arterial stenosis, atherosclerosis, and clinical signs of disease
in birds. Studies are also needed to establish and improve the potential of CTA in the diagnosis
of atherosclerosis in parrots.
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CONCLUSION
The series of research investigations presented here on psittacine atherosclerosis identified
several significant findings that are important for future research in the area.
Psittacine atherosclerotic lesions are similar to human lesions and animals used as
experimental models and the classification system endorsed by the AHA could be applied to
psittacine lesions. The use of this classification scheme in observational and experimental studies
on psittacine atherosclerosis will allow further findings to be more comparable between
experiments but also between animal species. Psittacine atherosclerotic lesions have the same
basic characteristics than other species. Early lesions (type I-II) are clinically silent and
characterized by mild lipid deposition and foam cells accumulation with minimal disruption of
the arterial architecture and no stenosis. Intermediate lesions (type III) are the transition between
early and advanced lesions and could either progress to advanced lesion types or regress to other
lesion types. Advanced lesions (types IV-V) are more likely to lead to clinical signs from which
the pathophysiology seems to preferentially be through flow-limiting stenosis in parrots.
Therefore these lesions are also qualified as clinically significant lesions and are characterized by
a large lipido-necrotic core covered by a fibrous cap of variable thickness.
Clinical atherosclerotic diseases are present in birds and likely underdiagnosed due to the lack
of reliable antemortem diagnostic techniques. Therefore in order to estimate the prevalence of
atherosclerotic diseases which is of greater clinical usefulness to avian practitioners than
atherosclerotic lesions that can remain silent for decades, we used advanced atherosclerotic
lesions (types IV-VI) diagnosed on necropsy as a surrogate to clinical diseases. The prevalence
was high and increased dramatically with age. Females showed a greater prevalence than males
but a sex effect was not observed in experimental induction of the lesions in Quaker parrots. As
previously suspected by many authors, African grey parrots, Amazon parrots, and cockatiels
appeared more susceptible to the disease than macaws and cockatoos. These clinically significant
lesions could be induced relatively quickly in a minimum of 4 months in Quaker parrots fed a
1% cholesterol diet. The lesions appeared similar than spontaneous lesions in the same species
but early lesions were more lipidic and contained less foam cells when compared to our first
study. With the differences in time of lesion development between experimental and spontaneous
lesions in mind, Quaker parrots appear to be a useful model for further studying diagnostic
imaging, pathophysiology, lipid physiology, biochemical changes, and therapeutics of
experimental atherosclerosis.
The complicated lesions (type VI) are the main cause of death in humans through fibrous cap
rupture, thrombosis, and emboli. For this reason a modification of the AHA classification which
is more clinical has been proposed in humans.(Virmani et al. 2000) Interestingly the fibrous cap
is generally fairly thin in psittacine atheromatous lesions and rupture and thrombotic
complications seldom happen. Only 3% (2/63) of sampled arteries all from a single bird in our
first study showed lesion complications which, in this case, were characterized by plaque fissure
without thrombosis. In our second study, only 1.9% (10/525) of birds displayed atherothrombotic
lesions and lesion complications could not be experimentally induced in our third study despite 8
months of cholesterol feeding. This may be due to the relative small size of birds which may
show different hemodynamic characteristics and the different thrombogenic properties observed
between avian thrombocytes and mammalian platelets.(Schmaier et al. 2011) Consequently,
clinical signs are mainly due to type IV-V advanced lesions as reported in our studies and in
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multiple published case reports.(Beaufrere, Holder, et al. 2011; Johnson et al. 1992; Phalen et al.
1996; Sedacca et al. 2009; Bennett 1994; Mans & Brown 2007)
Antemortem diagnosis of atherosclerosis remains one of the challenges of avian cardiology
and avian vascular imaging is still in its infancy.(Beaufrère et al. 2010) Since it was confirmed
from our research that atherothrombosis is rare but arterial stenosis associated with advanced
atherosclerotic disease is common and readily lead to clinical signs, further research should focus
on either direct plaque imaging or arterial luminal assessment. Our last study established a
standard CTA protocol and reference intervals for arterial diameter but this imaging modality
would need to be assessed in atherosclerotic cases before clinical use could be recommended and
to evaluate its diagnostic accuracy and precision. Significant stenosis was induced in our
psittacine model of atherosclerosis and our CTA protocol combined with a higher resolution
scanner could thus be further explored experimentally.
The epidemiology of atherosclerosis is important to know in order to select population at risk
for diagnostic screening and estimate the likelihood that clinical signs compatible with
atherosclerotic lesions are indeed caused by such lesions. From our second study, we know for
instance that aged birds, female birds, and several genera have an increased susceptibility to the
disease. Avian patients thought to have a high chance of having advanced atherosclerosis may
also be more prone to anesthetic complications and may require a closer anesthetic monitoring
and preanesthetic diagnostic workup. Furthermore, reproductive diseases are significantly
associated with increased prevalence of atherosclerotic lesions and may be a target for
prevention. Therefore chronic reproductive diseases should be treated medically or surgically to
prevent potential long-term health effects on other organ system such as the cardiovascular
system. In our third study, significant dyslipidemia was correlated to the severity of experimental
atherosclerosis but the occurrence, the nature, and the magnitude of dyslipidemia would need to
be studied in spontaneous cases before recommendations can be made. Future objectives should
include a better characterization of psittacine lipoproteins and cholesterol metabolic pathways,
improvements in lipid clinical pathologic diagnostic methods, and investigations into the
correlation of dyslipidemia and spontaneous atherosclerotic lesions. To assess the potential
beneficial effects of lipid-lowering therapeutics, target values for cholesterol, LDL, and HDL
will first need to be determined. Further studies are currently being planned to investigate the
pharmacologic and lipid-lowering properties of rosuvastatin in parrots and may bring some
useful insight into the use of such drugs for the treatment and management of psittacine
atherosclerosis. However anti-atherosclerotic effects will need to be assessed using a psittacine
experimental model such as the one proposed here or in lengthy prospective clinical trials.
In conclusion, atherosclerosis is one of the leading diseases of aging psittaciformes and
further research will be needed in this area in order to increase the captive lifespan of these
species. Our work provides both tools for more consistent and standardized experimental and
diagnostic procedures, and important epidemiological information. We hope this will help foster
additional research which will benefit both the captive psittacine population and their human
caregivers.
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